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SUMMARY
Stem cell differentiation is regulated by the complex interplay of multiple pa-
rameters, including adhesive intercellular interactions, cytoskeletal and extracellular
matrix remodeling, and gradients of agonists and antagonists that individually and
collectively vary as a function of spatial locale and temporal stages of development.
Directed differentiation approaches have traditionally focused on the delivery of sol-
uble morphogens and/or the manipulation of culture substrates in two-dimensional,
monolayer cultures, with the objective of achieving large yields of homogeneously
differentiated cells. However, a more complete understanding of stem cell niche com-
plexity motivates tissue engineering approaches to inform the development of phys-
iologically relevant, biomimetic models of stem cell differentiation. The capacity of
pluripotent stem cells to simultaneously differentiate toward multiple tissue-specific
cell lineages has prompted the development of new strategies to guide complex mor-
phogenesis of functional tissue structures [164]. The overall objective of this project
was to understand embryonic stem cell (ESC) interactions within the three dimen-
sional microenvironment, in order to control spatial and temporal aspects of pluripo-
tent cell fate and morphogenesis and ultimately enable the derivation of complex,
functional microtissues amenable to the replacement or regeneration of damaged tis-
sue.
The sensitivity of stem cells to environmental perturbations has prompted the
study of the quantitative influences of three-dimensional embryonic stem cell, or
”embryoid body” (EB), culture conditions on differentiation. Hydrodynamic sus-
pension cultures, routinely employed for cell expansion and scalable bioprocessing
xxii
applications, impart complex fluid shear and transport profiles, and influence cell
fate as a result of changes in the mixing conditions [111]. We have previously de-
termined that hydrodynamic environments alter the endogenous ESC differentiation
efficiency toward various lineages [282] and that simple hydrodynamic perturbation
of spheroid formation alters the dynamics of cadherin assembly and reorganization,
which impacts ESC cardiogenic differentiation via the β-catenin signaling pathway
(Appendix A; [167]). The impact of hydrodynamics on stem cells, therefore, manifests
via alterations in several key cellular processes, including aggregation (kinetics, size),
metabolism (viability, transport, proliferation), and phenotype (differentiation, func-
tion), which are inter-related within the context of stem cell biology [166]. The aim,
therefore, was to control the EB microenvironment in order to systematically decou-
ple various parameters (EB size, formation, and differentiation) that are modulated in
the context of complex hydrodynamic environments. Using micro-well technologies,
EB size and formation kinetics can be reproducibly controlled and distinct popu-
lations of pre-formed EBs can be maintained in rotary orbital suspension cultures
as a means to regulate and standardize EB size in scalable hydrodynamic cultures
(Chapter 3; [165]). Controlling EB formation and resultant size is significant for
bioprocessing applications to standardize EB morphogenesis; however, modulation of
the fluid mixing environment also indicated that there are several subtle, yet signif-
icant changes induced by hydrodynamic parameters. The response of stem cells to
hydrodynamic perturbations highlights important tissue engineering principles that
should be considered for implementation in bioreactor design.
The more uniform and reproducible EB differentiation afforded through the com-
bination of microwell and rotary orbital technologies provides a controlled platform
amenable to better understanding three-dimensional stem cell morphogenesis. The
secondary objective of this project was to characterize the physical changes (mechan-
ical, transport) that accompany morphogenesis of the 3D EB microenvironment, in
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order to inform engineering approaches for computational modeling [349] and control-
ling stem cell fate. The stiffness and viscoelastic properties of EBs were modulated
during ESC differentiation, and in response to mesenchymal morphogenesis (Chap-
ter 4). Additionally, mesenchymal stem cell spheroids exhibited increased stiffness
in response to incorporation of microparticles composed of matrix-derived materials
[15]. The stiffness of EBs was mediated largely by the actin cytoskeleton, as well
as cell-cell and cell-matrix adhesions, all of which are dynamically modulated during
tissue morphogenesis. Understanding the physical changes accompanying epithelial-
to-mesenchymal transition of ESCs has broad implications which may be analogous
to similar remodeling events during embryonic development, tissue morphogenesis
and cancer metastasis. In parallel with mechanical changes, EB remodeling also
limits the transport of soluble factors, including nutrients, waste and morphogens
(Chapter 5). Together, the dynamic remodeling that occurs during 3D ESC differ-
entiation motivates the development of engineering approaches for controlling spa-
tiotemporal administration of physical and chemical cues. To more precisely control
the EB microenvironment, a bioreactor platform was engineered in conjunction with
a computational fluid dynamic (CFD) model, in order to inform the development
of approaches to impart a pressure gradient across immobilized spheroids and drive
convective transport throughout the interior of EBs (Chapter 6). The increased un-
derstanding of convection within EBs developed through this project is expected to
inform novel approaches to more precisely control of parameters affecting ESC differ-
entiation, such as temporal kinetics and spatial localization of morphogen delivery.
Understanding biochemical and physical tissue morphogenesis, including the re-
lationships between remodeling of cytoskeletal elements and intercellular adhesions,
associated developmentally relevant signaling pathways, and the physical properties
of the EB structure together elucidate fundamental cellular interactions governing em-
bryonic morphogenesis and cell specification. Ultimately, this project has established
xxiv
a foundation for controlling, characterizing, and systematically perturbing aspects of
stem cell microenvironments in order to guide the development of complex, functional




Embryonic stem cells (ESCs) possess the unique capacity to differentiate into clini-
cally relevant somatic cell types, making them a promising cell source for regenerative
therapies. Moreover, the capacity of ESCs to simultaneously differentiate toward mul-
tiple tissue-specific cell lineages has prompted the development of strategies aimed to
guide complex morphogenesis of functional tissue structures. Traditionally, directed
differentiation methods have relied on the addition of morphogens to monolayer cul-
tures of ESCs, which permits homogeneous delivery; however, this culture format is
not easily amenable to the scalable production of differentiated cell yields necessary
for therapeutic applications. In addition, culture of stem cells as three-dimensional
aggregates is thought to more accurately recapitulate cellular adhesions and signal-
ing exhibited by stem cells found in native tissues. Specifically, the differentiation of
ESCs as multicellular aggregates enables the three-dimensional assembly and remod-
eling of intercellular adhesions, including cadherins, which are important for directing
morphogenesis and spatial patterning. Therefore, opportunities remain to develop a
more complete understanding of the interplay between biophysical and biochemical
cues during such morphogenic processes, as well as the spatial and temporal dynamics
of three-dimensional morphogenesis, particularly in the context of self-organization
and tissue patterning in ESC spheroids. Moreover, approaches to achieve controlled
spatial patterning of morphogenesis within microtissues remain largely unexplored.
Engineering approaches aimed to characterize and control biophysical cues within the
local stem cell microenvironment may ultimately enable the development of novel,
functional microtissues for tissue regeneration and repair.
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The long-term goal motivating this project was to develop methods for controlling
spatial and temporal aspects the pluripotent microenvironment, to engineer three-
dimensional ESC-derived microtissues. The objective of this project was to charac-
terize the spatiotemporal dynamics of stem cell biophysical characteristics and mor-
phogenesis, in order to engineer ESC culture technologies with defined and tunable
biochemical temporal delivery within the three-dimensional spheroid microenviron-
ment. The hypothesis was that the biophysical and biochemical cues present within
the 3D microenvironment are altered in conjunction with morphogenesis as a function
of stem cell differentiation stage. This hypothesis was based on principles of cell speci-
fication during embryonic development, whereby the presentation and organization of
cell-cell adhesions, intra- and extracellular structural elements, and signaling factors,
are precisely controlled spatially and temporally, in order to guide complex tissue
patterning. The rationale for this work was that employing engineering principles to
alter the biochemical context within three-dimensional multicellular assemblies would
enable enhanced morphogen delivery to control the spatiotemporal dynamics of stem
cell differentiation. The central hypothesis of the proposal was examined through the
following specific aims:
Specific Aim 1. Control the uniformity of morphogenesis and differenti-
ation in mixed suspension cultures. The working hypothesis was that upstream
processing by formation of EBs in microwells would standardize EB size across culture
conditions, in order to enable a more systematic understanding microenvironmental
influences on ESCs. Hydrodynamic environments were imparted by maintaining EBs
in rotary orbital suspension cultures across a range of mixing conditions and the
effects were assessed via analysis of morphological changes within EBs, as well as
through gene and protein expression based on markers of pluripotent and differenti-
ated (endoderm, ectoderm, mesoderm) cell populations.
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Specific Aim 2. Define the biophysical characteristics and phenotypic
changes that arise simultaneously during 3D stem cell morphogenesis. The
working hypothesis was that stem cell spheroids undergo changes to the biophysi-
cal microenvironment during three-dimensional cell fate determination and morpho-
genesis. The dynamic physical changes accompanying differentiation of ESCs were
characterized in the context of an epithelial-to-mesenchymal (EMT) morphogenesis,
characteristic of 3D mesoderm specification induced by bone morphogenetic protein
4 (BMP4). In addition, the role of the cytoskeleton was studied in the context of
the mechanical properties of stem cell spheroids, and perturbation of the cytoskele-
ton enabled the analysis of the interrelated changes in biophysical and phenotypic
characteristics during differentiation.
Specific Aim 3. Investigate and control the transport characteristics of
stem cell spheroids. The working hypothesis was that EBs exhibit spatial limi-
tations within diffusive transport platforms and that imparting convective transport
within the culture would enable more efficient spatial and temporal delivery of sol-
uble factors for directing differentiation of ESCs. A micro-bioreactor platform was
developed is capable of immobilizing individual spheroids and imparting a pressure
gradient to drive convective transport throughout the interior of EBs. The diffusive
and convective environments were characterized by tracking of fluorescently labeled
dyes and growth factor signaling, in order to understand the transport limitations
that arise within EBs as a function of differentiation.
This project is innovative because it established a platform to systematically study
the EB microenvironment, to inform approaches for engineering biophysical and bio-
chemical cues in stem cell spheroids. The biological design principles established
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within the context of stem cell spheroids are amenable to understanding and con-
trolling morphogenesis and organoid development via physical and biochemical per-
turbations within the three-dimensional structure. The outcomes of this work yield
insights regarding the biophysical properties and limitations in 3D tissues, which cre-
ates new opportunities for the scalable culture of multicellular assemblies and large




2.1 Cardiovascular tissue engineering
Differentiation of embryonic stem cells (ESCs) toward cardiac phenotypes is an at-
tractive application within tissue engineering and regenerative medicine, due to the
high mortality and morbidity rates related to cardiovascular disease worldwide [200].
Following cardiac infarction, few endogenous mechanisms exist to regenerate the dam-
aged myocardium [6], which leads to the formation of a fibrous scar and impairment of
conduction velocity, blood pressure, and cardiac output. Therefore, therapies aimed
at delivering multi- and pluripotent stem cell populations have garnered attention in
tissue engineering, due to the potential of exogenous cells to integrate into host tissue.
Several types of multipotent stem cells, including skeletal myoblasts [320, 229], and
mesenchymal progenitor cells [309, 326], have been successfully transplanted post-
infarction, with many of the studies demonstrating enhancement in myocardial func-
tion. Additionally, clinical trials have recently demonstrated the feasibility, safety
1Modified from: Kinney MA and McDevitt TC. Pluripotent stem cells. The Biomedical Engi-
neering Handbook, 4th Edition (eds. J. Fisher, A. Mikos, Tissue Engineering Section), CRC Press.
2Modified from: Kinney MA, Sargent CY, McDevitt TC. (2011). The multi-parametric effects of
hydrodynamic environments on stem cell culture. Tissue Engineering Part B: Reviews. 17(4):249-62.
doi:10.1089/ten.TEB.2011.0040
3Modified from: Kinney MA, McDevitt TC. (2013). Emerging strategies for spatiotem-
poral control of stem cell fate and morphogenesis. Trends in Biotechnology. 31(2):78-84.
doi:10.1016/j.tibtech.2012.11.001
4Modified from: Kinney MA, Hookway TA, Wang Y, McDevitt TC. (2013). Engineering three-
dimensional stem cell morphogenesis for the development of tissue Models and scalable regenerative
therapeutics. Annals of Biomedical Engineering. doi:10.1007/s10439-013-0953-9
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and efficacy of transplanting bone marrow-derived progenitor cells for microvascular
repair in humans post-infarction [12, 94, 186]. Embryonic stem cells are a promising
source for transplantation in cardiovascular defects, due to relative ease of expansion
compared to multipotent progenitor cell types, as well as the promise of pluripo-
tent cells for deriving many cell types necessary to regenerate the entire myocardium.
ESC-derived cardiomyocytes retain the capacity to proliferate after injection, undergo
angiogenesis, and electrically couple with the endogenous myocardium [155, 180]. In
an infarct model, injection of ESC-derived cardiomyocytes resulted in increased injec-
tion fraction and wall thickness, more closely resembling the functional and geometric
properties of the non-infarcted conditions [179]. However, the applicability of ESCs
in regenerative medicine applications is currently limited by the inability to efficiently
direct the differentiation of large yields of cells toward a desired lineage.
2.2 Embryonic stem cells
ESCs possess the unique capacity to proliferate indefinitely in culture and differentiate
into all somatic cells, thereby serving as a promising cell source for tissue engineering
applications, including the treatment of degenerative diseases, traumatic injuries and
chronic wounds. ESCs, derived from the inner cell mass of blastocysts, were first
isolated from mouse embryos [96, 209, 88], followed by the establishment of ESC
lines from primate [324, 325] and eventually human [323, 273] sources. ESCs are
characterized by unlimited self-renewal and pluripotent differentiation potential into
all three germ layers mesoderm, endoderm, and ectoderm as well as into germ cells.
One of the unique traits of ESCs is the capacity to generate any cell type, including
cells which can not be easily isolated from primary sources, such as pancreatic β-cells
[299, 28, 55], neurons [310, 284, 236], and cardiomyocytes [356, 204, 34, 99]. ESCs,
therefore, are a promising cell source for tissue engineering, either for the direct
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replacement of cells in degenerative diseases such as Parkinsons or heart disease,
or through the use of paracrine actions of trophic factors secreted by stem cells to
direct regeneration of endogenous tissue [16]. Additionally, stem cells serve as a
flexible platform for drug screening, in which pharmaceutical companies can employ
large quantities of differentiated cells for in vitro testing of cytotoxicity and for the
creation of pathological tissue models [216]. Large-scale culture technologies are likely
necessary for the bioprocessing of stem cells to produce the large cell yields required
for such clinical and screening applications.
2.3 ESC differentiation
2.3.1 Approaches for directing differentiation
Differentiation approaches often rely upon understanding the changes during embryo-
genesis in order to define environmental parameters for the differentiation of ESCs.
Many protocols rely on soluble delivery of factors in monolayer and exploit pathways
known to be important in the context of early development. In the absence of anti-
differentiation factors such as leukemia inhibitory factor LIF, murine ESCs (mESCs)
spontaneously differentiate. Early specification of ESCs proceeds similarly to gas-
trulation, with the commitment of either neuroectoderm or a primitive streak-like
population. Neuroectoderm specification is often referred to as the default path-
way, because ESCs differentiate into neural precursors with high fidelity without
the supplementation of serum of other exogenous growth factors [364]. Cells have
been induced to enter the primitive streak lineage by bone morphogenetic protein-4
BMP4, which requires active signaling of the FGF and TGFβ/Nodal/Activin path-
ways [351, 245, 372]. Addition of primitive streak (PS)-inducing morphogens results in
inhibition of neuroectoderm differentiation, which is consistent with the active signal-
ing pathways during gastrulation [13, 173]. PS induction was initially accomplished
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by the addition of serum; however, the components of serum are highly variable be-
tween lots and the identification of factors that actively promote differentiation has
led to the creation of serum-free defined media. The levels of various factors are also
important, as exemplified by the differential induction of mesoderm or endoderm,
depending on the concentration of exogenous Activin A [173].
Delivery of exogenous small molecules and growth factors is most often accom-
plished via monolayer culture of ESCs in the absence of anti-differentiation factors.
Culture of ESCs in monolayer format affords uniform application of external stimuli,
including biochemical factors and mechanical forces, resulting in increased efficiency
of directed differentiation compared to other formats [376]. Monolayer culture of ESCs
also permits co-culture with stromal cells, as a method of directing differentiation via
paracrine signaling [234]. For example, ESCs have been induced to differentiate into
hematopoietic precursors by co-culture with OP9 bone marrow derived stromal cells
[234, 61, 290], thereby elucidating possible mechanisms of hematopoietic differenti-
ation in vivo. Co-culture methods do not require supplementation with exogenous
growth factors; however, the signaling from stromal cells is often complex and poorly
defined. Additionally, in monolayer, ESCs undergo uniform fluid flow, which has been
employed as a method to alter the autocrine and paracrine signaling of ESCs [33] and
may be amenable for improved homogeneity of directed differentiation.
2.3.2 ESC differentiation formats
Stem cells respond to a variety of environmental cues in vitro to either maintain po-
tency or regulate differentiation; these cues include biochemical factors (both exoge-
nous and endogenous), cell-cell interactions, cell-matrix interactions, and mechanical
stimuli. Monolayer culture of stem cells provides a defined substrate for cellular at-
tachment and uniform application of external stimuli (Fig. 2-1). However, from a
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Figure 2-1: Stem cell differentiation formats. Stem cells can be cultured in
monolayer or in suspension, either adherent to spherical microcarriers or as aggregates
of cells. Suspension cultures generally increase the density of cells, and thus increase
the overall cell yield per volume or media. Although suspension cultures are more
scalable, the three-dimensional aggregate structure increases the diffusive distance
between the media and cells at the center, which may result in decreased transport and
the development of gradients of nutrients and metabolites throughout the spheroid.
bioprocessing standpoint, monolayer culture is not readily amenable to the produc-
tion of increased cellular yields necessary for regenerative therapies (upwards of 109
cells, depending on the application) [333, 199, 149]. Alternatively, colonies can be
enzymatically dissociated to obtain a single cell suspension, whereby ESCs sponta-
neously aggregate to form spheroids of pluripotent cells, known as embryoid bodies
(EBs) [183, 80]. Culture of stem cells as three-dimensional aggregates is scalable, and
thought to more accurately recapitulate cellular adhesions and signaling exhibited by
stem cells found in native tissues [7, 56], including morphological changes similar to
gastrulation during embryogenesis [228].
2.3.3 Mesoderm differentiation
Due to the promise of ESCs for repair and regeneration in myocardial infarction, car-
diovascular specification of ESCs is a widely studied differentiation scheme. The initi-
ation and progression embryonic cardiovascular development, including the signaling
patterns necessary for cell specification, have been detailed in literature [308]. Expres-
sion patterns of agonists and inhibitors, which lead to primitive streak formation and
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cell specification during embryogenesis, highlight several key genetic pathways which
are likely responsible for the temporal and spatial regulation of various differentiation
events in ESCs. The PS is associated with expression of transforming growth factor
β (TGFβ) factors (Lefty 1, Nodal) and Wnt, whereas the anterior visceral endoderm
(AVE) secretes Nodal and Wnt repressors (DKK1, Sfrp1 and Sfrp5) [100, 160, 275].
Cells traverse the PS to form the mesoderm and definitive endoderm lineages in a
spatially and temporally controlled manner within the embryo [184].
When differentiated as EBs in the presence of serum, mESCs differentiate into
cardiomyocytes, resulting in ∼8% of EBs exhibiting spontaneous contractility [154].
Cardiomyogenic differentiation of ESCs also results in functional cells that exhibit
action potentials consistent with different regions of the heart and are capable of
reacting to pharmacological treatments [204]. Additionally, the culture format al-
ters the efficiency of spontaneous cardiomyocyte differentiation, with rotary orbital
cultures resulting in ∼50% of EBs with contractile activity [283]. However, due to
the heterogeneity of differentiation within EBs, the overall efficiency of differentia-
tion in rotary orbital suspension is still less than 15% of the total cell yield. Several
groups have successfully increased the efficiency of cardiomyocyte differentiation by
co-culture with endothelial cells [224] or using soluble treatments, such as retinoic acid
[355]. Two widely adopted protocols for cardiac differentiation of ESCs involve the
temporal treatment with a series of morphogens, including activin A, BMP4, bFGF,
DKK1, and VEGF, and result in approximately 30% efficiency of cardiomyocyte
differentiation [179, 362], with purities of > 80% after density gradient centrifuga-
tion [179]. However, most current approaches for directing ESC differentiation rely
on monolayer culture, which is not easily amenable to the production of clinically
relevant cell yields, warranting the development of scalable directed differentiation
approaches.
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2.4 Microtissue formation and differentiation
2.4.1 Embryoid body differentiation
Spontaneous aggregation of ESCs is mediated by E-cadherin, a Ca2+ dependent ho-
mophilic adhesion molecule, which is also expressed in the morula and blastocyst
stages of embryogenesis [183]. As aggregates of ESCs begin to differentiate, the first
specification leads to a layer of primitive endoderm cells at the exterior of the EB.
The formation of primitive endoderm is mediated largely by fibroblast growth factor
(FGF) signaling and the downstream PI 3-kinase pathway [59, 95]. The primitive en-
doderm then differentiates to form the visceral and parietal endoderm, which deposit
a basement membrane-like layer of ECM comprised largely of laminin and collagen IV
[342, 193]. It is thought that cell survival within the EB is dependent upon contact
with the basement membrane layer, and death of interior cells often results in the for-
mation of cystic cavities within EBs [70, 305, 227]. After specification of the exterior
endoderm cells, differentiation of the remaining cells within the EB proceeds to form
the three germ lineages. The genetic regulation during differentiation demonstrates
a temporal sequence of events similar to the processes of embryonic gastrulation and
specification [146, 91].
PSCs exhibit striking examples of morphogenesis upon three-dimensional assem-
bly and differentiation [286], thereby providing an intriguing model system amenable
to studying and perturbing physiochemical elements mediating cell fate. For exam-
ple, induction of Rx+ neuroepithelium in 3D PSC spheroids via supplementation with
exogenous morphogens (Nodal) and matrix proteins (Matrigel) resulted in spatially
distinct patterns of differentiation, with the resulting neo-tissues exhibiting pheno-
typic markers and architecture reminiscent of the native optic cup [92, 235]. Interest-
ingly, the dynamic structural changes, including evagination of epithelial vesicles and
subsequent invagination, yielded distinct layers of neural retinal and retinal pigment
epithelial (RPE) cells that were directed solely by cell-intrinsic morphogenic processes
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and self-organization of cells in 3D [92]. Similarly, simple biochemical induction of
differentiation directed the morphogenesis of 3D microtissues comprised of organized
enterocytes, goblet, Paneth and enteroendocrine cells, thereby establishing an in vitro
organoid model of intestinal structure and function [307]. Another model exhibiting
self-formation of complex cerebral structures [182] was developed to study the patho-
genesis of human microcephaly using iPS cells. Moreover, similar approaches have
yielded functional anterior pituitary [311], thyroid [11], and hepatic [318], structures
which exhibit secretory functions when transplanted in vivo. Together, these stud-
ies highlight the capacity for pluripotent stem cells to direct self-organization and
patterning to yield functional structures, with relatively minimal exogenous cues.
Therefore, the 3D aggregation of stem cells provides opportunities to study tissue
morphogenesis and develop in vivo therapeutics, thereby providing a valuable tool
for developmental biology, drug discovery and regenerative medicine.
2.4.2 Enabling technologies for controlled EB formation
Several techniques have been developed to facilitate stem cell spheroid formation and
differentiation (Fig. 2-2), including methods that physically separate individual ag-
gregates, which yield homogeneous populations, and batch methods that result in
larger yields of EBs but with increased heterogeneity. Hanging drop cultures are
initiated by suspending small volumes of culture media (10-20 µL) containing a de-
fined number of cells (200-1000 cells) from the lid of a Petri dish. Although hanging
drops yield uniformly-sized aggregates, the number of spheroids formed per dish is
limited by the need to physically separate individual drops (∼ 100 per 10 cm plate);
thus, hanging drops are not readily amenable to scale-up methods [204, 350, 366].
Larger EBs also cannot be easily formed because the media volume is usually lim-
ited to less than ∼ 50µL, due to the surface tension needed to keep the inverted
12
drops suspended from lid surface. It is also traditionally difficult to exchange me-
dia in the hanging drop format, necessitating transfer to suspension cultures after
approximately 2-3 days of formation in hanging drops; however, this has recently
been addressed through the development of a modified 384-well hanging drop plate,
which contains access holes for manipulation of the media in individual drops [332].
Alternatively, larger yields of EBs (i.e. 1000s) can be produced simply by inocula-
tion of a single cell population of ESCs (103 − 106 cells/ml) into suspension culture
in bacteriological grade dishes or dishes coated with non-adhesive materials such as
agar or hydrophilic polymers [88]. The EBs form via random aggregation of cells and
are largely dependent on inoculation concentrations and local interactions between
cells. After initial aggregation, individual spheroids often agglomerate to form larger
masses, resulting in large, irregularly shaped EBs that are widely variable in size and
shape. When comparing different EB formation and culture methods, it is apparent
that there is an inherent tradeoff between the ability to control EB formation and
the yield of cells produced [79, 176, 52]. Recently, new methods have been estab-
lished which provide increased control of EB size and homogeneity, yet are amenable
to higher throughput production. Such methods, including encapsulation of ESCs
within beads, physical separation using micro-wells and growth of ESC colonies on
micropatterned substrates, rely on physical separation of EBs to promote controlled
formation [242, 219, 327, 217, 335].
The altered phenotype of differentiated ESCs in response to aggregation kinetics
and spheroid size has been established through research on the enrichment of meso-
derm and cardiogenic phenotypes when aggregates are formed using hanging drop
culture [34, 366, 175, 283]. Recent studies have reported that changes in ESC differ-
entiation as a function of EB size may be attributed to changes in cell signaling and
polarity within the spheroid [23, 142, 220, 22]. Bauwens et al reported that mod-
ulation of EB size alters the proportion of endoderm on the exterior surface of the
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Figure 2-2: Methods of embryoid body formation and propagation. (A)
Aggregates of stem cells can be formed and maintained statically by physically sepa-
rating cells in small volume drops or by spontaneous aggregation of cells within bulk
suspension cultures in liquid or semi- solid media. (B) Dynamic cultures are amenable
to supporting increased culture volumes (1013 L) for the production of large cell yields
in various formats, such as rotating wall vessels, or stirred bioreactors, which employ
external or internal agitation, respectively.
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EB, which results in increased mesoderm differentiation within EBs due to paracrine
signaling [22]. Cell organization is also central to morphogenesis and differentiation
through the expression of lineage specific cell adhesion molecules, such as E-cadherin,
which mediates both initial spheroid formation as well as subsequent cellular or-
ganization and signaling. Binding and remodeling of adhesion receptors can alter
differentiation through the activation of downstream signaling pathways such as the
Wnt/β-catenin pathway [183, 80], thus highlighting the importance of the tempo-
ral aspect of cell aggregation and the implications for altering downstream signaling
kinetics.
2.5 Biophysical pluripotent microenvironments
2.5.1 Microtissue mechanics
Three-dimensional morphogenesis, often associated with tumorigenesis and embryonic
development, is a fundamentally biophysical process [359], as cellular migration and
proliferation occur in conjunction with dynamic rearrangements of adhesions and the
cytoskeleton. Mechanics have been directly implicated in mediating aspects of em-
bryonic gastrulation [157], elongation [373], and dorsal and neural tube closure [107].
Moreover, the actomyosin cytoskeleton exhibits distinct dynamics during mesoderm
migration accompanying gastrulation, whereby the stochastic assembly and disassem-
bly of cortical actin in punctuated contractions mediates cell shape changes [161].
The three-dimensional remodeling of intercellular adhesions and ECM during mor-
phogenesis modulates the intracellular cytoskeletal architecture (Fig. 2-3), which is
responsible for transmitting forces within and between cells [144]. The mechanical
structure of individual cells is often described by the tensegrity model [143], in which
interior elements are maintained in compression by exterior elements in tension. The
primary load-bearing structures within cells include cytoskeletal filaments, such as
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Figure 2-3: Physical parameters influenced by 3D assembly of stem cells.
Multicellular assembly of stem cells alters the cell-cell and cell-matrix associations, the
mechanical tension resulting from cytoskeletal rearrangements, and the distribution
of exogenous and endogenous biochemical factors.
microtubules, microfilaments, and the actomyosin network [102]. Cellular forces are
also opposed through extracellular factors [304], such as ECM, which impart dynamic
feedback to mediate reorganization of the cytoskeleton [213] and associated cell-cell
and cell-matrix adhesions [198], including integrins and cadherins.
Approaches to manipulate cell shape have been extensively explored in two-dimensional
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cultures, as the regulation of inter- and intra-cellular tension mediates stem cell re-
sponses, including proliferation [237] and differentiation [215]. Such engineering ap-
proaches aim to control stem cell mechanics by changing adhesive ligand coating
density [329] or through manipulation of substrate cross-linking [93], independent of
ECM concentration [112]. Downstream signaling within the Rho associated protein
kinase (ROCK) pathway is often implicated in mediating both cytoskeletal reorga-
nization [202] and stiffness-mediated phenotypic changes [215]. For example, the
epithelial-to-mesenchymal transition (EMT), a common phenotypic switch relevant
to embryogenesis and pathophysiological processes [322], was patterned within re-
gions of high cellular tension, and is abrogated by perturbation of the ROCK pathway
[118]. Similarly, MSC differentiation was also patterned by controlling the geometry
of multicellular sheets, with increased osteogenesis in regions of high tension [276]. In
addition, defective mechanotransduction has been linked to decreases in the expres-
sion of nuclear proteins, such as nuclear lamins [181], which have also been implicated
as markers of hESC differentiation [67]. Therefore, in addition to adhesive and cy-
toskeletal changes, nuclear shape may also play a key role in transducing extracellular
forces and cellular tension to ultimately mediate cell signaling and transcription via
changes in chromatin structure [78], thereby demonstrating multiparametric effects
of the extracellular environment on cellular tension and stem cell fate.
The role of mechanics in mediating three-dimensional stem cell differentiation,
however, remains less defined; given the dramatic changes in cellular organization
and adhesive profiles when stem cells are assembled as spheroids [73], the cytoskeletal
organization, and thereby biomechanics, are fundamentally distinct from properties
measured in monolayer cultures. While integrin adhesions and ECM impart the pri-
mary forces opposing cytoskeletal tension in 2D, the cells themselves take on load
bearing processes in 3D, with the network of cell-cell cadherin adhesions and acto-
myosin cytoskeletal associations regulating cellular tension. Moreover, the orientation
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and composition of extracellular and pericellular matrices vary spatially and tempo-
rally during differentiation in 3D aggregates [230], and may play an active mechanical
role in mediating changes in adhesive signature or clustering [255]. Therefore, due to
the established role of biomechanics in mediating stem cell phenotype, opportunities
remain to develop methods to monitor and perturb local tension in 3D aggregates as
a novel approach to direct spatial patterns of differentiation and morphogenesis.
The dynamic regulation of cell morphology and migration associated with embry-
onic specification suggests an active role of biomechanics in gastrulation and analogous
mesoderm differentiation. The stiffness of tissues has been linked to force generation
[339], with mesodermal tissues, which actively migrate through the primitive streak,
being 10 fold stiffer than endoderm in embryonic explants [373]. Computational
simulations based upon mechanical models indicated that the homeostatic state of
epithelial tissue structure is maintained by cellular tension, and accurately recapit-
ulated cellular rearrangements upon laser ablation of individual cells [97]. Similar
methods have elucidated the biomechanical basis underlying the regulation of wing
size in the imaginal disc of drosophila embryos [140, 3]; despite the presence of bio-
chemical signals, cell growth is inhibited by cell compression at the center of the disc,
which ultimately dictates the final wing size. Similarly, non-uniform proliferation has
been linked to geometrical regulation of mechanical tension in cells [301], with prolif-
eration occurring in regions of increased local tension [237]. Together, the mechanical
mechanisms underlying proliferation and differentiation enable the formation of dis-
tinct shapes and cellular patterning to direct divergent lineages and form complex
tissues.
In addition, mechanical changes accompanying local cellular patterning are sup-
ported by the established role of ROCK signaling in mediating morphogenic processes
in vivo. For example, RhoA signaling is induced by TGF-β in epithelial cells and
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is implicated in mediating stress fiber formation during EMT [31]. Moreover, Rho-
mediated contractility increases the stiffness of tumor cells, with the transformed phe-
notype being reversed through inhibition of ROCK signaling [256]. ROCK signaling
has also been implicated as a mechanism underlying the dissociation of adherens junc-
tions [280], thereby demonstrating the interplay between biochemical and biophysical
processes mediating active cellular morphogenic processes. In addition to the syner-
gistic effects mediating cell phenotype, mechanical and biochemical signals are trans-
mitted across different length scales in tissues [90]. For example, in spheroids, tension
is transmitted between cells through the structure via the actomyosin-cadherin net-
work. In contrast, tissues comprised of large quantities of ECM or cells encapsulated
in hydrogel materials tension is resisted via integrin adhesions to static extracellular
structures, which may limit the range or dampen the force associated with extra-
cellular mechanotransduction. Therefore, the dynamics of tissue remodeling during
morphogenesis also dictate the local response to mechanical cues.
While ESCs, in particular, recapitulate many aspects of embryonic development
on the biochemical level, opportunities remain to elucidate the biomechanical mor-
phogenic processes in 3D stem cell spheroids, in order to draw from analogous in vivo
events to direct cell fate by recapitulating physical extracellular and intracellular cues
mediating cell migration and patterning in embryonic microenvironments.
2.5.2 Morphogen transport
Cell fate specification and tissue morphogenesis are orchestrated by precisely con-
trolled spatial and temporal presentation of biochemical signals within the three-
dimensional assemblies of cells. While current methods for directing ESC differ-
entiation toward specific lineages have focused on the exposing cell monolayers to
combinations of soluble factors, such culture techniques are limited in the temporal
precision of morphogen delivery.
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In addition to vascular flow, transport also occurs in vivo by mechanical or pres-
sure driven convection through the extracellular space, known as interstitial transport.
Interstitial flow has been most widely studied in the context of lymphatics [315], but
occurs in many tissues, including flow through cartilage as a result of dynamic me-
chanical compression [223]. Interstitial flow is generally characterized by low velocity
magnitudes, because the complexity and density of ECM leads to high resistance to
transport. Measurements of interstitial flow in vivo have reported velocities ranging
from 0.1 to 4.0 µm/s [57, 77], which is 102-105 times lower than flow in capillaries
and the aorta, respectively. Several models exist for estimating hydraulic conductiv-
ity, diffusivity, and resultant solute gradients in tissues [316]; however, many of the
parameters required for such calculations require knowledge of specific tissue prop-
erties (i.e. tissue geometry and composition, cell density, biochemical uptake rate).
Currently, few studies have analyzed the composition of the EB microenvironment as
a function of differentiation stage, thereby warranting studies to further quantify the
physical parameters of EBs, in order to understand transport within 3D aggregates
of ESCs.
The complexity of the three-dimensional structure of EBs leads to transport lim-
itations (Fig. 2-4) stemming from size of aggregates and the formation of a non-
permissive shell consisting of ECM (collagen I, collagen IV), and epithelial cells at
the exterior of the EB [278, 51]. The inherent diffusional barriers of the spheroids arise
as a function of differentiation state, which indicates that the EB microenvironment
also changes over time [278, 51]. The transport properties of the EB microenvi-
ronment underscore the inability to efficiently deliver morphogens for directing ESC
differentiation, which likely contributes to the heterogeneity in resulting cell types.
However, the influence of morphological events on the transport of molecules with
different properties (size, charge, uptake rate) has not been quantitatively assessed.
The limited ability to deliver morphogens to scalable EB cultures therefore motivates
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Figure 2-4: Transport in stem cell spheroids. (A) Macro-scale transport in
various stem cell culture formats. Blue intensity represents relative concentrations
of soluble morphogens and nutrients (such as O2) within populations of single cells
and (B, C) different-sized aggregates of stem cells. Concentration gradients arise in
spheroid culture, with diffusive limitations in large aggregates.
the development of methods for eliminating gradients of nutrients within the interior
of spheroids, in order to more homogeneously direct the differentiation of stem cell
aggregates. The incorporation of microspheres within stem cell aggregates enables the
delivery of morphogens more homogeneously throughout the multi-cellular microenvi-
ronment [203, 98, 51, 40, 53, 306]. However, many directed differentiation approaches
rely on temporally controlled delivery of morphogens. Biomaterial-based micropar-
ticle delivery methods are limited in the control of release profiles, as well as the
capacity for multi-factor release with varying kinetics. Additionally, the complex EB
microenvironment, including the secretion of autocrine and paracrine factors, may
modulate the local response of ESCs to factors delivered via microparticles, which
could potentially inhibit the effects of the delivered morphogens. Ultimately, under-
standing and overcoming transport barriers in EBs may serve as a novel route to
reduce gradient formation and enable homogeneous delivery of morphogens within
the EB microenvironment.
The derivation and expansion of tissues in vitro is one of the central aims of
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many tissue engineering technologies. Extensive research in the area of biomaterials
has developed sophisticated scaffolds for the 3D culture of various cell types [201].
However, the size of tissue-engineered constructs is currently restricted by the limited
ability to form functional vascular networks to provide adequate transport [187].
EB size also impacts the transport of nutrients and metabolites; in purely diffusive
culture conditions, necrosis occurs in spheroids larger than approximately 300 µm in
diameter [295, 104], presumably due to O2 transport limitations, which indicates that
the maximum diffusive distance is on the order of approximately 100-150 µm. The
use of bioreactors for the culture of 3D tissues has been explored in order to increase
transport throughout scalable culture volumes. However, standard bioreactor designs
provide mass transfer throughout the bulk media, with media passing around, rather
than through tissues. Therefore, current bioreactor designs largely rely on diffusion
through tissues and do not provide adequate transport for large constructs in vitro
[337]. The transport limitations that arise during in vitro culture of thick tissues
have been addressed through the development of a bioreactor platform that employs
forced convection of nutrients and morphogens through tissues, and has been shown
to significantly enhance the the viability of cells within thick brain slices [74, 271].
Forced convection is expected to provide more uniform nutrient delivery, metabolite




SYSTEMATIC ANALYSIS OF EMBRYONIC STEM CELL
DIFFERENTIATION IN HYDRODYNAMIC
ENVIRONMENTS WITH CONTROLLED EMBRYOID
BODY SIZE1
3.1 Introduction
New technologies at the interface of stem cell biology and bioprocessing are needed for
the production of functional tissues for regeneration or replacement in novel therapeu-
tic applications. The unique capacity of embryonic stem cells (ESCs) to differentiate
into all somatic cells [96, 209, 323] makes them an attractive alternative to cell types
for which primary cells are not easily isolated or derived. Strategies for the pro-
duction of clinically relevant cell yields in vitro (> 109 cells) [199, 149, 333] often
employ differentiation protocols based on principals of existing bioprocessing tech-
nologies which aim to scale traditional culture formats by producing batch cultures
with increased volumes (> 100 mL)[168]. However, stem cells are sensitive to en-
vironmental perturbations, including manipulation of cell adhesions [106, 172, 193],
morphogen availability [84, 245], and mechanical forces [101, 9, 112, 93], all of which
may be modulated due to the hydrodynamic environments created in large volume
mixed/stirred culture systems. Fluid shear stress is a critical factor for establishing
correct patterning and function during embryonic differentiation in vivo [2, 244, 138],
1Modified from: MA Kinney, R Saeed, and TC McDevitt. Systematic analysis of embryonic stem
cell differentiation in hydrodynamic environments with controlled embryoid body size. Integr Biol.,
2012, DOI: 10.1039/C21B00165A
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and likewise impacts the differentiation of pluripotent and multipotent stem cells to-
ward endothelial and hematopoietic lineages in two-dimensional, adherent monolayer
cultures [211, 371, 345, 361, 5]. Although monolayer cultures permit control and ma-
nipulation of the substrate properties, as well as uniform application of fluid shear and
soluble factors, ESC differentiation is commonly initiated by the formation of three-
dimensional cell aggregates, termed embryoid bodies (EBs); the cell-cell adhesions
and signaling within three-dimensional spheroid structure recapitulate many aspects
of tissue morphogenesis, as well as several signaling pathways of embryogenesis. Ad-
ditionally, the differentiation of ESCs as multicellular aggregates in suspension is not
constrained by surface area (as in adherent cultures), and therefore is readily scalable
to larger volume bioreactors. However, complexity arising from the three-dimensional
structure of EBs confounds analysis of environmental perturbations in hydrodynamic
cultures [166].
Although previous studies have noted that mixed cultures do not inhibit the
pluripotent differentiation potential of ESCs [104, 47, 365, 117], several groups have
reported changes in the relative efficiency of endogenous differentiation to various
cell types, including cardiac and hematopoietic phenotypes, when EBs are cultured
within hydrodynamic environments compared to those maintained in static suspen-
sion culture [283, 282, 197]. Additionally, various parameters of the hydrodynamic
environment (such as mixing speed and bioreactor type) differentially impact ESC
commitment [110, 282]. Scalable ESC cultures, however, generally rely on the spon-
taneous formation of cell aggregates within stirred bioreactors, which also results in
changes in EB formation kinetics and size as a function of bioreactor geometry, con-
figuration and mixing frequency [52, 47, 365, 117]. In rotary orbital cultures, slower
rotation frequency (e.g. 25 rpm) resulted in accelerated EB formation and larger EBs,
compared to aggregates formed at faster rotary orbital speeds (e.g. 40-55 rpm) [282].
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Recent studies have reported that changes in EB size may influence ESC differenti-
ation, which has been attributed to changes in cell signaling and polarity within the
spheroid [220, 142, 23, 22]. Similarly, the kinetics of cell-cell association during EB
formation may alter downstream signaling related to cadherin assembly [334, 321].
Overall, these studies indicate that hydrodynamic effects on differentiation may be
confounded by changes in EB formation kinetics and size in different mixed biore-
actor cultures, thus warranting a more systematic study of ESC differentiation in
hydrodynamic environments.
Recently, new technologies have been developed which are capable of reproducibly
forming large yields of uniform-sized EBs by forcing aggregation of the cells in micro-
wells or on micro-patterned substrates [253, 23, 219, 142, 335]. Such technologies
enable the study of EB differentiation in different hydrodynamic environments, be-
cause forced aggregation techniques can standardize the kinetics of EB formation,
independent of hydrodynamics. Additionally, pre-forming EBs prior to introduction
into mixed environments permits the maintenance of uniform populations throughout
the culture period and across different conditions. The objective of this study was to
analyze the impact of hydrodynamic environments on differentiation of ESCs, inde-
pendent of EB size, by developing a method for maintaining uniform EB populations
in different mixed suspension cultures. EBs were formed via forced aggregation in
polydimethylsiloxane (PDMS) micro-wells, and maintained through the course of dif-
ferentiation in rotary orbital suspension cultures [52, 283, 282]. The impact of mixing
conditions on size-controlled EBs was analyzed by morphometric, morphological, and
phenotypic metrics. The results from this study demonstrate that maintaining uni-
form populations of pre-formed EBs in different hydrodynamic environments overall
increases the uniformity of morphogenesis and differentiation within hydrodynamic
cultures, with relatively subtle changes in the differentiation toward certain lineages.
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The differentiation format developed in this study enables a more systematic under-
standing of the modulation of ESC differentiation within hydrodynamic environments
and provides an alternative technique for the standardization of scalable ESC cultures.
3.2 Materials and Methods
3.2.1 Embryonic stem cell culture
Murine ESCs (D3 cell line) were expanded on tissue culture treated polystyrene dishes
(Corning Inc., Corning, NY) adsorbed with 0.1% gelatin (Mediatech, Manassas,
VA). Undifferentiated ESC media consisted of Dulbeccos Modified Eagles Medium
(DMEM; Mediatech) containing 15% fetal bovine serum (Hyclone, Logan, UT), 100
U/mL penicillin (Mediatech), 100 µg/mL streptomycin (Mediatech), 0.25 µg/mL
amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 1x MEM non-essential
amino acid solution (Mediatech), 0.1 mM 2-mercaptoethanol (Fisher Scientific, Fair-
lawn, NJ), and 103 U/mL leukemia inhibitory factor (LIF; ESGRO, Millipore, Bil-
lerica, MA). The media was exchanged every other day, and cells were passaged at
approximately 70% confluence.
3.2.2 Embryoid body formation
A single cell suspension of undifferentiated ESCs was obtained by dissociating mono-
layer cultures using 0.05% trypsin-EDTA (Mediatech). Forced aggregation of ESCs
was accomplished by centrifugation (200 rcf) of ESCs into 400 µm diameter poly-
dimethylsiloxane (PDMS) micro-wells (AggrewellTM, Stem Cell Technologies, Van-
couver, Canada) as previously reported [335]. The cell inoculation concentration was
modulated to seed wells with approximately 500, 1000 and 2000 cells each in dif-
ferentiation medium, consisting of undifferentiated ESC media without LIF. After
incubation for 24 hours to allow formation, the resultant EBs were transferred to sus-
pension culture (approximately 2000 EBs in 10 mL of media) in sterile 100 x 15 mm
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bacteriological grade polystyrene Petri dishes (BD, Franklin Lakes, NJ) and main-
tained on rotary orbital shakers [52] at rotational frequencies of approximately 25, 45,
and 65 rpm. For static cultures, EBs were transferred from the micro-wells to dishes
coated with sterile 2% agar, which is used to prevent cell attachment to the dish.
90% of the media was exchanged every other day by gravity-induced sedimentation
in a 15 mL conical tube. Suspension cultures were maintained through 14 days of
differentiation.
3.2.3 Morphometric analysis
Phase images were acquired at days 1, 2, 7, 10 and 14 of differentiation using a Nikon
TE 2000 inverted microscope (Nikon Inc., Melville, NY), equipped with a SpotFlex
camera (Diagnostic Instruments, Sterling Heights, MI). The cross sectional area of
EBs was measured by using a custom-written computational macro in ImageJ soft-
ware (NIH), which delineates EB boundaries through a combination of thresholding,
edge detection, and smoothing, as described previously [282]. At least 100 EBs were
analyzed for each sample (n=3 independent samples per experimental condition), and
the distribution of EBs was visualized by frequency histograms.
3.2.4 EB yield analysis
The total yield of EBs in each culture at days 1, 2, and 7 was manually counted by
dilution of the total population and visual inspection using a Nikon Eclipse TS100
inverted phase microscope, which resulted in approximately 20-50 EBs per well of a
24 well non-tissue culture treated polystyrene plate. 3 separate counts were recorded
for each sample (n=3 independent samples per experimental condition).
3.2.5 Histology and immunohistochemistry
EBs were sampled from rotary cultures at days 7, 10 and 14 of differentiation, rinsed
in PBS and fixed in 10% formalin (4% formaldehyde) for 45 minutes with rotation at
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room temperature. Fixed EBs were rinsed 3 times in PBS and embedded in Histogel
(Richard-Allen Scientific, Kalamazoo, MI) at 4 ◦C overnight. Samples were processed
via a series of graded ethanol and xylene rinses and embedded in paraffin. Paraffin-
embedded samples were sectioned with a thickness of 5 µm, using a rotary micro-
tome (Microtom HM310). For histological analysis, samples were de-paraffinized by
rinsing in a series of xylene and graded ethanol concentrations, followed by stain-
ing with hematoxylin and eosin (H&E). H&E stained sections were imaged using a
Nikon Eclipse 80i microscope (Nikon, Inc.) equipped with a SpotFlex digital camera
(Diagnostic Instruments).
3.2.6 PCR array and quantitative real time PCR
EBs were sampled at days 7, 10, and 14 of differentiation for PCR gene expression
analysis. For real time (RT)-PCR, total RNA was isolated from EBs using the RNeasy
Mini kit (Qiagen Inc, Valencia, CA), followed by synthesis of cDNA from 1 µg of
RNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). To prepare
cDNA for use in PCR Arrays, the RT2 First Strand Kit (SABiosciences, Frederick,
MD) was used with 1 µg of total RNA. RT-PCR was performed with SYBR Green
technology and the MyIQiCycler (Bio-Rad), using primers that were designed with
Beacon Designer software (Invitrogen) and validated against cell-specific controls.
Primers for both pluripotency (Oct-4 ) and differentiated cell phenotypes (Nkx2.5,
AFP, Pax-6 ) were analyzed by RT-PCR. The relative concentration of each gene
transcript was calculated based on a standard curve, and normalized with respect to
expression of the housekeeping gene 18s [262].
Global gene expression was analyzed using the Mouse Embryonic Stem Cell RT2
ProfilerTM PCR Array (SABiosciences) which includes 84 genes related to pluripo-
tency and markers of differentiation toward all lineages, as well as 5 housekeeping
genes and several PCR controls. RT-PCR was performed on the arrays using a MyIQ
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iCycler (Bio-Rad) with SYBR green based RT2 qPCR Master Mix (SABiosciences).
All sample data were visually inspected post-run, including both the amplification
phases and melt curves, to ensure efficacy of the individual primers. To account for
changes in PCR efficiency between PCR runs, data from individual runs were nor-
malized with respect to the geometric average of 3 housekeeping genes. The PCR
arrays included 5 housekeeping genes (Gusb, Hprt1, Hsp90ab1, Gapdh, Actb), and
3 were chosen based on the calculation of gene stability that yielded a combination
with the least variability (Gusb, Hsp90ab1, Actb) [338]. The normalized Ct values
were then used to calculate the relative fold changes in gene expression relative to
the group of interest (45 rpm / ESCs, 65 rpm / ESCs, 45 rpm / 65 rpm) [262].
The Genesis software package was used to visualize heatmaps of gene expression,
represented as the log2 transform of fold change, and to calculate two-dimensional
hierarchical clustering between genes and experimental groups, based on Euclidean
distance and average linkage clustering. Statistical differences were calculated using
an independent samples t-test for each gene, and genes with p<0.05 were determined
to be statistically significant.
3.2.7 Flow cytometry
EBs were rinsed with PBS and dissociated at 37 ◦C with rotation, using 0.25% trypsin-
EDTA and triturating every 10 minutes for a total of 30 minutes in order to obtain a
single cell suspension. Cell solutions were centrifuged at 1000 rcf for 5 minutes, and
rinsed 3 times in PBS. Flow cytometry was conducted using an Accuri C6 cytome-
ter (Accuri Cytometers, Ann Arbor, MI), with a minimum of 30,000events within
the FSC/SSC gate collected per sample (n=3 independent samples experimental per
condition). After obtaining a single cell suspension, a LIVE/DEAD kit (Invitrogen)
was used to assess cell viability. Briefly, cells were resuspended in 1 mL of PBS and
stained for 15 minutes using 2 µL of 50 µM calcein AM and 4 µL of 2 mM ethidium
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homodimer-1 (EthD-1). Unstained and single stained populations were used for gat-
ing and compensation. Forward scatter (FSC) and side scatter (SSC) were analyzed
within the live (calcein AM+, EthD-1-) cell populations.
D3 mESCs were transduced using plasmids encoding EGFP under the AFP (pAF-
PpHyg/EGFP; provided by Iwao Ikai, M.D., Ph.D., Kyoto University, Kyoto Japan)
or Oct-4 (phOCT3-EGFP1; provided by Wei Cui, Ph.D., Imperial College, London,
UK) promoters, and stable clones were established following geneticin (G-418) selec-
tion. AFP-GFP+ and Oct4-GFP+ cells were analyzed by flow cytometry prior to
differentiation, and after 7, 10, and 14 days of differentiation. The dissociated cell pop-
ulation was initially identified by gating on the FSC/SSC plot. Within the FSC/SSC
gate, polygonal gating was used on the FSC/FL-1 (480nm excitation; 530 ± 15 nm
emission) plots, to include 2% of the untransduced (D3 mESCs; negative control)
population using FlowJo software (Tree Star, Inc., Ashland, OR).
3.2.8 Analysis of spontaneous contractile activity
After 7 days of differentiation in rotary suspension, single EBs were transferred to
individual wells of 0.1% gelatin-coated 48 well tissue culture dishes in a total volume of
500 µL of differentiation media, to promote adherence and spreading of cells (30 EBs
per sample, n=3 independent samples per experimental condition). The development
of contractile activity, indicative of cardiomyogenic differentiation, was monitored at
days 10, 12, and 14 by visual inspection using a Nikon Eclipse TS100 inverted phase
microscope. Blinded counts of contractile activity were conducted by scoring EBs
with one or more beating foci were as contractile, and representing the contractile
EBs relative to the total plated EB population.
3.2.9 Statistical analysis
All experiments were performed with triplicate samples with independent conditions
and data is represented as the mean of independent replicates (n=3) ± standard error.
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Statistical analysis was performed using an independent samples t-test between the
conditions (45 and 65 rpm), assuming either equal or unequal variances, depending
on the results from Levenes equality of variances test. Statistical analysis comparing
changes over time was conducted using a one-way ANOVA, with a post-hoc Tukey
or Mann-Whitney U test for comparison of individual samples, depending on the
equality of variances.
3.3 Results
3.3.1 Control of EB formation and size by forced aggregation
In order to investigate the ability to control EB formation and size in scalable sus-
pension cultures, EBs were formed via centrifugation of cells into 400 µm diameter
PDMS micro-wells (AggrewellTM) prior to transfer into rotary orbital cultures [335].
Micro-well aggregation produced large, homogeneous yields of EBs of defined size af-
ter 24 hours of formation, which were subsequently transferred into bulk suspension
cultures (Fig. 3-1 A). Additionally, the EB size was modulated by altering the seed-
ing density of cells in each well (500, 1000, and 2000 cells per well), which produced
uniform populations that could be distinguished by morphometric image analysis of
EB cross sectional area. Histograms of EB area demonstrated narrow distributions,
indicating homogeneity of resulting EBs, as well as distinct peaks, which distinguish
the populations formed with different cell seeding densities (Fig. 3-1 B).
EBs formed with different seeding densities were maintained in rotary orbital
culture at 45 rpm, in order to analyze the changes in EB morphogenesis during differ-
entiation in mixed suspension. During the first 7 days of differentiation, 500-, 1000-,
and 2000-cell EBs increased in size; however, the relative size differences initially
exhibited by EBs from different seeding densities were maintained, indicated by sta-
tistical differences (p<0.05) in EB cross sectional area immediately after formation
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Figure 3-1: Micro-well formation and rotary maintenance of size-controlled
EBs. Micro-well formation and rotary maintenance of size-controlled EBs. (A)
Forced aggregation of ESCs into micro-wells to form size-controlled EBs was accom-
plished via centrifugation of single cells, followed by 24 hours of incubation in wells,
and subsequent transfer to rotary orbital suspension (scale bar = 100 µm). (B) After
24 hours, the resulting EB populations exhibited narrow size distributions with dis-
tinct peaks modulated by ESC seeding density, and (C) relative size differences were
maintained over 7 days of differentiation in rotary orbital suspension culture.
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(day 1) and after 7 days of differentiation (Fig. 3-1 C). These results indicate that the
size and formation kinetics of EBs can be reproducibly controlled using micro-well
technologies, and that distinct populations of pre-formed EBs can be maintained in
rotary orbital suspension cultures as a means to regulate and standardize EB size.
To further investigate the feasibility of maintaining pre-formed EBs in different
hydrodynamic conditions, EBs formed with 1000 cells per aggregate in micro-wells
were transferred to static or rotary orbital cultures at a range of speeds from 25 to
65 rpm. Visual analysis after 24 hours in suspension indicated that agglomeration
of individual pre-formed EBs occurred in static cultures and at the lowest (25 rpm)
rotary orbital speed (data not shown). In contrast, when maintained at 45 rpm and
65 rpm, EBs maintained uniform spherical populations, and did not exhibit evidence
of substantial agglomeration. After 7 days of differentiation, EBs at 45 and 65 rpm
remained homogeneous and appeared to be similar in size; however, agglomeration
of individual EBs led to spherical, but substantially larger EBs at 25rpm and large,
irregularly-sized EBs, in static cultures (Fig. 3-2 A). The visual observations regarding
EB agglomeration were verified by quantification of EB size and yield over 14 days of
differentiation (Fig. 3-2 B-C). In 45 and 65 rpm rotary orbital conditions, EB size sig-
nificantly increased (p<0.05) at all time points compared to day 1, (immediately after
micro-well formation), but did not exhibit size differences between the hydrodynamic
culture conditions at 45 and 65 rpm. Additionally, similar EB yield was maintained
in both 45 and 65 rpm rotary conditions; the yield at day 7 of differentiation was
not statistically different compared to day 1, and was not different between rotary
conditions. Taken together, these results indicate that the hydrodynamic conditions
imposed at 45 rpm and 65 rpm prevent agglomeration of pre-formed EBs and enable
the culture of uniform EBs in different mixed culture environments. The combination
of micro-well formation with hydrodynamic cultures at 45 and 65 rpm was therefore
chosen for the further analysis of ESC morphogenesis and differentiation of uniformly
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sized EBs maintained in different hydrodynamic environments.
3.3.2 Impact of hydrodynamic cultures on ESC morphogenesis
Analyses of cell and EB morphology as well as cell viability after 14 days of differenti-
ation suggested similarities between different populations of pre-formed EBs, despite
differences in hydrodynamic culture conditions. Morphological features of EBs, ex-
amined following H&E staining of histological sections, indicated the appearance of
differentiated cell populations, including cells exhibiting tightly packed epithelial-like
morphologies, as well as more spread-out mesenchymal-like morphologies in all EB
populations; however, no obvious differences were noted between EBs cultured in
different hydrodynamic conditions (Fig. 3-3 A). Additionally, single cell analysis via
flow cytometry indicated similar refractive properties of single cells, with respect to
both forward and side scatter metrics, which are indicative of cell size and complex-
ity respectively (Fig. 3-3 B). Moreover, there were no differences in the proportion
of live and dead cells stained with calcein AM and ethidium homodimer-1, respec-
tively, between EBs from different hydrodynamic conditions and the yield of cells
per EB remained similar between hydrodynamic conditions (Fig. 3-3 C). Altogether,
these results indicate that changes in the hydrodynamic environment did not globally
alter the ability of ESCs to undergo morphogenesis within EBs through 14 days of
differentiation.
3.3.3 Impact of hydrodynamic cultures on gene expression
Changes in gene expression over the course of differentiation were analyzed using an
embryonic stem cell PCR array (SABiosciences), which included 84 genes commonly
associated with the maintenance of pluripotency and differentiation to the three germ
lineages. Heatmap visualization of the gene expression profiles indicated that there
were distinct subsets of genes that exhibited increased (Fig. 3-4 A, red) or decreased
(Fig. 3-4 A, green) expression in EB cultures compared to the starting population of
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Figure 3-2: Maintenance of EB populations in different hydrodynamic en-
vironments. (A) EBs maintained in rotary orbital suspension exhibited changes in
size and shape after 7 days of differentiation. The irregular shape and large size of
EBs maintained in static and low rotary orbital speed (25 rpm) conditions indicated
agglomeration of individual EBs (scale bar = 400 µm). (B) At 45 and 65 rpm, how-
ever, EBs maintained uniform, similarly-sized populations through 14 days (scale bar
= 200 µm). (C) Although EB size increased during the course of differentiation, the
EB area at 45 and 65 rpm was not significantly different. (D) Additionally, the total
number of EBs did not change over time or between conditions, indicating minimal
agglomeration of individual pre-formed EBs. * = p<0.05 (45 rpm) compared to all
time points; + = p<0.05 (65 rpm) compared to all time points; $ = p<0.05 (65 rpm)
compared to all time points except day 14; # = p<0.05 (65 rpm) compared to all
time points except day 7; N.S. = no statistical significance.
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Figure 3-3: Morphological features of EBs and ESCs in hydrodynamic envi-
ronments. (A) ESCs within EBs exhibited epithelial- and mesenchymal-like (arrows)
morphologies; however, few distinct changes were apparent between rotary conditions
(scale bars = 100 µm, 50 µm). (B) Overlays of Forward scatter (FSC) and side scat-
ter (SSC) histograms from flow cytometry indicated similarities in cell properties
between conditions. (C) viability and total cell yield per EB were not affected by
hydrodynamics at the mixing speeds tested.
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undifferentiated ESCs. After 7 days of differentiation, 20 genes exhibited a minimum
of 3-fold increase compared to ESCs, whereas 15 genes were decreased greater than
3-fold compared to ESCs. Two-way hierarchical clustering of all genes and experi-
mental groups separated the individual time points, reflecting distinct changes in gene
expression that arose during the course of differentiation; however, within individual
time points, the gene expression profiles of the experimental groups did not cluster
separately, which suggested a lack of global distinction between the EB populations
subjected to different hydrodynamic conditions.
Specific analysis of the subsets of genes that were differentially expressed compared
to ESCs (minimum of 1.5 fold change, and p<0.05 compared to ESCs) indicated that
∼93% of the genes (25/27) that were decreased compared to ESCs after 7 days of dif-
ferentiation were common to both hydrodynamic conditions (Fig. 3-4 B). Of the genes
that were significantly decreased compared to ESCs, many were transcription factors
(Oct-4, Nanog, Sox2 ) and signaling molecules (Fgf4, Lefty1, Lefty2, Nodal) known
to be associated with the undifferentiated, pluripotent state of ESCs (Fig. 3-5 A).
Temporal gene expression analyzed using RT-PCR with independent primers verified
the decrease in Oct-4 over the time course of differentiation (Fig. 3-5 B) and stably
transduced cells expressing GFP driven by the Oct-4 promoter exhibited a decrease
in the proportion of GFP+ cells (Fig. 3-5 C). Additionally, ∼44% (12/27) of genes
that were increased (minimum of 1.5 fold change, and p<0.05 compared to ESCs)
during EB differentiation were commonly increased in both hydrodynamic conditions
(Fig. 3-4 B), including markers of differentiated phenotypes related to epiblast (fi-
broblast growth factor 5, Fgf5 ), endoderm (alpha fetoprotein, AFP; forkhead box A2,
Foxa2; Sox17 ), and mesoderm lineages (Gata4, Podxl1; VE-cadherin, Cdh5; Flt1 ),
as well as signaling molecules, such as Noggin (Nog) and factors such as Laminin
(Lamb1-1 ), which are related to the morphogenesis of ESCs in EB differentiation
[260, 305]. Overall, compared to ESCs, the global patterns of gene expression in EBs
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Figure 3-4: Gene expression profiles of size controlled EBs in hydrody-
namic environments. Global gene expression of 84 genes related to ESC pluripo-
tency and differentiation was assessed in EBs from 45 rpm and 65 rpm after 7 and 14
days of differentiation using PCR Arrays. (A) Heatmap visualization of gene expres-
sion demonstrated (B) distinct subsets of genes up- and down-regulated compared
to ESCs, with (C) several significantly modulated genes being regulated differently
between the 45 rpm and 65 rpm conditions. Although several genes exhibited dif-
ferences in fold change (>1.5 fold, blue; represented as the fold change of 45 rpm /
65 rpm), few genes exhibited statistically significant differences (p<0.05, pink) be-
tween the hydrodynamic conditions, (D) including 4 genes increased in 65 rpm, and
1 gene increased in 45 rpm after 7 days of differentiation. (E) Rotary conditions also
modulated the temporal expression of genes from the mesoderm (Nkx2.5 ), endoderm
(AFP), and ectoderm (Pax-6 ) lineages. * p<0.05
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Figure 3-5: Pluripotency in EBs. Transcription factors related to maintaining
pluripotency exhibited decreased expression compared to ESCs in (A) PCR array
analysis, (B) RT-PCR for Oct-4, and (C) incidence of GFP+ cells in a cell line
expressing GFP driven by the Oct-4 promoter.
from both hydrodynamic conditions suggested the progressive loss of pluripotency,
with an increase in markers related to differentiation of ESCs.
However, of the genes that were increased compared to ESCs, there were also sev-
eral genes (45 rpm: 6/27; 65 rpm: 9/27) that were uniquely increased in the specific
hydrodynamic conditions, including markers of endoderm (Gata6, Ins2, Iapp, Ser-
pina1a) and mesoderm (Kit, Grb7, Hba-x, Hba-y) lineages, which warranted a direct
comparison of the gene expression profiles in different hydrodynamic environments.
Comparisons of the expression patterns between the hydrodynamic conditions indi-
cated that the profiles were largely similar at both time points, as evidenced by a
direct, positive correlation between data from 45 rpm and 65 rpm (R2=0.95, day 7;
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R2=0.95, day 14). Fold changes in gene expression between hydrodynamic conditions
(represented as 45 rpm / 65 rpm) indicated that a number of genes were modulated
greater than 1.5 fold (14 genes at day 7; 19 genes at day 14) (Fig. 3-4 C; blue).
However, only 5 genes exhibited statistically significant changes in gene expression
between hydrodynamic conditions at day 7 of differentiation, and 1 gene (out of 84)
was significantly modulated after 14 days (Fig. 3-4 C; pink). Of the 5 genes signifi-
cantly changed after 7 days of differentiation, 4 were increased in 65 rpm (2 genes >1.5
fold change), whereas 1 gene was increased in 45 rpm (Fig. 3-4 D). Genes related to
pluripotency and germ cell differentiation, Nuclear receptor family 5, group A, mem-
ber 2 (Nr5a2 ) [134] and synaptonemal complex protein 3 (Sycp3 ) [328], respectively,
exhibited overall decreased expression compared to ESCs, and both were significantly
increased in 65 rpm compared to 45 rpm. Diaphanous homologue 2 (Diap2 ), which
encodes a downstream effector of the RhoA signaling pathway, and is implicated in
cytoskeletal remodeling and stabilization of adherens junctions, was also increased in
the 65 rpm rotary orbital condition [280]. Additionally, contrasting patterns of gene
expression related to muscle (Myod1 ; increased in 45 rpm) and neural differentiation
(Sema3a; increased in 65 rpm), supported the divergent differentiation, albeit modest
based on the sub-set of genes examined, of size-controlled EBs cultured in different
hydrodynamic conditions (Fig. 3-6).
Individual RT-PCR using independently designed primers also confirmed the tem-
poral modulation of genes from all germ layers. Nkx2.5, a mesoderm marker which
is increased during early cardiac differentiation, was significantly increased at day 7
in 45 rpm, and significantly increased in 65 rpm at day 14 (Fig. 3-4 E); the pattern
of Nkx2.5 expression indicates a possible temporal shift in the onset and progression
of mesoderm differentiation within the hydrodynamic conditions. Further, the gene
expression for alpha fetoprotein (AFP), indicative of endoderm differentiation, was
significantly increased after 7 days of differentiation in 45 rpm EBs, whereas Pax-6,
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Figure 3-6: Genes differentially regulated between hydrodynamic condi-
tions. Several genes exhibited statistically significant changes in gene expression be-
tween the rotary orbital conditions, after 7 (Diap2, Myod1, Nr5a2, Sema3a, Sycp3 )
and 14 (Brachyury-T ) days of differentiation. Differences were apparent in genes that
were both increased and decreased compared to ESCs (dotted line). *p<0.05
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an ectoderm marker, was increased in 65 rpm rotary conditions after 14 days (Fig. 3-
4 E). Overall, gene expression patterns suggested that size-controlled EBs undergo
similar changes related to loss of pluripotency and differentiation, with a subset of
genes exhibiting subtle changes in temporal kinetics and relative expression levels due
to culture in distinct hydrodynamic environments.
3.3.4 Impact of hydrodynamics on visceral endoderm and cardiomyogenic
differentiation
EB morphogenesis commonly occurs through the differentiation of the cells at the
exterior of the spheroid toward the visceral endoderm lineage [193]. Although altered
efficiency of ESC differentiation toward visceral endoderm in hydrodynamic environ-
ments has been reported [282], the exterior endoderm has also been suggested as a
mechanism for changes in differentiation as a result of EB size [22]. Therefore, flow
cytometry and immunostaining were used to analyze the proportion and localization
of visceral endoderm cells within EBs from the hydrodynamic conditions at 45 and
65 rpm. Flow cytometry was performed using cells transduced to express GFP un-
der control of the AFP promoter. Prior to EB formation and differentiation, ESCs
expressed low levels of GFP; however, after a week of EB differentiation, increased
proportions of cells expressed GFP (>30% GFP+ by day 7 of differentiation), indi-
cating differentiation of ESCs toward the visceral endoderm lineage. Cytometry data
from the different hydrodynamic conditions demonstrated both differences in the to-
tal number of cells within the gate (45.5 ± 1.6% at 45 rpm compared to 37.6 ± 0.9%
at 65 rpm after 7 days of differentiation), as well as differences in the intensity and
distribution of expression of GFP expression (geometric mean relative fluorescence
values of 956.5 ± 11.6 at 45 rpm compared to 897.0 9.5 at 65 rpm; coefficient of
variation of 58.7 ± 1.0 at 45 rpm and compared to 64.7 ± 0.6 at 65 rpm) (Fig. 3-7
A). Quantification of the proportion of GFP+ cells over time also demonstrated a
greater number of GFP+ cells after 7, 10 and 14 days of differentiation in the 45
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rpm rotary condition compared to 65 rpm (Fig. 3-7 C). Additionally, as the exte-
rior visceral endoderm cells have been reported to direct mesoderm differentiation
via paracrine signaling [225], the development of spontaneous contractile foci, indica-
tive of cardiomyocyte differentiation, was quantified (Fig. 3-7 D). Consistent with
the increase in visceral endoderm, there was a significant increase in the proportion
of EBs maintained at 45 rpm that exhibited contractile foci after 10, 12, and 14
days of differentiation (46.8% at 45 rpm compared to 2.4% at 65 rpm after 10 days
of differentiation). Overall, the relative efficiencies of differentiation toward visceral
endoderm and cardiomyogenic phenotypes were altered due to perturbations in the
hydrodynamic culture environment.
3.4 Discussion
The results of this study demonstrate the ability to systematically decouple various
parameters (EB size, formation, and differentiation) which can be modulated by com-
plex hydrodynamic environments, in order to examine the impact on ESC differentia-
tion. This study and others establish the ability to reproducibly control the initial size
of EBs by forced aggregation methods in scalable formats [243, 253, 23, 219, 142, 335].
The combination of micro-well formation of EBs with maintenance in rotary orbital
suspension permits the prolonged culture of uniform EBs within a range of hydro-
dynamic environments, enabling increased standardization of scalable differentiation
protocols. Recent studies discuss the modulation of ESC differentiation as a function
of EB size [220, 142, 23, 22], and are consistent with similar reports demonstrating
changes in stem and progenitor cell differentiation as a result of cytoskeletal organiza-
tion and localization of cells within 3D aggregates [276, 331]. Bauwens et al reported
that modulation of EB size alters the proportion of endoderm on the exterior sur-
face of the EB, which results in increased mesoderm differentiation within EBs due
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Figure 3-7: Modulation of visceral endoderm and cardiac mesoderm dif-
ferentiation in response to rotary orbital culture. (A) AFP-GFP transduced
ESCs exhibited few GFP+ cells when maintained as an undifferentiated monolayer;
however after 14 days of differentiation, EBs from rotary orbital cultures increased
expression of GFP (AFP), with (B) EBs cultured at 45 rpm consistently exhibiting
increased expression of GFP+ cells after 7, 10 and 14 days of differentiation. (C)
Within EBs, the GFP+ cells appeared to cluster in distinct areas, which co-localized
with dark regions visualized under phase (overlay) (scale bars = 50 µm, 200 µm). (D)
The proportion of EBs exhibiting spontaneous contractile activity was increased fol-
lowing culture 45 rpm compared to 65 rpm after 10, 12, and 14 days of differentiation.
* p<0.05.
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to paracrine signaling [22]. The system developed and discussed in this study per-
mits the formation of EBs with a desired initial size, and maintenance of relative
EB size over time, which may be an important factor capable of aiding or hindering
differentiation toward distinct cell lineages.
Computational fluid dynamic modeling to determine the shear profiles within
rotary orbital cultures previously demonstrated that between cultures at 40 rpm and
55 rpm, there is an increase of approximately 1dyn/cm2 within the central region of
the plate traversed by EBs during the rotation, indicating changes in the fluid shear
environment due to modulation of rotary orbital speed [282]. The data presented here
demonstrate that pre-formed EBs can be maintained at higher rotational frequencies,
up to 65 rpm, which were previously reported to not support spheroid formation
from single cells [282]. Consistent with previous reports, decreased rotary speeds
result in larger EBs, due to the agglomeration of individual pre-formed EBs [282,
52], indicating that a hydrodynamic threshold (apparently near 45 rpm) may be
necessary to maintain homogeneous populations of individual EBs. Similarly, studies
have demonstrated decreased size of multicellular aggregates at higher mixing speeds
[282, 52, 68, 291], presumably due to modulation of cell collision frequencies, as well
as by perturbation of the kinetics of E-cadherin binding [166]. Although it remains
possible that hydrodynamics may modulate the growth kinetics of ESCs within EBs,
the lack of observed differences in EB size and the average number of cells per EBs
over 14 days of differentiation suggest that homogeneous populations of EBs can be
maintained within different hydrodynamic conditions.
In the context of the present and past experiments, it is difficult to separate
the effects of fluid shear and transport on EBs within hydrodynamic environments.
In monolayer culture of ESCs, fluid shear has been reported to impact hematopoi-
etic and endothelial differentiation [211, 371, 345, 361, 5]. However, the response to
fluid shear in 3D cultures is more complex and much less defined. The work herein
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demonstrates that the modulation of hydrodynamic environments in size-controlled,
three-dimensional cultures do not appear to dramatically impact overall morphogen-
esis or the gene expression profile of differentiating ESCs within EBs. It is important
to note that, within the context of this study, a relatively small set of genes and
phenotypes were analyzed, and it remains possible that there may be differences in
other phenotypes that were not directly examined. Additionally, although dramatic
changes in global expression patterns were not apparent, the subtle changes in gene
expression exhibited due to hydrodynamic conditions may significantly impact cell
specification. Interestingly, there was a change in the relative quantities of visceral
endoderm cells, with 45 rpm conditions exhibiting an overall increase in visceral endo-
derm differentiation compared to 65 rpm. As fluid shear is expected to more directly
impact the exterior of EBs, it is likely that visceral endoderm differentiation may be
responsive to fluid shear mechanotransduction at the EB surface. Additionally, EBs
cultured at 65 rpm exhibit significantly increased expression of diaphanous homolog
2 (Diap2), which is involved in microtubule organization and cell-cell contacts, thus
indicating changes in cytoskeletal organization, which is a characteristic response to
fluid shear in other cell types [108, 188].
This work also highlights shifts in the temporal kinetics of differentiation in hy-
drodynamic environments. The mixing conditions in bioreactors may have implica-
tions for paracrine signaling and for the delivery of exogenous soluble factors, due to
changes in transport and receptor-ligand binding kinetics in hydrodynamic environ-
ments. Mixing may potentially impact the transport of nutrients, metabolites, and
exogenous factors within the EB microenvironment. It is possible, therefore, that
the influence of hydrodynamic cultures may be altered by using chemically defined
media formulations, or by the addition of soluble factors to promote the endogenous
differentiation of ESCs. Additionally, gradients of oxygen may arise as EBs reach a
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critical size limit (∼300 µm in diameter) [295]. Hypoxic conditions have been asso-
ciated with modulation in β-catenin signaling and cardiomyogenesis [303], as well as
with expansion of pluripotent cell populations [214]. Although there may be changes
in fluid transport due to modulation of the mixing speeds, the normalization of multi-
cellular aggregate size may attenuate some of the effects of transport seen in previous
experiments where EBs were significantly larger at low mixing speeds [52, 282]. In the
studies presented, EBs were approximately 300 µm in diameter by day 14 of culture,
which indicates that few transport limitations likely arose within the system under
the experimental conditions used. The decrease in both EB size and cell yield between
days 7 and 14 of differentiation may be in part regulated by such transport limitations,
indicating that cellular remodeling may dynamically alter transport within EBs. It
is, however, difficult to quantitatively assess changes in transport gradients and avail-
ability of soluble factors in the EB microenvironment using traditional bioprocessing
technologies. As many protocols rely on tightly controlled signaling of factors at dif-
ferent stages in differentiation, shifts in the temporal kinetics of differentiation may
alter the efficacy of some directed differentiation approaches. Ultimately, the control
of EB size prior to introduction into large scale hydrodynamic cultures may enable
increased standardization, which is necessary for the efficacy and reproducibility of
directed differentiation protocols in the context of scalable bioprocessing.
3.5 Conclusions
We have developed a novel culture platform which enables the study of ESC differ-
entiation as 3D multicellular aggregates in hydrodynamic environments, independent
of the effects of mixed cultures on EB formation kinetics and size. The results of this
study indicate that, despite subtle changes in temporal differentiation toward certain
lineages, EBs maintained under different hydrodynamic conditions exhibit similarities
in morphogenesis and the overall differentiation profiles of ESCs. These data suggest
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that controlling EB formation upstream of hydrodynamic cultures may be amenable




MESENCHYMAL MORPHOGENESIS OF EMBRYONIC
STEM CELLS DYNAMICALLY MODULATES THE
BIOPHYSICAL MICROTISSUE NICHE1
4.1 Introduction
The biochemical composition and physical structure of tissue microenvironments are
critical regulators responsible for maintaining and directing stem cell fate and function
[288, 222]. in vivo, native stem cell niches maintain the self-renewing state through
short range soluble signaling[113] and extracellular signals [58], such as direct anchor-
age via intercellular or matrix adhesions. Conversely, dysregulation of niche elements
leads to differentiation and migration of resident stem cell populations [192]. There-
fore, the synergy of biophysical and biochemical signals and the complexity of the
local microenvironment have been increasingly recognized as critical mediators of the
delicate balance between self-renewal and differentiation. However, while engineer-
ing approaches often aim to dissect the relative influence of individual stimuli, the
signals regulating stem cell differentiation are interrelated, motivating the multipara-
metric analysis of stem cell structure and phenotype accompanying dynamic cell fate
decisions.
The pre-implantation embryo is one of the most dynamic tissue microenviron-
ments, whereby the patterning of structurally and functionally distinct tissue struc-
tures, such as liver, skin, and heart arise from adjacent, yet spatially defined, regions
during development [319]. In particular, embryonic gastrulation mediates the first
1Modified from: MA Kinney, R Saeed, and TC McDevitt. Mesenchymal morphogenesis of em-
bryonic stem cells dynamically modulates the biophysical microtissue niche. In press.
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somatic cell fate decisions, and results in spatially distinct localization of the three
germ lineages endoderm, ectoderm, and mesoderm. During gastrulation, the cells of
the epiblast that will comprise the mesoderm lineage undergo a rapid and concerted
morphogenesis [43, 64] through which the tightly adherent, epithelial cells become
less adhesive mesenchymal cells, in a process known as the epithelial-to-mesenchymal
transition (EMT) [322]. The dynamics and patterning of EMT is tightly regulated by
the biophysical and biochemical tissue microenvironment, through signals that main-
tain or abrogate the apical-basal polarity of epithelial cells. While biochemical signals
are often implicated in the induction of EMT, the changes in cell shape that occur
during gastrulation are a fundamentally biomechanical process, through which forces
arising as a result of adhesion remodeling are transmitted via changes in cytoskeletal
tension [157].
While the phenotypic and mechanical changes arising during embryonic develop-
ment have been characterized through orthogonal approaches and in various species,
several questions remain regarding the role of cellular biomechanics in determin-
ing cell fate, particularly during mammalian embryogenesis. The differentiation of
pluripotent embryonic stem cells (ESCs), the in vitro analog to the inner cell mass
of pre-implantation embryos, parallels many of the cell fate transitions in vivo, which
highlights the utility of ESCs as a model for systematically studying mammalian em-
bryonic development. ESC differentiation has also traditionally been studied through
orthogonal approaches aimed to recapitulate the biochemical and biophysical milieu of
the gastrulating embryo, including the perturbation of developmentally relevant sig-
naling pathways [228] and the manipulation of the composition and mechanical prop-
erties of adherent substrates [87, 93]. However, when assembled as three-dimensional
aggregates, ESCs undergo morphogenic processes, including EMT [302], which es-
tablishes a dynamic, cell intrinsic, developmentally relevant system through which to
study biomechanics in parallel with changes in cell fate and morphogenesis.
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The objective of this study, therefore, was to define the intrinsic cell biophysical
characteristics and phenotypic changes that arise simultaneously during the morpho-
genesis of three-dimensional pluripotent stem cell microenvironments and cell fate
specification. An interdisciplinary approach was employed to assess the dynamics of
morphogenesis and differentiation via gene expression and histological analyses, as
well as biomechanical characterization of 3D microtissue properties, paired with mul-
tivariate data modeling to distinguish correlations between the structure and pheno-
type of EBs. Overall, this study demonstrates that microtissue morphogenesis arises
via EMT during mesoderm differentiation and that the dynamic temporal changes in
phenotype are highly predicted by biomechanical characteristics. Ultimately, under-
standing the biophysical changes accompanying epithelial-to-mesenchymal transition
of ESCs has broad implications that may inform mammalian embryonic development,
as well as physical processes underlying tissue homoeostasis, pathological remodeling
and cancer metastasis.
4.2 Materials and Methods
4.2.1 Embryonic stem cell expansion
Pluripotent murine ESCs (D3 cell line) were expanded on 0.1% gelatin coated polystyrene
tissue culture treated dishes in Dulbeccos Modified Eagles Medium (DMEM) con-
taining 15% fetal bovine serum (FBS) and supplemented with penicillin (100 U/mL),
streptomycin (100 mg), amphotericin (0.25 mg/mL), L-glutamine (2 mM), MEM
non-essential amino acid solution (1x), 2-mercaptoethanol (0.1 mM), and leukemia
inhibitory factor (LIF; 103 U/mL). Media was exchanged every other day and ESCs
were passaged prior to 70% confluence.
51
4.2.2 Embryoid body formation and culture
A single cell suspension of ESCs was obtained by treatment of monolayer cultures
with 0.05% trypsin/0.53 mM EDTA solution. EBs were formed by centrifugation
(200 rcf) of ESCs into 400 µm diameter polydimethylsiloxane (PDMS) microwells
(AggrewellTM; Stem Cell Technologies), with approximately 1000 cells per well. Af-
ter 20 hours of microwell formation in serum containing ESC media without LIF, EBs
were transferred to suspension culture (∼2000 EBs per dish) and maintained on a
rotary orbital shaker platform at 65 rpm, as described previously (Chapter 3). EBs
were differentiated in basal serum-free media (N2B27) composed of DMEM/F12 sup-
plemented with N2 (5 µg/ml insulin, 100 µg/ml transferrin, 6 ng/ml progesterone,
16 µg/ml putrescine, 30 nM sodium selenite) and 50 µg/mL bovine serum albu-
min (BSA), combined 1:1 with NeurobasalTM media supplemented with B27 [364].
Antibiotics and L-glutamine were supplemented at the same concentrations as the
undifferentiated ESC media. 90% of EB media, including growth factor supplements,
was exchanged every other day by gravity-induced sedimentation of EBs. Mesoderm
induction was accomplished, as detailed in the results, by supplementation with 10
ng/mL BMP-4 (R&D Technologies) [266]. Perturbation of the cytoskeleton was ac-
complished by 1-hour treatment with inhibitor of the Rho-associated protein kinase
(ROCK) pathway (Y27632; 10 µM) [145] or by supplementation of the media be-
tween days 4-7 of differentiation with Y27632, Jasplakinolide (Jas, 50 nM) [358], or
Latrunculin B (LatB, 100 nM) [340]. DMSO (≤0.1%) was also included as a vehicle
control.
4.2.3 Parallel plate mechanical compression
The bulk mechanical properties of microtissues were measured using a micron-scale
mechanical testing system (Microsquisher; CellScale), which calculates force via mea-
surement of beam deflection in response to user-defined displacements (Fig. 4-4 A).
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All samples were tested in a PBS fluid bath (pH 7.4, containing 0.90 mM Ca2+ and
0.49 mM Mg2+). The cantilever beams were composed of Tungsten (modulus = 411
GPa), and beams of diameters from 76.2 µm to 152.4 µm were employed, depending
on the stiffness and sensitivity required for each aggregate.
To determine the bulk physical characteristics of EBs, a viscoelastic creep method
was employed, which exerts a constant force while measuring the changes in displace-
ment over time (Fig. 4-4 B). The magnitude of force was chosen as the average
force corresponding to approximately 40% strain, determined based upon constant
strain rate analysis of stress versus strain in n=3 samples. The time to relaxation was
determined to be less than two minutes, which was established based upon empirical
testing. The creep parameter was calculated as the percent increase in displacement
during constant force interval (Fig. 4-4 C). Relevant physical characteristics, in-
cluding moduli (instantaneous modulus, Eo; relaxed modulus E∞), time constants
(creep time constant, τσ; stress relaxation time constant, τε), and apparent viscosity
(µ) were calculated based upon a linear viscoelastic model of creep displacement (u)
behavior over time, described in equations 1 - 3, where Ro is the initial EB diameter,
the stress (σ) is calculated as the constant force normalized to relaxed cross sectional




















µ = τ (Eo − E∞) (3)
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4.2.4 Quantitative real time PCR
RNA was extracted from EBs using the RNeasy Mini kit (Qiagen Inc, Valencia, CA)
and cDNA was synthesized using the RT2 First Strand Kit (SABiosciences, Frederick,
MD) with 900 ng of total RNA. To assess gene expression, a custom RT2 ProfilerTM
PCR Array (SABiosciences) was used in conjunction with a MyIQ iCycler (Bio-rad)
and SYBR green master mix (information). The array consists of 26 genes relevant
to pluripotency and differentiation toward all three germ lineages, as well as 3 house-
keeping genes (Actb, GAPDH, Hsp90ab1 ) and PCR efficiency controls. Alternatively,
quantitative real time PCR was performed using primers for the hyaluronan synthase
isoforms (HAS-1, HAS-2, and HAS-3 ), which were designed using Beacon Designer
software [302]. PCR data were normalized to geometric average of the three house-
keeping genes and fold changes in expression were calculated from normalized Ct
values, relative to expression in ESCs [262]. The Genesis software package was used
to generate heatmap visualizations of the gene expression data.
4.2.5 Histology and immunohistochemistry
EBs sampled from rotary orbital culture were rinsed in PBS and fixed with 10%
formalin (4% paraformaldehyde) for 45 minutes with rotation at room temperature.
Fixed EBs were embedded within Histogel (Richard Allen Scientific), and processed
through a series of ethanol and xylene rinses prior to paraffin embedding. Paraffin
embedded EBs were sectioned with a thickness of 5 µm using a rotary microtome
(Microtom HM310) and mounted on slides. Sections were deparaffinized prior to
staining via ethanol and xylene rinses and subsequently stained with hematoxylin
and eosin, alcian blue (pH 2.5; nuclear fast red counterstain) or safranin-O (fast
green counterstain).
Alternatively, for immunohistochemistry, slides were blocked in 1.5% normal goat
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serum (NGS) for 1 hour at room temperature, incubated in mouse monoclonal anti-
human smooth muscle actin (α-SMA) primary antibody (Dako; clone 1A4) for 1 hour,
and subsequently incubated in biotinylated donkey anti-mouse IgG (1:400, Vector
Labs). Slides were then incubated with avidin and biotin-based horseradish perox-
idase, based on manufacturer instructions (Elite Vectastain Kit, Vector Labs) and
developed using a 3, 3-diaminobenzidine (DAB) substrate (Vector Labs). Nuclei
were counterstained with hematoxylin. After staining, slides, were cover slipped and
imaged using a Nikon 80i upright microscope. Sections of mouse intestine, cartilage,
and heart, were included as positive control for alcian blue, safranin-O, and α-SMA,
respectively.
4.2.6 Whole mount immunostaining
For whole mount immunostaining, formalin fixed EBs were blocked and permeabilized
in 2% BSA/0.1% Tween-20, containing 1-1.5% Triton X-100 for 30 minutes at 4◦C
with rotation, re-fixed in formalin for 15 minutes and blocked for an additional 3 hours.
EBs were then stained with Alexa Fluor 546 phalloidin (1:40, Molecular Probes),
counterstained with Hoechst (10 µg/mL) and imaged using a Zeiss LSM 710 Confocal
microscope.
4.2.7 Scanning electron microscopy
For ultrastructural analysis, EBs were fixed in 2.5% glutaraldehyde in cacodylate
buffer (pH 7.2) for 1-2 hours, followed by rinses in buffer. The samples were subse-
quently incubated in 1% osmium tetroxide for 1 hour, followed by rinses in water and
dehydrated through a series of graded acetone rinses (60 min each) from 25-100%.
Prior to imaging, EBs were dried using a Polaron E3000 critical point dryer, adhered
to an aluminum stub using double sided carbon adhesive tape and gold coated using a
Polaron range sputter coater (120 s at 2.2 kV). Scanning electron microscopy (SEM)
was conduced using a Hitachi S-800 microscope.
55
4.2.8 Multivariate partial least squares regression (PLSR) modeling
A data matrix (MxN) was constructed with M culture conditions (Jas, LatB, etc), and
N experimental parameters (Oct-4, Nanog, modulus, etc), where each column of the
independent X (input) matrix represents a unique gene expression signal and the de-
pendent variables in the Y (output) matrix represent mechanical properties. All data
were mean-centered and scaled to unit variance and SIMCA-P (Umetrics) was em-
ployed to construct the PLSR model using a nonlinear iterative partial least squares
(NIPALS) algorithm [116]. Predictions were determined based on cross-validation,
with standard error of predicted values determined via jack-knifing, and the pre-
dictability was calculated from the root mean squared error of estimation (RMSEE)
[254].
4.2.9 Statistical analysis
All experiments were conducted with replicate data are represented as the mean of
n=3-6 independent replicates +/- standard error. Prior to statistical analysis, all
data were pre-processed using a box-cox power transform, in order to normalize data
according to a Gaussian distribution. Statistical tests were conducted between groups
and time points using one-way or two-way ANOVA, combined with either a post-hoc
Tukey or Mann-Whitney U test for comparison of individual samples, depending on
the results from Levenes equality of variances test.
4.3 Results
4.3.1 Biochemical induction of mesoderm differentiation in ESC micro-
tissues
Homogeneous populations of EBs were formed via forced aggregation and maintained
in controlled hydrodynamic suspension culture, as described previously (Chapter 3),
in order to systematically examine three-dimensional stem cell morphogenesis. EBs
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remained uniform in size and homogeneous across populations through the initial
4 days of differentiation (Fig. 4-1 A); however, EBs cultured in basal, serum-free
culture conditions lost the characteristic uniform, spherical structure and adopted
EB morphologies with less smooth exterior appearances by 7 days of differentiation.
Moreover, supplementation with BMP4 (10 ng/mL) led to the appearance of dis-
tinctly polarized regions exhibiting different opacities within individual EBs after 14
days of differentiation. In addition, supplementation with BMP4 altered the overall
gene expression profile, resulting in increased expression genes related to mesoderm
lineages at days 4 and 7 of differentiation compared to those maintained in basal,
serum-free culture conditions (Fig. 4-1 B). Although, the pluripotency markers Sox2
and Oct-4 were not significantly different between the two culture conditions, mark-
ers of hematopoietic mesoderm (Gata2, Hba-x ) were increased by BMP4 treatment
(Gata2 p=0.07; Hba-x p=0.03), and genes related to endoderm (Foxa2 ) and ec-
toderm (Fgf5 ) were significantly increased (Foxa2 p=0.04; Fgf5 p=0.004) in basal
conditions, thereby illustrating the morphogenic influence of BMP4 in directing meso-
derm differentiation in 3D cultures, analogous to previous reports using monolayer
differentiation techniques [150, 191].
4.3.2 Mesenchymal morphogenesis of ESCs during 3D mesoderm differ-
entiation
Consistent with the gross changes in EB morphology, distinct differences in cellular
morphology and organization within EBs were observed during the course of differen-
tiation, in a soluble factor-dependent manner (Fig. 4-2). While EBs within both con-
ditions exhibited similarly homogenous epithelial populations initially, biochemical-
mediated differentiation led to changes in cellular organization and morphogenesis,
with basal EBs continuing to exhibit tightly packed, epithelial cell morphologies, in
contrast to BMP4-treated EBs, in which populations of elongated, mesenchymal-like
cells were apparent by 7 days of differentiation (Fig. 4-3 A). In addition, BMP4 treated
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Figure 4-1: Induction of mesoderm differentiation within EBs via BMP4
treatment. (A) Phase contrast images demonstrate similar gross morphology of
EBs cultured in basal, serum-free media or media supplemented with BMP4 after 4
days of differentiation, with differences apparent at 7 and 14 days of differentiation.
(B) Gene expression profiles also differed between EBs cultured in different soluble
culture environments after 4 and 7 days of differentiation, resulting in similar levels
of pluripotency factors, with divergent expression of markers for hematopoietic meso-
derm (Gata2, Hba-x ), endoderm (Foxa2 ), and ectoderm (Fgf5 ). Scale bar = 200 µm;
n = 3; * = p≤0.05
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Figure 4-2: Mesenchymal EB ultrastructure. Cells at the exterior of EBs ex-
hibited dramatically different morphologies, with basal EBs exhibiting more tightly
packed, epithelial-like cells, in contrast to the mesenchymal morphology of cells at
the exterior of BMP4-treated EBs. Scale bars = 20 µm.
EBs exhibited deposition of a non-sulfated glycosaminoglycan (GAG) rich matrix, as
evidenced by positive alcian blue (pH 2.5) and negative safranin-O staining within
the interstitial space between cells exhibiting mesenchymal morphologies (Fig. 4-3
B). The putative mesenchymal cells also expressed α-smooth muscle actin (α-SMA),
a hallmark of EMT. In addition to the increased deposition of non-sulfated GAGs,
EBs also exhibited increased expression of the hyaluronan synthetase (HAS) isoforms
during the course of differentiation, with significantly increased expression of HAS-2
(day 4 p=0.001; day 7 p=0.003) in BMP4-treated EBs (Fig. 4-3 C). Taken together,
EBs differentiated toward mesoderm lineages via BMP4 treatment undergo EMT-like
morphogenic processes to yield characteristic mesenchymal cell populations.
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Figure 4-3: Mesenchymal morphogenesis of ESCs within EBs. (A) EBs exhib-
ited dynamic remodeling of the microenvironment through 14 days of differentiation,
with distinct differences apparent between EBs in different soluble media formula-
tions. (B) After 7 days of differentiation, mesenchymal-like regions within EBs ex-
hibited positive staining for alcian blue and α-SMA, whereas safranin-O stained pos-
itively within epithelial-like regions and was largely absent within the mesenchymal-
like regions of BMP4-treated EBs. (C) EBs also exhibit increasing expression of genes
related to hyaluronan synthetase isoforms, with increased expression in BMP4-treated
EBs. Scale bars (A) = 200 µm, (B) = 50 µm; n = 3; * = p≤0.05.
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Figure 4-4: Mechanical testing methods. (A) Mechanical testing of EBs was
accomplished through parallel plate compression, in which (B) the displacement was
measured over time under constant force. (C) The resultant creep curves enable
calculation of viscoelastic properties, including characteristic creep displacement, as
well as parameters determined from the fit to a linear viscoelastic model. Scale bar
= 200 µm.
4.3.3 Dynamic changes in biophysical microtissue characteristics during
ESC differentiation
To characterize the physical remodeling of the microenvironment during the ESC
differentiation, the biomechanical microtissue properties were measured via micron-
scale parallel plate compression (Fig. 4-4 A). Descriptive physical characteristics,
including moduli, were calculated by measuring the viscoelastic creep (change in
deformation under constant force), which was well described by a linear viscoelastic
model (average R2 = 0.97; Fig. 4-4 B&C).
EBs treated with BMP4 exhibited increased viscous responses (p=0.0003), or
an increased resistance to deformation, as evidenced by decreased creep deformation
compared to those differentiated in basal conditions at day 7 of differentiation (Fig. 4-
5 A). In addition, BMP4-treated EBs were significantly stiffer than basal EBs, with
a 1.5 fold increase in modulus (p=0.004) after 7 days of differentiation (Fig. 4-5 B).
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Figure 4-5: Dynamic modulation of EB mechanical properties. (A) EBs
exhibit differences in viscoelastic creep and modulus after 7 days of differentiation,
including (B) a significant correlation between modulus and EB diameter within
BMP4-treated EBs. In addition, modulus and viscoelastic time constant characteris-
tics were modulated as a function of time, with differences between culture conditions
after 14 of differentiation. n=6; * = p≤0.05.
Therefore, EBs exhibiting distinct morphological characteristics also exhibited dis-
tinct biomechanical changes, both in terms of viscoelasticity and microtissue stiffness.
Interestingly, while the stiffness and size of basal EBs were not correlated (Fig. 4-5
C), those differentiated with BMP4 demonstrated an inverse relationship (p≤0.001),
with smaller BMP4 treated EBs exhibiting increased stiffness (Fig. 4-5 D). In ad-
dition to the increased population stiffness of BMP4 treated EBs, the correlation
between size and stiffness suggests a relationship between the extent of morphogen-
esis and biomechanical characteristics, thereby providing single EB metrics to assess
population heterogeneity.
Moreover, the biomechanical characteristics of EBs were dynamically modulated
during the course of differentiation, whereby significant differences in the stiffness and
62
viscosity were observed over time, both within and between individual biochemical
differentiation conditions (Fig. 4-5 E&F and Fig. 4-6). Specifically, basal conditions
exhibited decreased stiffness between days 2 and 4 of differentiation (p=0.04), whereas
BMP4-treated EBs exhibited similar stiffness through day 7 of differentiation; the
stiffness of EBs both conditions was significantly increased at day 14 compared to
day 4 (basal p=0.01; BMP4 p≤0.001), thus indicating an overall increase in stiff-
ness during differentiation in both conditions. Both conditions also exhibited similar
initial viscosity dynamics, whereby the viscous response decreased (increasing de-
formation time, or creep time constant) during the initial 7 days of differentiation
(basal p=0.04; BMP4 p=0.04); however, the viscosity of basal conditions continued
to decrease through day 14 of differentiation, whereas the viscosity of BMP4-treated
EBs increased over the same time frame, resulting in significantly increased viscosity
of BMP4-treated EBs compared to basal EBs (p≤0.001). Overall, the biomechani-
cal ESC microenvironment is dynamically modulated during differentiation, whereby
BMP4-treated EBs stiffen and increase viscosity as cells commit toward mesoderm
lineages and undergo EMT.
4.3.4 Cytoskeletal regulation of biophysical microtissue environments
The actomyosin cytoskeleton is one of the main structural components of cells, and
is particularly important in mediating cell shape, force generation, and stiffness in
embryonic tissues [374]. However, the role of cytoskeletal tension in cell fate speci-
fication during three-dimensional morphogenesis and differentiation remains unclear.
The actin filament organization of basal serum-free EBs appeared largely cortical in
structure at all stages of differentiation, consistent with the epithelial cellular mor-
phology; however, BMP4-treated EBs exhibited decreased assembly of F-actin, with
the cortical structures being less continuous after 4 days of differentiation (Fig. 4-7).
Moreover, consistent with the mesenchymal morphology, cells within BMP4-treated
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Figure 4-6: Mechanical characterization. (A) Although EB diameter was not
significantly modulated by culture environment, treatment with BMP4 resulted in
increased (B) instantaneous and (C) relaxed moduli after 7 and 14 days of differenti-
ation, as well as decreased (D) stress relaxation and (E) creep time constant. (F) The
apparent viscosity increased over time, but was not modulated by culture condition.
n=6; * = p≤0.05.
EBs exhibited thicker stress fibers with localization throughout the cytoplasm by
day 7 of differentiation. The observed modulation of cytoskeletal architecture during
three-dimensional ESC differentiation, therefore, motivates a more systematic analy-
sis of the role of cytoskeleton in mediating tissue stiffness during EB morphogenesis
(Fig. 4-8 A). Disruption of the Rho associated protein kinase (ROCK) pathway with
a small molecule inhibitor (Y27632; 10 µM; 1 hour) [145] decreased the stiffness of
EBs from both differentiation conditions and across all time points (p≤0.03 in all con-
ditions), indicating that active cytoskeletal elements significantly contribute to the
stiffness of EBs (∼50%) (Fig. 4-8 B&C). In addition, despite similar overall stiffness,
the active cytoskeleton of BMP4-treated was stiffer compared to basal EBs after 2
days of differentiation (p≤0.001), demonstrating unique biophysical characteristics at
early stages of differentiation, even before morphological or phenotypic changes were
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Figure 4-7: F-actin localization within EBs during differentiation. EBs dis-
played largely cortical F-actin structures, which were dynamically remodeled during
the course of differentiation after 2 (A&D), 4 (B&E), and 7 (C&F) days of differ-
entiation in basal, serum free cultures (A-C) or upon soluble treatment with BMP4
(D-F). Scale bar = 50 µm.
observed (Fig. 4-8 D). Moreover, the relative contribution of active cytoskeletal ten-
sion to the overall modulus decreased during the differentiation of BMP4-treated EBs,
suggesting the decreasing influence of the cytoskeleton at later stages of mesenchymal
morphogenesis. Together, the filamentous actin cytoskeletal structure is remodeled
during mesenchymal morphogenesis and active cytoskeletal tension significantly con-
tributes to ESC microtissue stiffness, which suggests a role for the cytoskeleton in
mediating the observed changes in biomechanical characteristics during mesoderm
differentiation and mesenchymal morphogenesis.
While the static cytoskeletal structure directly mediates tissue stiffness, the dy-
namics of actin polymerization has also been implicated in morphogenic processes,
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such as EMT [118]. Therefore, the cytoskeletal dynamics were perturbed via treat-
ment with an agonist (Jasplakinoide, Jas) [358] or antagonists (latrunculin B, LatB;
Y27632) [340] during ESC morphogenesis in order to assess the impact on biome-
chanics, morphogenesis, and cell phenotype (Fig. 4-8 E). BMP4-treated EBs exhib-
ited decreased viscosity in response to the cytoskeletal mediators, whereby treatment
with Jas and Y27632 significantly increased creep deformation, compared to both
untreated (Jas p≤0.001; Y27632 p=0.01) and basal (Jas p≤0.001; Y27632 p=0.003)
EBs (Fig. 4-8 E); in contrast, the viscous response of basal EBs remained similar
across all conditions. The kinetics of the viscous response, in terms of the creep time
constant, was increased by treatment with Y27632 in both conditions (Fig. 4-8 F),
which suggests differences in the magnitude and kinetics of the viscous response upon
cytoskeletal perturbation. In addition, Jas increased the stiffness of EBs cultured in
basal, serum-free media compared to untreated EBs, consistent with its known role
in mediating actin polymerization (p≤0.001); however, the stiffness of BMP4-treated
EBs was not affected by Jas (Fig. 4-8 F). In contrast, Y27632 significantly decreased
the stiffness of BMP4 EBs compared to untreated conditions (p≤0.001), but did not
affect EBs differentiated in basal conditions. Interestingly, although LatB has been re-
ported to decrease actin polymerization, BMP4-treated EBs were significantly stiffer
when cultured in LatB compared to untreated EBs (p≤0.001). Together, compounds
implicated in altering the dynamics of cytoskeletal tension and actin polymerization
significantly altered the biomechanical characteristics of microtissues during differen-
tiation and morphogenesis of ESCs.
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Figure 4-8: Influence of cytoskeletal tension on EB mechanical properties.
Treatment of EBs with the ROCK inhibitor Y27632 for 1 hour significantly decreased
the modulus of (A) basal and (B) BMP4-treated EBs and (C) demonstrated differ-
ences in the relative contribution to the overall naive EB modulus at 2 and 7 days of
differentiation. In addition, EBs were differentiated in the presence of (D) cytoskeletal
agonists and antagonists, and exhibited changes in the (E) viscoelastic creep response
and (F) modulus after 7 days of differentiation. n = 6; * = p≤0.05 compared to basal;
$ = p≤0.05 compared to untreated.
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4.3.5 Biomechanics predict microtissue phenotypic profiles
The impact of biomechanical forces on stem cell phenotype has been increasingly
appreciated as an exogenous means to direct cell fate [93, 279, 215]; however, a quan-
titative relationship between ESC phenotype and biophysical properties of three-
dimensional microtissues has not been established. Therefore, the morphology and
phenotype of ESCs were assessed in parallel with the changes in microtissue stiff-
ness upon treatment with small molecules. The cytoskeletal agonist and antagonists
did not induce marked morphological changes, based on gross histology (Fig. 4-9);
however, subtle differences were noted, as LatB-treated BMP4 EBs exhibited more
epithelial-like cells, similar to basal EBs (Fig. 4-9 S), whereas Jas and Y27632 treat-
ment induced more mesenchymal morphogenesis within BMP4 EBs (Fig. 4-9 Q,R).
In addition, treatment with the small molecules altered the gene expression profiles
of both basal and BMP4 EB populations after 7 days of differentiation; hierarchical
clustering indicated marked phenotypic differences for Jas treated EBs from both
conditions relative to untreated EBs (Fig. 4-10). Similarly, a PLS model (R2Y=0.70,
Q2=0.10; 3 significant PCs) illustrated the variance in gene expression signatures due
to BMP4 treatment and cytoskeletal perturbations, which were distinctly separated
along the first and second principal components, respectively (Fig. 4-10); although
the biochemical morphogen treatment in the presence or absence of BMP4 dominated
the phenotypic gene expression, subtle variations in the phenotypic profile were in-
duced by cytoskeletal perturbations, thereby indicating the utility of PLS modeling
for capturing variations not detectable through traditional analytical methods, such
as hierarchical clustering. Consistent with the histological observations, LatB-treated
EBs exhibited phenotypic profiles indicative of decreased EMT, similar to basal EBs,
whereas Jas-treated BMP4 EBs exhibited increased mesoderm differentiation and
mesenchymal morphogenesis, as evidenced by the position along the first principal
component. Increased expression of pluripotency genes such as Nanog, Sox-2, and
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Figure 4-9: Morphology of EBs cultured with cytoskeletal agonists and
antagonists. Phase images (A-E, K-O) and H&E staining (F-J, P-T) of EBs cultured
in basal, serum free media (A-J) or upon supplementation with BMP4 (K-T) exhibit
changes largely consistent with the soluble growth factor treatment, with few subtle
changes due to cytoskeletal perturbation with Jas (C, H, M & R), LatB (D, I, N &
S), and Y27632 (E, J, O & T). Scale bar (A) = 200 µm, (F) = 50 µm.
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Figure 4-10: Multivariate association between phenotypic characteristics in
response to biophysical perturbations. PCR array analysis of gene expression
suggested differences in cell fate after 7 days of differentiation due to small molecule-
mediated perturbation of the cytoskeleton from days 4-7. In addition, the score
plot demonstrates distinctions between culture conditions across the first and second
principal components, based upon gene expression profiles, shown in the loadings plot.
Separate PLS with gene expression as inputs and mechanical properties as outputs
demonstrated a high degree of predictability of mechanical properties based upon
phenotypic traits.
Oct-4, indicated that LatB treatment delayed the differentiation kinetics of ESCs for
both culture media conditions. Interestingly, the same mesendoderm genes (Hbb-y,
Sox17, Nkx2.5, Fgf5 ) increased by Jas treatment of BMP4 EBs were decreased by
Jas in basal EBs, thus demonstrating that actin polymerization was not sufficient to
induce a mesendoderm gene expression profile within basal EBs (Fig. 4-10).
Based on the biochemical-mediated variability between experimental groups cap-
tured by the first principal component, separate PLS models were constructed based
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upon the gene expression (input, X) and mechanical properties (output, Y) to dis-
tinguish the cellular responses to cytoskeletal perturbations for EBs differentiated in
basal, serum-free media (R2Y=0.70, Q2=0.10; 1 significant PC) and in the presence of
BMP4 (R2Y=0.65, Q2=0.30; 1 significant PC) (Fig. 4-10). The models reflect changes
in biomechanical properties as a function of the gene expression profile, thus enabling
a quantitative relationship between biophysical microtissue environments and ESC
differentiated phenotypes. Overall, the gene expression profile was highly correlated
with several of the mechanical characteristics; however, the strength of correlations
varied between individual biomechanical parameters and across differentiation condi-
tions. The model theoretically predicted the EB stiffness, with R2 coefficients of 0.90
and 0.75 in the basal and BMP4 conditions, respectively. In contrast, the viscous
creep response of EBs did not correlate as highly with the phenotype of EBs in either
condition, indicating that the changes in individual mechanical properties, such as
viscosity, could not be fully explained through phenotypic changes and may also be
influenced by extracellular factors, such as ECM deposition. To illustrate the complex
relationship between biophysical characteristics and ESC phenotype, the model was
instead constructed using the biomechanical parameters to predict gene expression
profiles (Fig. 4-11). Overall, the biomechanical profile significantly (background Q2Y
< 0.05) predicted the responses of 61.5 and 65.4% of the genes, respectively, which
established subsets of genes responsive to biophysical perturbations. Moreover, the
upper quartile of genes (Basal: Pax-6, Oct-4, Bmp4, Hba-x ; BMP4: Hba-x, Hbb-y,
Bmp4, Gata4 ) within each condition were predicted by the models with >70% accu-
racy. Interestingly, Bmp4 and Hba-x, which were highly predicted by both models,
exhibited divergent responses to small molecule treatments within basal- and BMP4-
treated EBs, thereby demonstrating the capacity for multivariate analytics to identify
putative markers highly correlated with biomechanics across different environmental
conditions. In addition, the genes most highly predicted in basal EBs included those
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that exhibited decreased (Hba-x, Hbb-y), increased (Gata4 ), and unchanged (Bmp4 )
expression patterns in response to cytoskeletal perturbations, indicating that the me-
chanical model captured an array of different phenotypic responses. In contrast,
while the mechanical model largely recapitulated the phenotypic profile of BMP4-
treated EBs, several individual genes were not as highly correlated, which may be
due to diverse responses arising within less uniform microtissues. The data together
indicate that distinct phenotype profiles could be accurately described by multivari-
ate analyses based upon multiple viscoelastic parameters. In summary, these results
collectively suggest that ESC differentiated phenotypes are directly related through
complex, multiparametric changes in the stiffness and viscoelastic characteristics of
EBs.
4.4 Discussion
Taken together, the studies presented employ a novel approach which enables a more
mechanistic understanding of embryonic-derived microtissue properties, including
changes in morphogenesis, remodeling of cytoskeletal elements and modulation of bio-
physical characteristics during three-dimensional ESC differentiation. The biochemical-
mediated differentiation of ESCs toward mesoderm lineages via BMP4 highlights
parallels between three-dimensional ESC differentiation and embryonic development,
particularly in terms of remodeling and morphogenesis leading to regions comprised
of mesenchymal-like populations, similar to primitive streak migration during gastru-
lation [43]. Overall, the insight regarding biophysical dynamics accompanying ESC
differentiation provides distinctions from adult tissue models and highlights important
principles for establishing relevant microenvironments to direct early fate decisions.
Much previous work has aimed to recapitulate the mechanical microenvironment
of stem cell niches through the development of substrates with elasticity comparable
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Figure 4-11: Prediction of microtissue stiffness and ESC phenotypes by
multivariate modeling. PLS models based upon mechanical characteristics demon-
strated different degrees of predictability for the associated gene expression profiles
when trained with the full biomechanical profiles.
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to the range of adult tissues (1 kPa - 100 kPa) [93, 363], which is a >104 fold decrease
compared to standard polystyrene culture dishes. In contrast, the modulus of the ESC
microenvironment appears to be substantially decreased compared to that of native
tissues (≤0.1 kPa). Such biophysical observations, however, are consistent with dra-
matic differences in tissue structure and composition between adult- and embryonic-
derived tissues. The mechanical properties herein were measured between days 2-14
of differentiation, with most of the emphasis prior to day 7; previous characterization
of the EB microenvironment at such stages of differentiation has indicated minimal
ECM deposition [230]. Moreover, the high nuclear density evidenced by histological
staining (Fig. 4-3 A&B) is distinct from the structure of adult tissues; therefore, the
principal structural elements within EBs are likely the cells themselves (cytoskeletal
elements), and the adhesions between cells, which is supported by the loss of EB
structure upon simple removal of calcium. Consistent with such hypotheses, the EB
modulus appears to be more comparable with the moduli of single cells, which is sub-
stantially decreased compared to that of tissues, with the cytoplasmic regions often
measured in the range of ∼1 kPa [212]. Moreover, the modulus of embryonic tissues
has been measured in the range of 10-100 Pa [373], consistent with the reported data,
thereby highlighting the unique characteristics of embryonic microenvironments.
The single cell modulus of hESCs has been measured as approximately 0.5 kPa,
and the cells exhibited a >3 fold increase in modulus upon differentiation toward
chondrogenic lineages [247]. thereby indicating that undifferentiated, pluripotent cells
may be inherently less stiff compared to more mature cell phenotypes. Moreover, the
mechanical properties of adipose stem cells (ASCs) have been correlated with differ-
entiation potential [119]. which highlights the interrelationship between biophysical
cell characteristics and phenotype. In addition, the modulation of MSC morphol-
ogy via changes in cell spreading [215] or substrate stiffness [93] has been linked to
altered differentiation trajectories. PLSR modeling of the mechanical response to
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changes in gene expression (Fig. 4-10) suggests a similar relationship between mor-
phology, phenotype, and mechanical properties of pluripotent stem cell aggregates.
The data presented collectively suggest that three-dimensional mesoderm differen-
tiation and associated mesenchymal morphogenesis are correlated with increasing
microtissue stiffness.
The mechanism for increased stiffness upon differentiation has been suggested to
be largely a result of cytoskeletal mediated changes in the morphology [247, 86]. The
measurement of EB biophysical characteristics enables quantitative analysis of the
mechanisms underlying biophysical tissue properties via systematic perturbation of
cellular elements; in ESC microenvironments, the cytoskeleton provides significant
contributions (>50% of modulus) to the overall modulus during all stages of differ-
entiation (Fig. 4-8 A-C). In addition, changes in relative cytoskeletal contributions
provide insight into the physical mechanisms contributing to morphogenesis and re-
modeling. Interestingly, very early changes in cytoskeletal organization have been
previously used to successfully predict the differentiated phenotypes of MSCs [331].
Therefore, the measured modulation of cytoskeletal tension between basal and BMP4-
treated EBs as early as day 2 of differentiation may be indicative of such dynamic
processes occurring prior to observing changes using standard biochemical or histolog-
ical approaches. In addition, cytoskeletal tension exhibited a decreasing contribution
over time to overall microtissue modulus over time in BMP4-treated EBs (Fig. 4-8 C),
despite increases in the bulk EB modulus compared to basal conditions. One hypoth-
esis to explain the decreasing cytoskeletal contribution over time is due to the loss of
E-cadherin during EMT [49]. which has been shown to directly affect actin assembly
dynamics through Arp2/3 [171]. However, the studies presented also establish that
the increased modulus in BMP4-treated EBs is not a result of increased cytoskeletal
tension, thereby implicating extracellular factors, such as cell-cell and cell-matrix ad-
hesions as mediators of the biophysical mesenchymal microenvironment. Together, we
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describe a complex and unique scaffold-free biophysical multicellular model in which
the cytoskeletal tension is transmitted between cells via ESC intercellular adhesions
and dynamically remodeled during differentiation and EB remodeling.
Cytoskeletal remodeling is a dynamic process, particularly during EMT [210] and
embryonic development [103, 19], whereby cytoskeletal treadmilling causes the poly-
merization of actin at the leading edge of migration with reciprocal actin depolymer-
ization at the opposite end of the cell.[314] Previous studies have demonstrated the
role of jasplakinolide or latrunculin in increasing or decreasing motility, respectively
[127]. In addition, EMT has been shown to occur in regions of increased cytoskeletal
tension, and is inhibited by decreasing tension with agonists of ROCK or myosin II
via transcriptional activation of serum response factor and myocardin related tran-
scription factor [118]. Consistent with such previous observations, polymerization
of actin via Jas treatment appeared to act synergistically with BMP4 to increase
EMT and mesoderm differentiation. Interestingly, while Jas increased the stiffness
of basal EBs, those treated with BMP4 and Jas did not exhibit statistical differ-
ences compared to untreated conditions. It appears, however, that polymerization of
actin was not sufficient, in this case, to initiate EMT within basal, serum-free cul-
ture conditions in the absence of BMP4. Similarly, inhibition of actin polymerization
via LatB decreased the BMP4-induced mesenchymal transition and mesoderm dif-
ferentiation (Fig. 4-10, Supplemental Fig. 4-8). However, despite its known role in
depolymerizing actin, LatB treated BMP4 EBs exhibited increased stiffness, suggest-
ing the possibility role of redundant or compensatory mechanisms, including those
within the Rho/ROCK pathways, in maintaining the structure of the epithelial-like
aggregates. Finally, BMP4 EBs treated with Y27632 exhibited decreased stiffness,
consistent with decreasing cytoskeletal tension; however, PLSR modeling suggested
a slight increase in EMT and mesoderm differentiation upon inhibition of ROCK.
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The likely mechanism for such observations, however, is through the known associ-
ation of ROCK signaling with maintaining E-cadherin [38], without which cells are
free to undergo EMT and migrate. Together, the dynamics of cytoskeletal changes
and the insight provided through biophysical and phenotypic changes in response to
cytoskeletal perturbations highlights important factors governing the morphogenesis
of ESCs during cell fate specification.
Overall, the understanding of dynamic changes in embryonic tissue microenviron-
ments during ESC differentiation highlights important principles for the design of
tissue engineering strategies aimed to direct differentiation and patterning of com-
plex, functional tissues amenable to modeling embryogenesis, screening pharmaceu-
tical compounds, and developing molecular therapeutics.
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CHAPTER V
SPATIOTEMPORAL DYNAMICS OF DIFFUSIVE SMALL
MOLECULE AND GROWTH FACTOR SIGNALING IN
STEM CELL AGGREGATES
5.1 Introduction
Cell specification during embryonic development is orchestrated by precisely con-
trolled spatial and temporal signaling arising from the establishment of morphogen
gradients via paracrine signaling. Such gradients have been extensively explored over
the past 40 years, with the earliest reports identifying biochemical diffusion as a
molecular determinant, leading to the spatial patterning and segmentation arising
from threshold responses to local morphogens [71, 357]. While the bicoid gradient
in drosophila embryos is among one of the most studied developmental events [89],
spatial organizers have also been established within more complex species, such as the
Spemann organizer in Xenopus [114] and Hensens node in the chick [137], which are
the sources of many morphogenic signals, analogous to that of the node and anterior
visceral endoderm in mammalian development [24, 26]. Originating from localized
subpopulations, growth factors, including agonists (BMPs, Wnts) and antagonists
(Noggin, Chordin, Frizzled, Axin, Dkk) are responsible for axis asymmetry, bound-
ary formation and tissue divergence in utero [375, 190, 370]. While the identity of
such signals has been established across several organisms, questions remain regarding
the molecular mechanisms responsible for the initiation and regulation of gradients.
In the context of embryonic morphogenesis, computational approaches proven power-
ful for interrogating factors contributing to the fidelity of gradients and boundaries,
including the complex kinetics of morphogen synthesis, diffusion, and degradation
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[281], across a range of embryonic size scales corresponding to different species [122].
Pluripotent embryonic stem cells (ESCs) derived from the inner cell mass of the
embryonic blastocyst [209, 323, 96] respond to similar embryonic morphogenic cues,
including biochemical and biophysical exogenous stimuli. Directed differentiation ap-
proaches commonly implement growth factors, including BMPs, Activin, and Wnts,
to direct cell fate in monolayers via conserved embryonic developmental pathways
[228]. However, recent striking examples of self organization and tissue morphogene-
sis leading to organoid formation within three-dimensional aggregates of pluripotent
stem cells [92, 235, 307, 182, 311, 11, 318], termed embryoid bodies (EBs), have led
to questions regarding the regulation of cell fate by the three-dimensional biophys-
ical microenvironment [163]. Specifically, the dynamics of exogenous and paracrine
signaling within EBs remains largely undefined. We and others have demonstrated
the unique physical characteristics of stem cell spheroids, including tightly packed
cells with an outer shell comprised of epithelial tight junctions, and evidence of small
molecule transport limitations [51, 278]. However, it remains unclear how the trans-
port dynamics of small molecules and growth factors within EBs compares to other
biological systems, including native tissue structures, as well as monolayer cells and
3D constructs in vitro.
The objective of this study was to implement a data-driven mathematical ap-
proach to quantitatively measure the population dynamics of molecular transport
and downstream signaling in parallel with computational interrogations to ultimately
inform approaches for manipulating biochemical delivery and understanding paral-
lels with embryonic development. Small molecule and growth factor transport were
quantified by measuring uptake and signaling via flow cytometry and implemented in
the context of a mathematical model to interrogate the influence of various physical
and microenvironmental factors specific to stem cell expansion and differentiation.
Overall, we demonstrate that the high density of cells within EBs leads to marked
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transport limitations, particularly for small molecules with high uptake rates. In
addition, the physiologically relevant BMP4 signaling pathway also exhibited popu-
lation heterogeneity and signal attenuation. Moreover, a rules-based computational
model was employed to further interrogate the effects of phenotypic spatial inhomo-
geneities on transport during stem cell differentiation. Together, these data indicate
important biophysical principles of three-dimensional stem cell derived microtissues,
which may inform the development of novel tissue engineering strategies to establish
uniform molecular delivery, as well as approaches to engineer biomimetic gradients of
exogenous or endogenous cytokines and growth factors.
5.2 Materials and Methods
5.2.1 Embryonic stem cell culture
Murine ESCs (D3 cell line) were expanded on 0.1% gelatin-coated tissue culture
polystyrene culture plates in media consisting of Dulbeccos Modified Eagles Medium
(DMEM) supplemented with 15% fetal bovine serum (FBS), 100 U/mL penicillin, 100
µg/mL streptomycin, 0.25 µg/mL amphotericin, 2mM L-glutamine, 1x MEM non-
essential amino acid solution, 0.1 mM 2-mercaptoethanol, and 103 U/mL leukemia
inhibitory factor (LIF). ESCs were expanded undifferentiated in the presence of LIF
and routinely passaged at 70% confluence.
5.2.2 Embryoid body formation and maintenance
Differentiation of ESCs was initiated via the formation and culture of cells as three
dimensional aggregates, termed embryoid bodies (EBs). EBs were formed via forced
aggregation of single cells in 400 µm microwells, as previously described [335, 165],
with a seeding density of 1000 cells per well in ESC expansion media without LIF.
After 24 hours of formation, EBs were transferred into suspension (∼1200 EBs per
10 mL of media) and maintained on a rotary orbital shaker platform at 45 rpm,
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in order to support subsequent growth while preventing agglomeration of individual
aggregates. EBs were maintained in rotary orbital suspension culture through 7 days
of differentiation.
5.2.3 Measurement of embryoid body physical metrics
Phase images were acquired after 2, 4, and 7 days of differentiation using a Nikon TE
2000 inverted microscope equipped with a SpotFlex camera. The cross sectional area
of individual EBs was quantified via a custom-written macro in CellProfiler, which
iteratively processes images by correcting the background irregularities, including
removing single cells and uneven illumination, followed by identification of objects
using the Otsu Adaptive method. Several images (5-10) were quantified per plate,
with a total of >200 EBs per independent replicate for each condition (n=3). To
quantify the yield of cells, EBs from the same stages of differentiation were washed in
PBS and dissociated using 0.05% trypsin / 0.53mM EDTA, followed by quantification
using a Coulter counter. EBs were also sampled, diluted, and manually counted (3
counts per replicate) in order to verify that agglomeration was limited throughout
the culture duration.
5.2.4 Small molecule transport
0.1 µM Calcein AM was supplemented in 2 mL of serum-free media containing either
5x105 cells or ∼200 EBs, either as trypsin-dissociated single cells or intact EBs. After
15 minutes of incubation, 5 volumes of PBS were added and cells were collected by
centrifugation at 200 rcf for 5 minutes. After centrifugation, fluorescence was directly
measured via flow cytometry on an Accuri C6 cytometer using a blue laser (excita-
tion: 488 nm) with an attenuated FITC filter (FL1 90%; 530 ± 15 nm). Following
the calcein staining and washing procedures, EBs were dissociated via incubation in
0.05% trypsin/ 0.53 mM EDTA and fluorescence intensity was measured using flow
cytometry as described. In all cases, the cell population was identified within the
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forward- versus side-scatter plot, and 2x104 events were collected within the cell gate.
Subsequent analysis of flow cytometry data was conducted by measuring the mean
fluorescent intensity and intensity distributions using FlowJo software. The radial flu-
orescence profiles were subsequently determined by exporting the raw intensity data
collected by the Accuri CFlowPlus software into a custom program in MATLAB,
which normalized and binned the intensity as a function of EB radius, for a theoreti-
cal EB of size representative of the population average, with the assumption that the
intensity decreases with increasing radius, based upon the principles of diffusive mass
transfer.
5.2.5 Spheroid diffusion model & parameter case studies
The Thiele modulus (φ) was determined at each stage of differentiation by using
a nonlinear regression based upon iterative least squares estimation in MATLAB
to fit the non-dimensionalized radial fluorescence profiles according to the transport







where C∗ is the nondimensional concentration (C/Co), r
∗ is the nondimensional
radius (r/R). The effectiveness factor (η) and molecular uptake rate (Q; mol/cell/s)











where I0 and I1 are Bessel functions of the 0th and 1st order, respectively, C
is the bulk concentration (mol/m3), D is the molecular diffusion coefficient (m2/s),
ρ is the cell density (cells/µm3), and R is the spheroid radius (m). To interrogate
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comparisons with other physiological systems and microenvironmental changes, the
Thiele modulus and effectiveness factor were calculated from Eq. 7 upon varying the
effective cell density (ρ) and biochemical concentration (C) and molecular uptake rate
(Q), based upon published values. Cell density within EBs was estimated based upon
the measured physical parameters (cell and EB counts, as well as EB cross sectional
area), assuming population uniformity and spherical nature of aggregates at early







The cell density in physiological tissues was modeled within the range from 5x107
to 2x108 cells/cm3 in cartilaginous and hepatic tissues, respectively [123], with a
lower range of densities in tissue engineered constructs, ranging from 1x106 to 1x107
cells/cm3 [69]. A case study of transport changes upon biomaterial microparticle
incorporation (effective cell density change) was constructed based upon published
incorporation ratios (1:2, 1:1, 2:1 MP:cells) for microparticles via forced aggregation
into spheroids composed of 1000 cells [40] and the volumetric changes in density were
calculated for microparticles of varying sizes and assuming spherical packing. Simi-
larly, the molecular uptake rate (2x10−22 mol/cell/s) and Kd (1 nM) were interrogated
for epidermal growth factor (EGF), as a representative growth factor [123] and com-
pared to the measured uptake of calcein AM, with comparison to oxygen uptake rates
(2x10−17 to 7x10−17 mol/cell/s) as a higher extreme [123, 337]. In all simulations the
diffusion coefficient was assumed to be 380 and 20 µm2/s for small molecules [343]
and growth factors [123], respectively.
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5.2.6 Growth factor transport
Growth factor transport was assessed in physiological conditions using transcriptional
signaling sentinel mESCs that are responsive to regulatory sequences in the BMP sig-
naling pathway. As previously reported [297], the cells harbor an inserted response
element within a deletion at -228 bp within the constitutive Rosa26 locus. The re-
sponse element for BMP signaling is the IBRE element from the promoter region of
the Smad7 gene, fused to a TATA element and the CFP reporter (-228/IBRE4-TA-
CFP). Smad7, which is an inhibitor Smad, or I-Smad, is part of a negative feedback
loop and one of the early targets of the BMP signaling pathway [4]. The IBRE element
binds protein dimers of Gata-1 -5 or -6 with Smad1 and has been previously demon-
strated responsiveness to lower concentrations of BMP compared to other response
elements in the Smad7 gene [27]. Cell responsiveness to BMP4 was first validated
by plating undifferentiated cells into ESC media (with LIF) either in the presence or
absence of BMP4 (10 ng/mL) and incubated for 24 hours prior to collecting and fixing
the cells in 10% formalin. The fluorescent profiles were assessed via flow cytometry,
and the sentinel cells with and without BMP4 were compared to naive, untransduced
D3s as a negative control (Fig. 5-1). To assess transport, equal cell yields, either as
EBs or as single cells dissociated from EBs at day 2 of differentiation, were incubated
in ESC differentiation media supplemented with 0, 5, 10 or 20 ng/mL recombinant
BMP4 and incubated overnight. After 24 hours, cells were collected by retrieval of
monolayer cells or dissociation of EBs using 0.05% trypsin / 0.53 mM EDTA. Single
cells from each culture context were subsequently fixed in 10% formalin and washed
with PBS prior to analysis via flow cytometry. The CFP signal within the signaling
sentinels was assessed using a BD LSR II flow cytometer equipped with a 405 nm
violet laser with a 450/50 nm filter. Flow cytometry analysis was conducted using
FlowJo software, with the cells identified via the forward (FSC-A) and side scatter
(SSC-A) profiles, with doublets removed from the SSC-W vs. SSC-H profile.
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Figure 5-1: BMP sentinel signaling cell validation. Sentinel signaling cells
exhibited increases in the mean fluorescence and percent of positive cells, in a dose-
dependent manner, with approximately 14% of cells positive in basal differentiation
conditions (with serum but without supplementation of BMP4; 0 ng/mL BMP4) and
an increase to 45% positive cells with the addition of 10 ng/mL BMP4. * = p<0.001
compared to naive cells (untransduced D3s). † = p<0.001 compared to signaling
sentinels without BMP4 (0 ng/mL). The schematic representation of sentinel signaling
cell construction was reproduced from [297].
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5.2.7 Computational spatial diffusion model
Transport was further studied in the context of spatial changes in stem cell phenotype
during EB differentiation using a previously described computational framework [349].
Briefly, EBs were modeled using a custom C# physics simulation which assumes
the cells to be rigid spheres connected by springs. The kinetics of the simulations
were fit to experimental observations of cell growth and division was assumed to
be symmetrical, with both daughter cells exhibiting the same phenotype. The loss
of pluripotency was subsequently modeled in Python, based upon the previously





where β is the number of differentiated neighboring nodes and γ is the num-
ber of undifferentiated neighboring nodes. The phenotypic patterns at discrete time
steps were then paired with the steady-state diffusion-reaction equation (Eq. 9), with
the boundary conditions based upon a specified bulk concentration (C=Co(r=R)) and
spherical symmetry ([dC/dr]r=0 = 0) in order to calculate transport phenomena as a











−Q = 0 (9)








To simulate changes in receptor expression upon differentiation, the consumption
rate (Q) was varied within the population of differentiated cells, in order to represent
increased and decreased sensitivity upon regulation of receptor expression accompa-
nying cell fate changes.
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5.2.8 Statistical analysis
All experiments were conducted with replicate data are represented as the mean
of n=3 independent replicates ± standard error. Prior to statistical analysis, all
data were pre-processed using a box-cox power transform, in order to normalize data
according to a Gaussian distribution. Statistical tests were conducted between groups
and time points using one-way or two-way ANOVA, combined with either a post-hoc
Tukey or Mann-Whitney U test for comparison of individual samples, depending on
the results from Levenes equality of variances test.
5.3 Results
5.3.1 Changes in microtissue characteristics during embryoid body dif-
ferentiation
Consistent with previous reports [165], embryoid bodies formed via forced aggregation
and maintained in rotary orbital suspension culture exhibited uniform formation, size
and morphology (Fig. 5-2 A), thereby providing robust and reproducible control of
population homogeneity during the course of differentiation. Specifically, EBs main-
tained spherical ultrastructure, with no significant changes in the yield over the 7
days of differentiation (Fig. 5-2 B), indicating that individual EBs remained distinct
and did not exhibit evidence of agglomeration. In addition, the cell yield (p<0.001)
and EB size (p<0.001) both increased over the course of differentiation (Fig. 5-2 B),
resulting in >7 fold increase in the number of cells per EB during after 7 days (Ta-
ble 1); however, interestingly, the cell density significantly decreased between days
2 and 7 of differentiation (p = 0.006; Table 1), which indicates biophysical changes
in the EB microenvironment due to morphogenesis and remodeling that occur con-
comitant with cell fate changes. Together, the control enabled through this platform
and the analysis of biophysical cellular properties in parallel with transport assays
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Figure 5-2: EB biophysical characteristics. (A) EB populations exhibit charac-
teristic uniform round morphology during the course of differentiation, with changes
in the size and ultrastructure during by day 7 of differentiation. (B) While the yield
of EBs did not change statistically during the course of differentiation, the overall cell
yield and EB size were both significantly increased at each stage of differentiation. *
= p<0.05 compared to all other days of differentiation. Scale bar in (A) = 300 µm.
enables the development of novel quantitative models for understanding morphogen
dynamics in stem cell spheroids.
5.3.2 Attenuation of small molecule transport in embryoid bodies com-
pared to single cells
Based upon the common practice of adapting monolayer culture conditions to three-
dimensional spheroid formats, the transport profiles were first compared between
single cells and EBs incubated in calcein AM (0.1 µM), a fluorescent hydrophobic
small molecule. In all experiments, the single cells were derived from dissociated
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Table 1: Biophysical characteristics of EBs during differentiation
Day Cells per EB EB diameter (µm) Cell density (cells/µm3 x10−3 )
2 3089 ± 163 217 ± 1.3 0.58 ± 0.04
4 5015 ± 626 282 ± 2.3 0.43 ± 0.06
7 7439 ± 642 375 ± 4.2 0.27 ± 0.03
EBs at the same stage of differentiation and an equivalent total number of cells were
stained in each format (Fig. 5-3 A). At all stages of differentiation, the fluorescence
profile of cells derived from embryoid bodies was distinct from that of both naive,
unstained cells, as well as calcein AM stained single cells (Fig. 5-3 B). The fluores-
cence profile of EB-derived cells exhibited significantly decreased mean fluorescence
intensity (p<0.001), with an increased coefficient of variance (CV; p<0.006 at days
2 and 7); the more spread distributions and decreased fluorescence (Fig. 5-3 C) to-
gether indicate that exogenous delivery of small molecules may result in increased
heterogeneity within EBs compared to monolayer cultures.
5.3.3 Increasing heterogeneity in small molecule uptake during EB dif-
ferentiation
In contrast to the previous experiment, the EB number was, instead, maintained
constant, in order to compare the changes in EB transport over the course of dif-
ferentiation, analogous to standard in vitro feeding and supplementation regimens,
which traditionally do not vary the concentration over time, despite increased cell
yields (Fig. 5-4 A). During the course of differentiation, the fluorescence intensity sig-
nificantly decreased (p<0.001), while the CV increased at day 7 (p=0.007 compared
to day 2; p=0.03 compared to day 4), indicating an overall decrease in the number
of stained cells, with an increased population heterogeneity over time (Fig. 5-4 B).
Assuming spherical reaction-diffusion kinetics, the raw flow cytometry fluorescence
profiles were plotted along the radius of the EB, with the highest intensity cells at the
exterior and lowest at the interior (Fig. 5-4 C). Analysis of the data-driven spatial
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Figure 5-3: Transport limitations due to spheroid culture format. (A) To
assess changes in transport between spheroids and cells cultured in a traditional
monolayer format, the same number of cells (corresponding to a decreasing number
of EBs) was incubated with calcein AM (0.1 µM) in the two contexts after days
2, 4 and 7 of differentiation. (B) The cells from dissociated EBs (red) exhibited
unique dye uptake profiles compared to those in monolayer (black), (C) with overall
decreases in the mean fluorescence and increased coefficient of variance (CV). * =
p<0.05 compared to (A) all other days of differentiation or (C) denoted comparison.
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model indicated that the fluorescence intensity was significantly attenuated within
the first cell layers of the EB (D90 ∼10-13 µm; Fig. 5-5). The corresponding region of
highly stained cells at the exterior of the EB led to an increase (p<0.05) in the total
number of stained cells over time; however, due to the geometrical changes in EBs
during the course of differentiation (Fig. 5-5 B), the highly stained cells represented a
decreasing (p<0.001) fraction of the total cells over time (Fig. 5-4 D), consistent with
the measured population averages. Together, these data suggest that supplementa-
tion of culture conditions with a constant small molecule morphogen concentration
results in decreasing intensity and increasing spatial heterogeneity during the course
of stem cell spheroid differentiation.
5.3.4 Mathematical model of small molecule and growth factor distribu-
tion in stem cell spheroids
In order to relate the measured fluorescence profiles to engineering parameters, the
radial distributions were fit to determine two dimensionless constants: (1) the Thiele
modulus (φ), which describes the ratio of diffusion time to reaction time in a system
and (2) the effectiveness factor (η), which quantifies the ratio of internal reaction
compared to reaction in the bulk media. The Thiele modulus in EBs ranged from
32.8 to 44.6 (Fig. 5-6 A) during the course of differentiation, which indicated sig-
nificantly decreased transport (Fig. 5-6 B) at day 7 compared to earlier time points
(p=0.001 compared to day 2; p=0.004 compared to day 4). The calculated Thiele
modulus corresponded to low effectiveness factors (<1), further supporting the re-
stricted transport in the experimental system. In addition, the calculated uptake
rate for calcein AM also increased after 7 days of differentiation (p=0.007), which
may have contributed to the increase in Thiele modulus.
As the cell density within EBs (∼108 cells/cm3) was measured as orders of mag-
nitude above that reported for native tissues (∼107 cells/cm3) and scaffold-based
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Figure 5-4: Transport limitations during EB differentiation. (A) To assess
the changes in transport within spheroid populations over the course of time, the
same total number of EBs (corresponding to an increasing number of cells) were
incubated with calcein AM (0.1 µM) after days 2, 4 and 7 of differentiation. (B) The
cells from dissociated EBs (black) exhibited unique dye uptake profiles at each stage
of differentiation, with decreasing fluorescence and increasing coefficient of variance
(CV). * = p<0.05 compared to (A) all other days of differentiation or (B) denoted
comparison.
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Figure 5-5: Spatial transport limitations arise from spheroid geometry.
(A) When the profiles were spatially mapped using a computational approach, the
attenuation of fluorescence (B,C) occurred within the first cell layers of the EB. (D,E)
While the number of highly stained cells increased over time, the radial changes in
relative EB proportions at each stage of differentiation led to a decreasing proportion
of stained cells within the EB. * = p<0.05 compared to (A,D) all other days of
differentiation or (B) denoted comparison. Scale bar in (C) = 100 µm.
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Figure 5-6: Influence of cell density on spheroid transport characteristics.
(A) Chemical engineering parameters, including the Thiele modulus, effectiveness
factor, and biochemical uptake rate upon treatment with calcein AM were altered
as a function of differentiation stage in EBs, (B) leading to parameters indicative of
a large central zone consisting of zero concentration at the center of EBs. (C) The
Thiele modulus and effectiveness factors were increased and decreased, respectively,
as a function of cell density, with tissue engineered constructs (green) and native
tissues (blue) exhibiting densities characteristic of decreased transport limitations
compared to EBs (red), resulting in (D) dramatically different spatial concentration
profiles within computationally derived spheroids of the same size and biochemical
conditions. Scale bar in (D) = 50 µm.
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culture platforms (∼106 cells/cm3), a comparison of the Thiele modulus and effec-
tiveness factor was calculated across microtissues of different cellular compositions.
Increasing cell density over several orders of magnitude led to an increase in the
Thiele modulus and reciprocal decrease in effectiveness factor, which highlights the
increased transport limitations in EBs compared to in vivo tissues and in vitro tis-
sue engineered constructs, simply due to changes in cell density (Fig. 5-6 C). In a
simulation maintaining constant microtissue size, small molecule concentration, up-
take rate, and physical properties while simply varying the cell density, there was an
apparent distinction between the radial profiles, both in terms of concentration and
spatial attenuation of morphogen (Fig. 5-6 D).
Similar to tissue engineering approaches which seed cells onto scaffolds, bioma-
terials have also been implemented within the context of stem cell spheroids in the
form of microparticles composed of synthetic or natural polymers [41, 51]. While
microparticles have traditionally served as point sources for local morphogen release
inside of EBs, unloaded microparticles may also alter transport by creating void re-
gions, thereby altering the effective cell density. Based on volumetric void space
calculated using previously measured rates of incorporation for gelatin microparti-
cles into stem cell aggregates [40], the effective cell density for stem cell aggregates
decreased with increased microparticle incorporation (Fig. 5-7 A). Moreover, when
microparticle diameter approached that of the cells (∼15 µm), the effective density
within the spheroid approached the density of in vivo tissues at high incorporation
ratios (2:1 MP:cell). Similar to previous simulations of cell density, increasing mi-
croparticle incorporation (and thus decreasing effective density) decreased the spa-
tial heterogeneity and the magnitude of morphogen attenuation within the spheroid
(Fig. 5-7 B&C). Together, these mathematical simulations highlight the biophysical
transport properties within stem cell spheroids as a result of high cell density and
demonstrate principles by which tissue engineering approaches may alter transport
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Figure 5-7: Impact of microparticle incorporation on aggregate density and
transport. (A) The effective cell density in spheroids with incorporated biomateri-
als was decreased as a function of both the microparticle size (circle = 5 µm; square
= 10 µm; triangle = 15 µm) and the incorporation ratio. (B,C) Upon incorpora-
tion of microparticles approximating the size of individual cells (15 µm), the spatial
concentration profiles suggested decreasing transport limitations with increasing in-
corporation (effectively decreasing spheroid density) within MP:cell ratios of 1:2 (red),
1:1 (blue) and 2:1 (green). Scale bar in (C) = 50 µm.
via simple microenvironmental perturbations.
While the measured data and mathematical simulations provide context for small
molecule uptake into stem cell spheroids, questions remain regarding other classes
of physiologically relevant morphogens, including growth factors. To interrogate the
changes in transport under different biochemical contexts, engineering parameters
were calculated by varying the cellular uptake rate, which varies based upon the
mode of morphogen interaction with cells. Consistent with known relations, the
Thiele modulus increased as a function of uptake rate, with a reciprocal decrease in
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effectiveness factor (Fig. 5-8 A). Therefore, for molecules with high uptake rates, such
as oxygen, the transport is increasingly restricted, whereas growth factors may ex-
hibit a decreased propensity to exhibit gradients and transport limitations. However,
further simulations using relevant uptake and physical parameters for growth factors
[123] also indicated that sufficiently high concentrations are required to decrease the
Thiele modulus and increase the effectiveness factor in EBs (Fig. 5-8 B). For exam-
ple, the radial profile of EBs supplemented with epidermal growth factor (EGF) at a
concentration corresponding to 10 Kd (10 nM) demonstrated 60% attenuation at the
center of the EB. While in vitro cultures are often supplemented in the range of ∼10
Kd [292], these simulations highlight the need for supraphysiological concentration
(>50 Kd) in order to maintain biochemical homogeneity throughout EBs.
5.3.5 Growth factor signaling in aggregates of ESCs
In addition to the kinetics of small molecule uptake within spheroid structures, growth
factor signaling was assessed using a novel enabling technology, previously described
by Serup et al, which employs recombinase mediated cassette exchange to substi-
tute regions within the Rosa26 gene with a response element for the BMP signaling
pathway in mESCs [297]. Therefore, upon incubation of cells, either in monolayer
or as EBs, with BMP4 at various concentrations, the downstream signaling activa-
tion was assessed indirectly via the corresponding CFP fluorescence profile. This
system provides a physiologically relevant method of assessing the effect of exogenous
growth factor addition within cultures (Fig. 5-9). As with the small molecule uptake
and fluorescence, growth factor signaling within monolayer cultures from day 2 of
differentiation was accentuated compared to the signaling within EBs of the same
differentiation stage, across a range of BMP4 concentrations (5-20 ng/mL). Both
conditions exhibited low basal activity when unstimulated, which was not statically
increased over naive cells; in addition, both monolayer and EB cultures exhibited a
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Figure 5-8: Transport profiles with varying molecular characteristics. (A)
The Thiele modulus and effectiveness factor were increased and decreased, respec-
tively, as a function of cellular uptake rate, with the uptake rates for growth factors
(blue) suggesting decreased transport limitations compared to small molecules (pur-
ple) and oxygen (orange). (B) Conversely, the Thiele modulus was decreased as a
function of biochemical concentration, with (C,D) decreased spatial heterogeneity
upon increasing from 10-fold to 50-fold increases in the growth factor dissociation
constant (Kd). Scale bar in (D) = 100 µm.
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significant response compared to nave cells all concentrations (p<0.01). However,
even at concentrations as low as 5 ng/mL, 14.5% of monolayer cells were CFP+,
compared to only 4.5% of cells from EBs (p=0.003). Interestingly, the coefficient of
variance was significantly increased at lower BMP concentrations, but decreased with
the addition of 20 ng/mL BMP4, suggesting a decrease in heterogeneity with increas-
ing morphogen concentrations, consistent with the mathematical results (Fig. 5-8).
5.3.6 Computational dynamics of growth factor distribution during with
phenotypic transitions
While the sentinel signaling cells provide an approach to assess downstream signaling
activation upon exogenous growth factor stimulation, direct comparison of the bio-
chemical transport during the course of time remains difficult due to dynamic changes
in cell phenotype, which alters the responsiveness to biochemical signals. For exam-
ple, upon differentiation, cells may either increase or decrease cell surface receptor
presentation, leading to increased or decreased uptake rates, respectively. Moreover,
the response to various pathways is altered temporally as cells proceed down various
differentiation trajectories. We have previously established a rules-based computa-
tional platform capable of recapitulating spatial patterns of early differentiation due
to competing feedback from the intercellular communication of neighboring cells [349].
To assess growth factor transport as a function of differentiation, the model was used
to generate representative patterns of undifferentiated and differentiated cells from
transitional stages (Fig. 5-10). The differentiated cells either maintained the same
uptake rates as the undifferentiated cells or exhibited increased of decreased uptake.
Overall, these data suggest that the influence of the differentiated cells is not appar-
ent at early stages, but dominates later stages of differentiation. Moreover, while the
transport patterns remain largely reminiscent of spherical diffusive transport profiles,
the patterns of differentiation also lead to spatial heterogeneity, particularly in the
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Figure 5-9: Attenuation of growth factor signaling in spheroids. Forward
scatter (FSC) versus CFP fluorescence profiles for monolayer (top) and spheroid
(bottom) cultures, across a range of BMP4 concentrations, including 0, 5, 10 and
20 ng/mL. The denoted gate was established based upon 1% in naive, untransduced
D3s. Cells cultured in monolayer demonstrated increased proportions of CFP+ cells,
with a decreased coefficient of variance. † = p≤0.01 compared to nave cells (untrans-
duced D3s). * = p<0.005 compared to denoted comparison.
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transitional stages whereby approximately half of the cells are differentiated. To-
gether, these data indicate that changes in the molecular identity of differentiating
cells may dynamically alter growth factor signaling within spheroids, leading to in-
creases and decreases in the transport limitations characteristic of specific growth
factors.
5.4 Discussion
This study elucidates the dynamics of diffusive transport during stem cell differen-
tiation and highlights characteristics of stem cell aggregates that lead to transport
limitations. The analysis of both small molecule uptake and growth factor signal-
ing via quantitative, single cell metrics provided a foundation for mathematically
probing a larger experimental space by varying individual parameters such as cell
density, biochemical characteristics (uptake, concentration), and cell phenotype. As
stem cell aggregates pose unique challenges due to dynamic changes in cell identity
and aggregate size, as well as exquisite sensitivity to both microenvironmental and
biochemical cues, this study provides a foundation for understanding the role of ex-
ogenous morphogens during differentiation. Together, these data highlight the stark
transport limitations in stem cell spheroids, thereby suggesting an increasing role of
endogenous factors in the regional patterning and morphogenesis that occur within
differentiating structures and organoids and ultimately highlighting individual pa-
rameters, which may be exploited through engineering approaches to modulate the
delivery of exogenous biochemical cues.
The transport within spheroids has long been an area scientific interest, particu-
larly in the context of oxygen transport [337], as the high oxygen uptake rates lead to
hypoxic conditions, which can cause necrosis [347] and decreased growth rates [46].
Interestingly, Wartenburg et al measured a 10 fold increase in the diffusion coefficient
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Figure 5-10: Spatial heterogeneity in growth factor transport due to phe-
notypic transitions. EBs consisting of undifferentiated (cyan) and differentiated
(blue) cells from representative transitional stages of differentiation, consisting of 25,
50 and 75% differentiated cells, were developed using a computational algorithm. The
transport was modeled in the instances where: all cells exhibited constant uptake,
differentiated cells exhibited 10-fold increased sensitivity to the soluble morphogen,
and differentiated cells exhibited 10-fold decreased sensitivity.
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within vascularized EBs compared to early stage, avascular spheroids [347]; similar to
the incorporation of microparticles, modeled herein, the development of voids within
the spheroid structure highlight opportunities for engineering spheroids with altered
diffusive transport kinetics via incorporation of internal structures via guidance of
biological phenomena or integration of novel biomaterial structures. Moreover, the
increased diffusive transport within vascularized EBs has implications for the role
of exogenous morphogens during the course of time and in the context of directed
differentiation protocols toward different germ lineages, particularly within spheroids
composed of tightly packed, epithelial structures which remain avascular, even at
later stages of differentiation.
In addition, regions of tumor formation in vivo also rely primarily on diffusion
[296], due to the lack of lymphatics, which has prompted parallel studies of tumor
spheroids [313], which exhibit similar dense cellular organization and avascular char-
acteristics, analogous to stem cell aggregates. Multicellular tumor spheroids have
provided valuable insight into cancer biology, as they recapitulate aspects of in vivo
pathology, including cellular heterogeneity [369], morphology [60], cell growth kinet-
ics [132, 109], and drug resistance [348, 330], more accurately compared to the same
cells in monolayer cultures, thus underscoring the context dependence of responses
to environmental cues. In addition, the density within cellular aggregates comprised
of other stem and progenitor cell types (i.e. MSC spheroids, neurospheres, cardio-
spheres) [20, 17, 30, 82] dictates similar consideration in the experimental design, as
the in biochemical milieu will likely be distinct from that of cells in monolayer or
other scaffold-based 3D formats.
In contrast to cancer therapeutics, which largely rely on the transport of small
molecule drugs, embryonic development and stem cell differentiated occurs via the
integrated effects of a wide range of different morphogens [228]. For example, retinoic
acid, which is secreted by Hensens node in chick development [136], is a hydrophobic
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small molecule (300 Da) that is membrane permeable and does not depend on ex-
tracellular receptor binding for downstream signaling [261]. Therefore, the transport
characteristics of small molecule dyes such as calcein AM (995 Da) may more accu-
rately recapitulate the spatial transport characteristics of retinoic acid. In contrast,
growth factors exhibit a wide range of molecular sizes and signaling is dependent
upon receptor presentation, which dramatically alters the availability, analogous to
molecular consumption or uptake rates. As the cell surface identity of cells is dy-
namically altered during the course of stem cell differentiation [289], the changes in
receptor distribution are expected to alter the transport characteristics of stem cell
spheroids, both due to spatial and temporal changes in cell fate (Fig. 9). While
growth factor signaling has previously been difficult to characterize quantitatively,
the novel technology [297] implemented herein provides a proof-of-concept for under-
standing BMP4 signaling in spheroids; in combination with imaging platforms [135],
signaling reporter cells may be amenable to further elucidating the spatiotemporal
kinetics of signaling in real time during differentiation.
In addition to direct changes in receptor availability upon phenotypic changes, cell
fate also alters the metabolic and proliferative properties of the differentiated cells
[135, 205], which may also change the efficacy of delivered morphogens. For example,
the responsiveness of tumor cells to cancer therapeutics is altered spatially [147], and
hypothesized to originate due to the metabolic and hypoxic state of cells at the cen-
ter of the tumor [85]. The oxygen transport in spheroids has been computationally
[337] and experimentally [346, 278] studied in various contexts, with reports of hy-
poxic regions, particularly at the center of large EBs. Therefore, regions of hypoxia
within EBs may also lead to spatial heterogeneity due to increased signaling via the
HIF pathway [50], and may therefore alter the response to exogenous morphogens
and the profile of endogenously secreted morphogens as a function of differentiation
stage. Moreover, extracellular matrix molecules [105], such as glycosaminoglycans,
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alter transport via steric hindrance as well as through binding of growth factors,
which alters the availability and diffusion coefficient of molecules within multicellular
spheroids [239, 152]. In addition, one parameter not accounted for in this model is
the internalization and degradation of molecules. While such dynamics depend upon
receptor availability and ligand concentration, the dynamic changes in response to
exogenous molecules may also contribute to spatial changes in the diffusive trans-
port profile, particularly at high concentrations [123]; in addition, as typical media
replenishment regimens are on the order of several days, the steady state transport
may be altered over time due to degradation of supplemented morphogens. This phe-
nomenon highlights the possibility that endogenous molecules may play increasing
roles at distinct stages of differentiation, depending on the timing and precision of
the supplementation regimen, which may ultimately alter the differentiation trajec-
tories and/or the inter-experimental variability either within or across laboratories.
The results presented demonstrate the attenuated small molecule and growth fac-
tor signaling within spheroids, highlighting the need for increased concentrations
and/or alternative delivery modalities. These results have direct implications for
the adaptation of protocols developed in monolayer, and highlight the increased role
of paracrine signaling in spheroids. Therefore, in the context of current techniques
for organoid differentiation and morphogenesis, it is likely that the signals dictating
patterning and interior structure formation are derived from paracrine signals de-
rived from various populations within the spheroid. However, there may also be an
essential role for the exogenous milieu in directing differentiation via the exterior cells
[39, 164]. For example, EB differentiation in the presence of serum has been well char-
acterized to occur via specification of the exterior cells toward the endoderm lineage
[95]; moreover, the endoderm cells further direct differentiation within the spheroid
toward cardiac fates [22], analogous to similar signaling roles in embryonic develop-
ment [293]. In addition, polarity has been postulated to play a role in the spatial
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context for embryonic development [341], which highlights possible innate differences
in the cells at the exterior and interior of spheroids.
The stark transport characteristics of EBs also highlight opportunities to develop
engineering approaches amenable to altering the exogenous delivery to impart spa-
tially precise gradient or present localized morphogen delivery. Therefore, the in-
creasing implementation of stem cell spheroids within microfluidic platforms [368] is
a promising to route to impart controlled culture conditions and is easily amenable
to gradient formation [63] and fluidic convection [162]. In addition to the physical
and structural role for microparticles in modulating the effective cell density within
spheroids, morphogen delivery via microparticles also provides a method for local
exogenous presentation of growth factors and small molecules in the interior of cell
aggregates [41, 51]. With the advent of new approaches to precisely control bio-
chemical loading and release [185], it may be possible to create a more homogeneous
biochemical context, analogous to differentiation of stem cells in monolayer or to di-
rect patterning via precise, localized point sources of morphogen secretion [124], in
order to recapitulate the activity of organizing centers in development.
Ultimately, the biophysical characteristics of stem cell aggregates, including high
cellular density, minimal ECM deposition, and embryonic-like biophysical characteris-
tics (Chapter 4), paired with the high metabolic demand of stem cells and complexity
arising from divergent differentiation trajectories, contribute to unique transport pro-
files accompanying the initiation and differentiation of stem cell-derived microtissues
and highlight routes to harness or modulate the exogenous gradients for the develop-
ment of tissue engineered constructs or patterning of organoid structures.
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CHAPTER VI
DEVELOPMENT OF A BIOREACTOR PLATFORM FOR
CONVECTIVE TRANSPORT IN STEM CELL
AGGREGATES
6.1 Introduction
The growing interest in the clinical promise of stem cells has prompted parallel strate-
gies to engineer scalable manufacturing platforms for the implementation of stem cell
expansion and differentiation schemes within bioprocess development pipelines. Inter-
estingly, the culture of pluripotent embryonic stem cells (ESCs) as three-dimensional
spheroids, traditionally implemented as a route to induce differentiation [146], is
easily amenable to traditional scalable bioreactor platforms, across different volume
scales [377, 47, 104]. Such large volume mixed configurations such as spinner flasks,
rotating wall vessels (RWV), and slow turning lateral vessels (STLV) enable batch
processing, with increased control of the physiochemical parameters of the culture
environment [42] via automation and monitoring [291, 21], thus allowing increased
reproducibility within and between lots of the biological product. Moreover, the stem
cell spheroids, termed embryoid bodies (EBs), enable parallel processing of individ-
ual microtissues within a single reactor volume; however, in contrast to traditional
tissue engineering strategies which employ fixed scaffolds within the reactor [32], mi-
crotissues freely move with the fluid flow [282], thereby complicating the analysis of
hydrodynamic parameters such as fluid shear and transport within stem cell spheroids
[166]. In addition, stem cells pose distinct requirements due to the extreme sensitiv-
ity to biophysical and microenvironmental perturbations [52, 282, 165], as well as
heterogeneity stemming from the three-dimensional microtissue structure [39]. While
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stem cell expansion and differentiation within platforms adapted from other indus-
tries have provided a proof-of-concept for the feasibility of implementation in scalable
bioprocesses, the increased understanding of stem cell biology motivates parallel tai-
lored approaches for engineering novel platforms to direct three-dimensional stem cell
differentiation.
Routes to direct stem cell differentiation have traditionally relied on conserved sig-
naling pathways studied in embryonic development and morphogenesis, and therefore
largely focus on the delivery of biochemical cues, such as growth factors and small
molecules, to alter stem cell fate in a temporally sensitive manner [228]. However,
within stem cell spheroids, the biochemical context is also spatially altered, due to
diffusive transport limitations [278, 51], thereby resulting in spatially heterogeneous
signals, which may ultimately impact cell fate. Therefore, understanding and con-
trolling transport within stem cell spheroids has implications for directing stem cell
differentiation and patterning. In analogous avascular microtissues, low velocity ex-
tracellular fluid flow improves viability of large tissue constructs [271, 75, 76] and
has been implicated in morphogenesis and remodeling. For example, implementation
of interstitial flow in vitro [35] directs blood and capillary formation [294, 130, 131],
ECM deposition [267] and as well as cell alignment [240], and migration [264], likely
due to the development of morphogen gradients and proteolytic remodeling. More-
over, at velocities in the range of interstitial transport (0.1-1 µm/s) [123], the local
shear stresses have been measured on the order of 10−2 - 10−3 dyn/cm2 [257], suggest-
ing that interstitial transport may be amenable to overcoming transport limitations
in avascular tissues, without imparting high shear forces.
The objective of this study, therefore, was to engineer a novel bioreactor platform
to impart convective transport, based on the design constraints specific to stem cell
biology and spheroid differentiation. A custom bioreactor was designed and fabri-
cated in order to impart controlled convection by altering the pressure drop across
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aggregates immobilized within individual fluidic microwells. Interestingly, while EBs
were immobilized with high specificity, there was no significant evidence of increased
dye uptake upon forced convection via perfusion. To inform the parameters for a
computational fluid dynamics (CFD) model of fluid transport in stem cell spheroids,
the bioreactor platform was instead employed as a novel route to directly measure
fluidic resistance and permeability within EBs. Overall, while EBs exhibited a range
of permeability (∼107 cm2) conducive to fluidic transport at low velocities with min-
imal stress (<1 dyn/cm2), CFD modeling suggested that the mismatch in bulk and
EB permeability within the bioreactor design resulted in non-uniform flow within the
EB. Together, these data suggest a computational proof-of-concept for the implemen-
tation of low velocity fluidic convection by matching bulk permeability with that of
stem cell spheroids as a novel route to deliver morphogens and engineer gradients to
manufacture three-dimensional microtissues amenable to implementation as clinical
regenerative therapeutics.
6.2 Materials and Methods
6.2.1 Bioreactor fabrication and assembly
A perfusion bioreactor was custom designed using SolidWorks and fabricated via
stereolithography using a Viper SLA system (FineLine Prototyping), which is ideal
for manufacturing fine details, with a minimum feature size of 0.004 inches. The
bulk bioreactor material was a Somos 9120 resin, which is a UV cured photopolymer.
The parts underwent standard finishing by sanding to remove SLA artifacts prior to
assembly. The internal features of the bioreactor were created from a 500 µm thick
sheet of polyethyl ethyl ketone (PEEK), with holes created via laser drilling. The
array was specified with 110 holes of 80 µm diameter, with 750 µm spacing between
the holes. The final bioreactor platform was assembled via standard hardware and
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using polydimethylsiloxane (PDMS) to create an air- and water-tight seal.
6.2.2 Bioreactor operation and validation
The bioreactor design implemented threaded input ports for cross flow and EB seed-
ing, as well as output ports for the cross flow and perfusion. The tubing configuration
was set up such that the two outputs were driven independently by individual syringe
pumps (KD scientific), with working flow rates in the range of µL/min. Initial filling
of the channels was accomplished via subsequent washes with ethanol and PBS in
order to ensure removal of all bubbles from the system. In addition, three-way valves
were implemented within the tubing upstream of the device input in order to avoid
bubble entry while switching solutions.
The validation of cross flow and residence time was accomplished using dye in-
jected into the system at a series of flow rates. The videos of dye flow through the
device were collected using a digital camera and were analyzed via a custom written
MATLAB code, whereby the image analysis was conducted across samples from var-
ious locations in the chamber, and iterated over the course of time. The normalized
concentration was plotted as a function of time, and the residence time was calculated
as the difference between the curves at opposite ends of the channel.
6.2.3 Embryoid body formation & culture
Murine embryonic stem cells (D3 cell line) were expanded undifferentiated in Dulbec-
cos Modified Eagles Medium (DMEM) containing fetal bovine serum (FBS; 15%),
L-glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 µg/mL), ampho-
tericin (0.25 µg/mL), non-essential amino acids (1x), β-mercaptoethanol (0.1 mM)
and leukemia inhibitory factor (LIF; 1000 U/mL). Media was replenished every other
day and cells were routinely passaged at 70% confluence.
Embryoid bodies were formed via forced aggregation of undifferentiated ESCs
into 400 µm diameter agarose microwells, with 1000 cells per well. After 24 hours
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of formation, spheroids were removed from the microwells and transferred into bulk
suspension in 100 mm petri dishes on a rotary orbital shaker. EBs were maintained
by exchanging 90% of the media every other day through day 7 of differentiation. EB
formation was accomplished using complete ESC media without LIF, as previously
described, and were subsequently differentiated in either the same serum containing
media or a chemically defined serum-free media containing N2 and B27 supplements.
6.2.4 Mathematical modeling of oxygen concentration & fluid shear
The steady state oxygen concentrations within the bioreactor channel were math-
ematically assessed using standard models for transport and consumption within
a well-mixed volume. The oxygen consumption rate was assumed to be 4x10−17
mol/cell/s, based on previous reports in stem cells [337], and were assumed to remain
constant during the course of differentiation. The number of cells within the system
was assumed to increase based on previously measured growth kinetics, with ∼7 fold
increase over the course of differentiation. The total number of cells was modeled
based on the previously measured metric of cells per EB, assuming 100% seeding
efficiency within the perfusion array. Curves of oxygen concentration as a function of
flow rate were constructed for each day of differentiation and the minimum flow rates
were established, defined as the rate at which oxygen concentration was maintained
at 90% of the bulk concentration at steady state. The wall shear due to fluid move-
ment was calculated across the same range of fluid flow conditions, according to the





where Q (m3/s) is the volumetric flow rate, µ (Pa·s) is the fluid viscosity, b (m)
is the chamber width, and h (m) is the chamber height.
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6.2.5 Small molecule transport
The transport within EBs was characterized via fluorescent dye distribution in EBs,
using calcein AM (0.1 µM) in DMEM. In all cases, EBs were immobilized in the
microwell array using DMEM alone, as previously described. Media containing calcein
AM was then flowed through the channel at an exchange range of 200 µL/min for 10
minutes (total volume of 2 mL), followed by washing with DMEM at the same flow
rate for 20 minutes. In addition to the cross-flow delivery of calcein AM, perfusion
flow was imparted at rates of 10 and 50 µL/min. In each case, the cross flow rate was
decreased to 190 and 150 µL/min, respectively, in order to conserve the total molar
quantity of calcein AM delivered to the EBs over the course of the experiment. After
washing, EBs were collected from the outlet, dissociated using 0.05% trypsin / 0.53
mM EDTA, and suspended in PBS. The fluorescent intensity profiles within the cell
populations were assessed via flow cytometry using an Accuri C6 cytometer with an
attenuated FITC filter (FL1 90%; 530 15 nm). Subsequent analysis was conducted
with FlowJo software.
6.2.6 Measurement of EB permeability
EB permeability was assessed directly within the perfusion bioreactor configuration
by measuring the pressure drop across EBs. EBs were immobilized within the mi-
crowells by adding a large excess of spheroids within the bioreactor volume. The flow
configuration was modified to include a series of two pressure transducers upstream
of the inlet and downstream of the perfusion outlet. The pressure drop was recorded
as a function of flow rate, across a range of relevant perfusion flow rates (50-500
µL/min). Baseline measurements without EBs were recorded in order to determine
the baseline resistance of the empty reactor volume and subsequent measurements
of EBs were then normalized by subtracting the empty baseline. The slope of the
resultant curve (pressure vs. flow rate) was then used to define the fluidic resistance
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where ∆P/Q (Pa·s/m3) was the slope of the curve, µ (Pa·s) is the fluid viscosity,
∆L (m) is the diameter of the EB, and A (m2) is the cross sectional area of flow
through the series of 110 holes (80 µm diameter). The diameter and cellular com-
position of EBs was characterized in parallel using morphometric analysis of phase
images and coulter counter metrics, respectively.
6.2.7 Computational fluid dynamics
To model the perfusion flow within EBs, a simplified geometry was developed in
COMSOL, consisting of an EB immobilized over a single microwell with single inlet
and outlet. The model employed coupled fluidic and solid mechanics physics modules
in order to assess the transport as well as physical changes in EB ultrastructure under
perfusion conditions. Within the free and porous media flow model, the bulk media
was approximated to have the same properties as water, with the EB modeled as
a porous media of defined properties (Table 2). The permeability and mechanical
characteristics were based upon previously measured values; the porosity was based
on the previously validated assumption of spherical packing within EBs [349] and
the remaining geometries were based upon constraints from the bioreactor design.
The fluid was driven by laminar outflow at defined velocities from 1-100 µm/s, with
laminar inflow assuming atmospheric pressure. The secondary solid mechanics module
employed the solution for pressure drop in response to fluid flow as the boundary
condition for determining the stress and deformation on the spheroid, with the EB
modeled as a linear viscoelastic material. A stationary solver was used to determine
the solutions within a physics-controlled mesh consisting of 63131 elements. Based
upon the 2D solution, a vertical 1D cut line was created corresponding to the length
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of the EB along the center of microwell outlet and the pressure drop was calculated as
the pressure difference across the EB length. The minimum and average calculations
for stress and deformation were calculated over the domain corresponding to the EB
area.
Table 2: Computational fluid dynamics model biophysical parameters
Parameter Value Reference
Permeability 1x10−11 m2 Measured
Porosity 0.25 Spherical packing
Young’s modulus 200 Pa Measured
Poisson’s ratio 0.45 Measured
Outlet diameter 80 µm Design constraint
Chamber height 800 µm Design constraint
Velocity (output) 1-100 µm2/s Independent variable
6.2.8 Statistical analysis
All experimental analyses were conducted with n=3 replicates, and represented as
the mean ± standard error. Prior to statistical analysis, all data were pre-processed
using a box-cox power transform, in order to normalize data according to a Gaussian
distribution. Statistical tests were conducted between groups and time points using




6.3.1 Design constraints & principles of operation
The central objective of this project was to design a novel bioreactor platform to
enable convection within stem cell spheroids. The design criteria were developed
based on engineering (Table 3) and biological (Table 4) constraints, which together
accomplish the two major goals of: (1) supporting standard spheroid culture condi-
tions, while simultaneously (2) imparting convection through spheroids. Specifically,
the simple parallel plate channel design (Fig. 6-1 A) enables laminar flow, with well-
mixed concentrations via a series of pillars at the input and output, in order to permit
exchange of media, waste, nutrients, analogous to bulk media exchange in standard in
vitro cultures. Moreover, in addition to supporting cell viability via media exchange,
the parallel plate flow configuration also enables morphogen supplementation and
removal, in order to direct differentiation via biochemical cues with high temporal
sensitivity. Within the channel design, a laser-drilled grid is housed above the per-
fusion outlet. The polyether ether ketone (PEEK) grid serves the dual purposes of
enabling immobilization of spheroids within microwells (110 wells per channel; 80 µm
diameter) and ensuring that all flow exiting the perfusion outlet occurs through the
microwells, and thus through the immobilized EBs. By arraying the spheroids with
fixed well spacing (750 µm), the device design enables independent culture of EBs,
and avoids agglomeration that can lead to size heterogeneity [165] and increased trans-
port limitations. Moreover, the fluid convection constrained through the microwells
decreases the cross sectional area for flow, and thus decreases the overall magnitude
of velocity required within the system. Finally, when assembled, the device can be
maintained as a closed-loop, with separate modes of operation for: (1) EB seeding,
(2), cross flow, and (3) perfusion flow, each of which has independent control via
input/output ports and syringe pumps (Fig. 6-1 B). A port at the top of the channel
enables direct EB input to the channel volume; upon deposition into the channel,
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the perfusion flow is employed to capture the spheroids over microwells, while any
free spheroids are removed via cross flow. During the culture duration, the cross and
perfusion flows are operated separately via downstream syringe pumps, in order to
modulate the delivery and/or transport kinetics of the system. EBs can be retrieved
by simply ceasing perfusion flow and collecting the fluid volume from the cross flow
channel outlet.
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6.3.2 Exchange of nutrients, waste, and supplements
In order to enable flexibility in terms of exchange kinetics, the parallel plate flow
channel was designed with a small volume (∼0.5 mL). In addition to the channel size,
the small number of immobilized EBs enables the implementation of low velocity
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Figure 6-1: Bioreactor design and operation. (A) The perfusion bioreactor con-
sists of an assembly of three pieces: (1) a lid containing the inlet port for EBs, (2)
the main body of the bioreactor with parallel channel geometry, cross flow inlet and
outlet and perfusion outlet, and (3) a laser drilled grid amenable to arraying immobi-
lized EBs, which is housed above the perfusion outlet. (B) The assembled bioreactor
operates in three independent modes, by enabling EB seeding (blue), providing cross
flow of media and morphogens (gray), and perfusion through the microwells (red; in-
set). Bioreactor drawn to scale, based upon SolidWorks drawing, with relevant length
scales denoted. Scale bar in (B) = 50 µm.
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flow in order to provide adequate oxygen and nutrient transport (Fig. 6-2 A). Based
on known growth kinetics and molecular consumption rates of oxygen, the average
concentration was calculated across a range of flow rates, assuming well-mixed con-
ditions within the channel (Fig. 6-2 B). Particularly at early stages of differentiation
with smaller EBs (∼1700 cells/EB), flow rates as low as 50 µL/min would maintain
adequate oxygenation within the channel volume. However, by 7 days of differenti-
ation (∼14,000 cells/EB), a minimum exchange of 350 µL/min would be required.
Although the increase in cell yield during differentiation necessitates a >7 fold in-
crease in the fluid exchange, the magnitude of flow rates remains low, with fluid shear
below 1 dyn/cm2 (Fig. 6-2 C). Therefore, the parallel plate bioreactor design is
amenable to providing adequate oxygenation while imparting minimal fluid shear on
EBs.
In addition to functionality in terms of media replenishment, the cross flow design
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Figure 6-2: Oxygen exchange via laminar cross flow. (A) Schematic represen-
tation of the bioreactor cross flow. (B) The oxygen concentration was mathematically
calculated across a range of flow rates, based upon standard mass balance equations
with known rates of ESC oxygen consumption and EB sizes after days 2 (blue), 4
(green) and 7 (red) of differentiation. The concentrations for standard in vitro culture
concentrations at atmospheric (21% O2) and low or hypoxic (5% O2) oxygen levels
are denoted for reference. (C) Based upon calculated oxygen concentration curves,
the flow rate corresponding to 90% of atmospheric oxygen (90 µM) was determined
as the minimum flow rate for each day of differentiation. Moreover, the fluid shear
stress arising due to cross flow within the parallel chamber was calculated for the
minimum flow rates corresponding to each day of differentiation.
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within the parallel plate chamber also enables temporal control of the biochemical
microenvironment, including additional and removal of supplements such as growth
factors or other morphogens. While the exchange time varies depending on the ap-
plication and cross flow velocity, there is a rapid transition in concentration, on the
order of minutes, within the range of expected cross flow rates (Fig. 6-3 A). For ex-
ample, while the expected cross flow rates varied from 50-350 µL/min during the
course of EB culture, the corresponding exchange times range from 27 to 3 minutes,
respectively (Fig. 6-3 B). Moreover, the fast temporal dynamics of media exchange
also enables rapid swapping of media compositions; by implementing a manual or
automated valve system, it is possible to continuously alter the biochemical concen-
tration on the order of minutes. While the temporal dynamics of morphogen addition
to stem cell culture has been identified as a critical determinant of cell fate, the fea-
tures implemented within the perfusion bioreactor platform are amenable to more
systematically perturbing the temporal experimental space.
6.3.3 Embryoid body immobilization
In addition to the spatiotemporal control of the biochemical composition enabled by
the parallel plate cross flow design, the bioreactor also integrates a novel, laser-drilled
grid microwell configuration for EB immobilization and perfusion. The array of 110
wells was first validated for the capacity to immobilize an array of EBs. The seeding
procedure was developed such that a large excess (∼10 fold) of EBs were added to
the chamber volume via an input port at the top of the bioreactor design (Fig. 5-2)
while simultaneously imparting a pressure drop through the microwells via suction
at the perfusion outlet. Subsequently, the remainder of EBs were removed from the
chamber via the cross flow, using 30% Percoll, in order to increase the EB buoyancy
and facilitate entry into the cross flow stream. Upon further washing with media to
remove the Percoll, the seeding was assessed via two metrics: 1) efficiency, or the
120
Figure 6-3: Biochemical exchange via laminar cross flow. (A) Dye entry into
the bioreactor channel exhibits characteristics of laminar flow, and occurs over the
course of minutes at a flow rate of 200 µL/min. (B) When varying the flow rates
within a relevant range for EB culture, the channel reaches equilibrium via curves
of logarithmic character (red lines), with equilibrium reached more quickly at higher
cross flow rates. (C) Experimental measurements and mathematical calculations for
the exchange time, defined as the time to reach 90% equilibrium, were consistent
across a range of flow rates, and corresponded to exchange times in EBs (based upon
minimum flow rates denoted in Fig. 2) <25 minutes. (D) The flow characteristics
and fast exchange rates of the platform are also amenable to oscillatory control of
concentration within the bioreactor on the order of minutes, by simply changing the
input solution. Scale bar in (A) = 5 mm.
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percentage of microwells containing immobilized EBs, and 2) specificity, or the per-
cent of EBs remaining in the bioreactor which were properly immobilized over wells
(Fig. 6-4). The second metric is particularly important, as EBs remaining on the
solid PEEK grid area would not undergo convective perfusion. Under the established
seeding procedure, the efficiency of seeding varied between ∼50-90% within individual
channels of the bioreactor; however, the overall seeding procedure was reproducible,
with no statistical differences between individual seeding trials. Upon visual inspec-
tion of dye efflux from the microwells, it was clear that some of the wells were blocked,
due to the small cross sectional area. Moreover, a qualitative estimate of free holes
demonstrated that there was a difference between channels, with channels 1 and 3
exhibiting ∼70-80% microwells freely permeable to convection, whereas channels 2
and 4 exhibited low instances of clogged microwells, with ∼90-100% open. There-
fore, it is likely that the seeding efficiency discrepancies can be explained by relative
variability between channels and that all channels exhibit high seeding efficiency, as
a percentage of open microwells (∼80-90%). Moreover, the specificity remained high
within all channels and across individual trials, indicating that, although all wells
were not necessarily filled, the majority (∼90%) of EBs within the bioreactor grid
region were immobilized within microwells. Together, these data suggest that the
majority of EBs seeded within the bioreactor are immobilized within the microwells,
and therefore would undergo perfusion upon implementation of a pressure drop across
the microwells.
6.3.4 Convective transport within stem cell aggregates
As previous work indicated striking transport limitations of small molecules dyes
within diffusive transport regimes (Chapter 5), the transport of calcein AM was stud-
ied in the context of bioreactor delivery and perfusion of EBs after days 2 (Fig. 6-5)
and 4 (Fig. 6-6) of differentiation. As previously established, the formation of EBs
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Figure 6-4: EB immobilization within perfusion microwell arrays. Quan-
tification of efficiency and specificity of EB seeding within the perfusion bioreactor
microwell array, both as a comparison across individual channels and seeding trials.
n = 3 independent trials for n=4 bioreactor channels; * = p<0.05 within indicated
comparison.
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via forced aggregation followed by culture in rotary orbital suspension enables the
maintenance of relatively homogeneous, size-controlled populations (Chapter 3). Af-
ter 2 days of differentiation, EBs exhibit a narrow distribution in terms of EB cross
sectional area, with an average diameter of 250.7 µm, whereas EBs were slightly larger
(296.9 µm) by day 4 of differentiation. Therefore, both populations were studied, as
the transport limitations were expected to be more pronounced in larger EBs. Con-
sistent with purely diffusive transport studies (Chapter 5), the delivery of 0.1 µM
calcein AM via cross flow (200 µL/min, total volume of 2 mL) led to EBs exhibiting
similar transport limitations, as denoted by a small shift, yet substantial overlap, in
fluorescence intensity profile, compared to unstained cells. Therefore, the fluorescence
profile of EBs under perfusion was hypothesized to exhibit a more pronounced shift,
approaching that of cells stained as a single cell suspension (Chapter 5, Fig. 5-3).
However, upon perfusion of EBs at 50 µL/min and a conserved mass flow rate of
calcein delivery (200 µL/min), EBs exhibited similar fluorescence intensity profiles
compared to those maintained in the absence of perfusion, and did not exhibit sta-
tistically significant changes in terms of the median and coefficient of variance of
fluorescence or the percentage of positive cells. Moreover, EBs maintained under the
same conditions at day 4 of differentiation exhibited similar results, with comparable
fluorescence profiles in the presence and absence of perfusion.
6.3.5 Measurement of EB permeability
Although the growth characteristics, size and morphology of EBs have been well char-
acterized during the course of differentiation (Fig. 6-7 A; Chapter 3), relatively little
is known regarding the biophysical characteristics of the three dimensional microen-
vironment; therefore, the bioreactor platform was also employed as a novel approach
for directly measuring the fluidic properties of stem cell spheroids. The fluidic re-
sistance of EBs, defined as the change in pressure over a range of flow rates, was
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Figure 6-5: Convective small molecule transport within day 2 EBs. EBs after
day 2 of differentiation exhibited spherical morphology with a narrow size distribution.
The fluorescence profiles after staining with calcein AM exhibited a shift compared
to unstained EBs (gray), both without perfusion (black) and after perfusion at 50
µL/min (red). However, the median, coefficient of variance (CV) and percent of
positive cells were not statically different when comparing perfused EBs to those
maintained without perfusion.
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Figure 6-6: Convective small molecule transport within day 4 EBs. EBs af-
ter day 4 of differentiation exhibited changes in morphology and size coincident with
differentiation, resulting in a wider distribution and overall larger EBs. The fluores-
cence profiles after staining with calcein AM exhibited a shift compared to unstained
EBs (gray), both without perfusion (black) and after perfusion at 50 µL/min (red).
However, the median, coefficient of variance (CV) and percent of positive cells were
not statically different when comparing perfused EBs to those maintained without
perfusion.
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calculated by measuring the pressure drop across the perfusion outlet in the pres-
ence of immobilized EBs. Between days 2 and 7 of differentiation, the resistance of
EBs to fluid flow significantly increased (p<0.05 compared to days 2 and 3), with an
apparent transition between days 3 and 4 of differentiation (Fig. 6-7 B&C). Recipro-
cally, the permeability of EBs decreased during the course of differentiation; however,
EBs remained more permeable to fluid flow compared to tissue engineered constructs
or native tissues (Fig. 6-7 D). In addition, the number of cells per EB was directly
correlated (p=0.01) with the resistance, whereas the cell size exhibited a significant in-
verse correlation (p<0.001) with resistance, thereby demonstrating that morphogenic
changes that occur during differentiation are related to changes in the fluidic prop-
erties of EBs. Together, the measurement of EB permeability provides a basis for
further understanding diffusive and convective transport in stem cell spheroids.
6.3.6 CFD analysis of perfusion flow within EB microwells
To more throughly dissect the mechanisms underlying convective transport in the
bioreactor platform developed herein, computational fluid dynamics (CFD) model-
ing was employed to inform spatially aspects of the fluid flow within the bioreactor
platform, based upon measured biophysical characteristics (transport, mechanical),
as well as the geometric design constraints. CFD is an advantageous approach for
providing preliminary assessments of fluid dynamics, as the solvers employ numerical
algorithms to determine approximations for parameters that can not be solved ana-
lytically; while such approaches are subject to caveats such as spatial discretization
associated with finite element methods and insufficient convergence, CFD modeling
provides a relatively rapid and cost-efficient method to study variations in geomet-
rical and fluidic parameters [246]. In the model employed herein, the solutions have
been verified to ensure conservation of mass across several different cross sections of
the bioreactor. However, the numerical solutions and conclusions presented herein
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Figure 6-7: Measurement of EB permeability. (A) Representative EBs exhibit
changes in size and morphological characteristics during the course of differentiation,
thus motivating the analysis of biophysical characteristics, such as permeability. (B)
The pressure drop across EBs in the perfusion bioreactor was measured at days 2
(blue), 4 (green) and 7 (red) of differentiation and (C) the slope of the relative curves
was used to calculate the resistance during the course of differentiation. (D) Known
geometrical characteristics of the bioreactor and EBs were then used to calculate the
permeability, and compared to previously reported characteristics of other microtis-
sue and native tissues. The fluidic resistance was also directly compared with physical
characteristics of EBs, including the cellular composition (cells per EB) and the av-
erage cell size, both of which were significantly correlated with resistance. (C) p <
0.05 compared to: * day 2, † day 4 of differentiation. Scale bar in (A) = 200 µm.
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should also be validated by experimental approaches such as particle image velocime-
try (PIV).
Across several relevant orders of magnitude for permeability, the model predicted
flow through the EB, approximated as a spherical porous material, to varying extents
(Fig. 6-8 A), with increasing spatial heterogeneity arising coincident with increasing
resistance (decreasing permeability). Specifically, at high permeabilities (10−6 10−7
cm2), the velocity profiles exhibited uniform flow within the EB; however, as the per-
meability decreased, the velocity profiles were not uniform and exhibited increased
flow within the bottom portion of the spheroid, adjacent to the the microwell edges.
While EBs exhibit relatively low fluidic resistance (Fig. 5-5), the CFD profiles within
spheroids of increasing resistance suggest that much of the flow may circumvent the
EB, with even more stark implications for imparting fluidic convection in more ma-
ture tissues which exhibit further decreased permeability. In addition, as expected,
the pressure drop across the spheroid increased with increasing resistance, with mag-
nitudes on the order of 1 Pa (Fig. 6-8 B). Although localized regions of stress were
apparent at the contact region between the EB and the microwell (Fig. 6-8 C), the av-
erage stress across EBs under a relevant range of perfusion velocities did not exceed 1
N/m2 (10 dyn/cm2), with the stress at interstitial flow rates as low as 0.05 N/m2 (0.5
dyn/cm2). In addition, the spheroid formation in response to fluidic pressure drop
remained low, with maximum deformation less than 1 µm (Fig. 6-8 D). Together,
these data suggest that across the range of experimental perfusion velocities, EBs are
not expected to undergo appreciable stress or deformation, thereby enabling analysis
of the direct effects of fluid convection and biochemical transport.
One additional complicating factor highlighted by the experimental data is that
of incomplete seeding, which may potentially result in relative changes in resistance
within regions exhibiting open microwells, thereby leading to increased flow through
open microwells and reciprocal decreases in flow through adjacent EBs. Consistent
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Figure 6-8: Computational fluid dynamic model of microwell perfusion
of EBs. (A) A simple model was constructed in COMSOL, consisting of an EB
immobilized above a single perfusion well, with the EB approximated as a porous
material of known properties (Table 1). The velocity profiles through the EB are
depicted for a range of characteristic permeabilities (square = 106 cm2, circle = 107
cm2, triangle = 108 cm2). (B) The pressure drop across the EB also increases as a
function of flow rate, as well as the inherent fluidic resistance of the EB. (C) Localized
regions of Von Mises stress were apparent at the interface between the EB and the
microwell; however, the average stress remained low (<1 N/m2) within EBs across
a range of flow rates. (D) Although solid mechanics physics were used to model EB
deformation within the microwell region, based upon previously measured mechanical
properties (Chapter 4), the deformation remained less than 1 µm within the relevant
perfusion flow rates. All images represent outlet velocities of 20 µm/s. Scale bar in
(A) = 100 µm.
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with such hypotheses, CFD analysis suggested that wells without EBs were expected
to exhibit increased flow velocities and those with EBs immobilized exhibit a de-
creased velocity; however, the relative magnitude of change is relatively low, particu-
larly based on the high seeding efficiency within the bioreactor design; with seeding
efficiencies on the order of ∼80%, the CFD model suggests that there would only be
∼20-30% decrease in velocity through EBs. At the relatively high flow rate tested
experimentally (50 µL/min), a 20-30% change would likely not explain the lack of
transport through EBs under perfusion. In addition, effectively blocking the open
holes by increasing bulk permeability (i.e.immobilizing EBs within hydrogel in the
bioreactor volume) would minimize this effect, but only for instances where the bulk
is closely matched with EB permeability, thereby suggesting an approach whereby
controlling the bulk properties may alleviate heterogeneity due to seeding variability.
In addition, as the CFD analysis highlighted the EB permeability and spherical
geometry as potential factors contributing to the lack of perfusion throughout the
EBs experimentally, the bulk resistance was also explored as a parameter amenable
to controlling the flow patterns around and within EBs. Interestingly, within a spe-
cific range of permeabilities, CFD analysis suggested that altering the bulk material
resulted in more uniform flow through spheroid. Specifically, the flow pattern ob-
served upon perfusion in liquid media results in a very high maximum velocity within
the EB, at the region adjacent to the microwell opening, and relatively low average
velocity throughout the EB. At the point where the bulk permeability matches that
of the EB, the maximum velocity decreases, which suggested a decrease in the pre-
viously modeled flow through the bottom of EBs. Moreover, at the same point, the
average velocity through EBs increased, resulting in more homogeneous flow through-
out. Interestingly, at high bulk permeabilities, the velocity profiles within EBs was
disrupted, suggesting an ideal scenario whereby the bulk is closely matched with EB
permeability.
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Figure 6-9: CFD analysis of the relative changes in perfusion flow rate due
to seeding variability. An expanded Images and analysis based upon 10 connected
perfusion microwells with a common outlet (bottom) was created to assess relative
magnitude and spatial changes in velocity in response to empty microwells. Empty
microwells exhibit increased flow velocities, compared to those through microwells
containing immobilized EBs, with the relative magnitude of decrease related to the
fraction of holes empty. In addition, altering the bulk permeability across several
orders of magnitude, including those matched with EBs (red), alters the relative
change in velocity in response to empty microwells. outlet velocities of 20 µm/s.
Scale bar = 200 µm
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Figure 6-10: Fluid flow patterns in response to changes in bulk permeabil-
ity. Modulation of the bulk permeability across several orders of magnitude (10−5 -
10−9 cm2) alters the flow patterns around and within EBs. The maximum velocity
is decreased, with a peak in average velocity within EBs at the point where the bulk




Together, the data presented highlight a novel route for imparting convective trans-
port within high-density aggregates of stem cells, as an approach to control the bio-
chemical milieu and ultimately engineer the spatiotemporal kinetics of differentiation.
The development of a bioreactor platform has enabled the measurement permeability
in stem cell spheroids, a previously unknown biophysical property. Moreover, the
understanding of EB ultrastructure gained through these approaches, in combination
with previous work, informs the rational design of a bioreactor platform for microflu-
idic perfusion of stem cell aggregates. Ultimately, the increased control of biochemical
transport will create opportunities to understand and perturb three-dimensional mor-
phogenesis and patterning concomitant with in vitro organoid development.
The central motivation for the design and implementation of micron-scale flow
within stem cell spheroids is derived from physiological phenomena, whereby biochem-
ical transport to avascular regions occurs via low velocity, interstitial flow [277, 316].
A common hypothesis is that the steady state size of spheroids in vitro is controlled
by the transport of nutrients and morphogens, with transport limitations restricting
further growth [346]. Therefore, avascular microtissue structures, such as stem cell
and tumor spheroids and tissue engineered constructs, may be amenable to controlled
growth and/or differentiation via implementation of a low magnitude pressure drop
to drive fluidic convection, analogous to interstitial flow. Interstitial flow has been
extensively studied in vivo, with velocities measured on the order of 10−1 -102 µm/s.
In the bioreactor platform developed and described herein, the corresponding mass
flow rates have been calculated on the order of 10−3 - 100 µL/min, which equates to
volumes on the order of ∼5 µL - 5 mL over 24 hours. While the lower range of flow
rates are not expected to provide sufficient oxygenation, the implementation of a low
velocity cross flow, on the order of 102 µL/min or ∼102 µm/s is amenable to delivery
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of biochemical morphogens and nutrients, with removal of waste. Together, the plat-
form described is amenable to implementing fluidic convection on the same order of
magnitude as interstitial flow, as a novel technology to modulate the metabolic and
biochemical context of high density stem cell spheroids.
In the context of tissue engineering, analogous approaches for imparting convec-
tion within larger constructs have been developed and tested, and range on size scales
over several orders of magnitude. For example, the device developed herein is based
upon a model system that was designed to impart a pressure drop across neural
constructs (500-750 µm thickness) comprised of cells embedded in Matrigel [76, 75].
Similarly, cardiac tissue constructs (1.5 mm thickness) have been cultured within a
perfused flow loop, with evidence that the configuration supports increased cell viabil-
ity of explants on the order of millimeters [270, 269]. Interestingly, one commonality
between existing systems is the use of a hydrogel structure to embed cells or tissues
[264, 35], which has traditionally been a central tenet of tissue engineering. However,
the size scale and traditionally scaffold-free culture of stem cell spheroids prompted
additional design constraints to address the parallel processing of many individual
units.
The data presented describe fluidic resistance, inversely proportional to perme-
ability, as a novel metric to characterize the EB biophysical structure. Interestingly,
EB permeability was calculated to be orders of magnitude greater than that of porous,
cell seeded hydrogel constructs [241] or native tissues [189]. Previous work has iden-
tified the structural components of EBs as largely comprised of cell-cell adhesions
and cell-intrinsic tension via cytoskeletal elements (Chapter 4), with minimal ECM
deposition [230], particularly at early stages of differentiation. EBs have also been
previously reported to exhibit epithelial-like morphology and a characteristic shell for-
mation at the exterior [51], with evidence that the EB ultrastructure leads to diffusive
transport limitations for small molecules [278], as well as growth factors (Chapter 5).
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However, the transport characteristics have also been mathematically linked to the
high cell density and uptake rates, rather than physical restrictions.
Previous measurements of the interstitial space within tumor spheroids reported 1
µm spaces between cells, with the interstitial volume constituting ∼16% of the total
spheroid volume [8]. In contrast, while the pore size remains similar [259], the void
fraction within spheroids is much lower than that of hydrogels, which are typically
comprised of >90% water when swollen [258]. In hydrogels comprised of hydrophilic
monomers, the permeability can be controlled by cross-linking density. In addition,
decreasing permeability serves as a route to protect the specimen against mechanical
forces, as the permeability is modulated when the specimen is subjected to either
a fluidic pressure drop or maintained in compression [153]. Therefore, while hydro-
gels and spheroids exhibit different structural characteristics, the permeability may
be tuned such that the bulk properties of the system exhibit similar permeabilities
compared to that of spheroids. Ultimately, the increased understanding of EB perme-
ability permits the incorporation of additional design constraints for the development
of next generation convective bioreactors.
While stem cell spheroids are traditionally expanded and differentiated in the ab-
sence of biomaterial scaffolds, encapsulation of aggregates within polymer beads has
been extensively explored in the context of physical protection from hydrodynamic
mixing as well as for in vivo, immunologically shielded cellular therapies [354, 353].
Such approaches typically employ natural polymers, such as alginate, due to its rapid
and reversible cross-linking via divalent cations. Other thermally reversible natural
polymers, such as Matrigel, fibrin, or collagen, have been explored for their utility in
3D stem cell differentiation; however, as Matrigel is derived from basement membrane
of sarcoma cells, the presentation of ECM molecules and adhesive moieties may dras-
tically alter the trajectory of stem cell differentiation [263] and disrupt the spheroid
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structure by promoting migration into the gel. Therefore, as a relatively inert mate-
rial with respect to cellular interactions, alginates are ideal for the encapsulation of
stem cell aggregates. While encapsulation typically yields spherical droplets, which
may lead to similar convective velocity profiles as exhibited computationally by EBs
alone, it is also possible to create bulk gels from alginates [174]. Moreover, purified
forms of alginate are readily available with different molecular weights and ratios of
the two anionic monomers, which together are amenable to engineering a wide range
of gel properties [169, 354].
Microfluidic platforms have been implemented to array individual spheroids [312]
or tissue structures [62] for real-time monitoring of morphogenic events. However, in
such platforms, the design may limit precise control of the exogenous and endoge-
nous biochemical concentrations, as the array is often immobilized along a single, long
channel. Therefore, factors secreted by EB populations may affect those downstream,
and, reciprocally, uptake of morphogens may deplete the concentration upstream in
the device. The system developed is somewhat analogous to a packed bed bioreactor
design, albeit at much smaller scale, with the implementation of a single layer of EBs
within a common reservoir; while the spacing between spheroids in this particular
prototype remains large (750 µm between wells), the modular nature of the bioreac-
tor enables the simple integration of different grid designs. The controlled bulk media
delivery and removal, in this context, is a particularly interesting variable, which has
not been systematically studied in the context of three-dimensional stem cell differ-
entiation. For example, Csaszar et al., demonstrated that hematopoietic stem cell
(HSC) expansion is hindered by negative feedback, which leads to the secretion of
endogenous inhibitory factors; simple perfusion or fed-batch media supplementation
strategies greatly reduced the concentration of such factors, leading to increased HSC
expansion [72]. Similarly, the role of autocrine factors in ESC self-renewal and dif-
ferentiation has been increasingly appreciated through systematic studies of media
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perfusion in microfluidic platforms [265, 33, 162, 221]. While large volume bioreactor
platforms have enabled the controlled physiochemical environments and media perfu-
sion of EBs [21], the capacity to immobilize EBs within a small volume, parallel-plate
flow configuration enables the systematic study of multiple parameters in parallel,
including the delivery, removal, and recycling of media components, across a range of
time scales.
Together, the design parameters identified through this study motivate the de-
velopment of a novel bioreactor for the parallel processing of individual aggregates
within a bulk hydrogel, in order to control both the extracellular milieu via media
recycling, as well as the intra-EB milieu via modulation of the biochemical transport
dynamics. Ultimately, such culture platforms will allow systematic variation of hy-
drodynamic parameters, biochemical composition, and EB ultrastructure in order to




Current approaches to direct stem cell differentiation focus on systematically under-
standing the relative influences of microenvironmental perturbations and simultane-
ously engineering platforms aimed at recapitulating physicochemical aspects of tissue
morphogenesis. Together, the data presented collectively identify the biophysical ba-
sis for stem cell differentiation as three-dimensional spheroids, including biomechan-
ical and transport properties, which are distinct from those of adult tissues or tissue
engineered constructs. This thesis provides a basis for developing novel approaches to
control the spatiotemporal dynamics of stem cell signaling and morphogenic remodel-
ing to direct the differentiation of stem cells, in order to ultimately develop functional
microtissues for in vitro screening and regenerative medicine technologies.
7.1 Controlling EB ultrastructure & ECM composition to
direct downstream signaling and morphogenesis
The studies presented in this dissertation collectively highlight the important role
of EB formation and composition on subsequent morphogenesis and differentiation.
Specifically, controlling the kinetics of aggregation and the subsequent EB size dra-
matically decreased intra- and inter-experimental variability (Chapter 3). Moreover,
the spheroid aggregation kinetics were linked to β-catenin signaling and cardiomy-
ocyte differentiation (Appendix A). Interestingly, recent studies have demonstrated
the role of altering surface area, and thus endoderm composition, on cardiogenic dif-
ferentiation [22]; therefore, the role of β-catenin should be further studied in EBs
of varying sizes. In addition, although the studies presented in this dissertation
139
have significantly contributed to systematically controlling the size and decoupling
aggregation kinetics, opportunities also remain to study the opposite to control ag-
gregation, independent of EB size. In the studies presented, the EB formation and
size were coordinately regulated, with those undergoing rapid aggregation - and in-
creased β-catenin signaling - also resulting in larger EBs. As β-catenin signaling is
implicated downstream of E-cadherin, the polarity of cells within the spheroid likely
influences Wnt pathway activation via β-catenin; therefore, the size the EBs, and
the corresponding surface area to volume ratio, likely modulate β-catenin activity
as well. Although studies are increasingly moving to high throughput forced aggre-
gation formation techniques which result in rapid aggregation within hanging drop,
microwells or multi-well plate formats, it remains unclear whether such techniques
bias differentiation toward certain trajectories. Therefore, future studies should sys-
tematically investigate and develop novel aggregation methods, in order to inform
directed differentiation approaches from the initial stage of spheroid formation.
In addition, the aforementioned link between β-catenin signaling and cardiac dif-
ferentiation (Appendix A) motivates further study of the signaling pathway in the
context of mesoderm differentiation. Consistent with our results, Wnt signaling has
been previously characterized to exhibit biphasic regulation during cardiogenesis, with
a requirement for Wnt signaling during early mesoderm specification, followed by a
later decrease, implicated in the maturation of cardiac lineages. Conversely, continued
activation of Wnt signaling following mesoderm specification leads to hemangioblast
differentiation and maturation of cell fates along the hematopoietic lineages. In our
studies, we demonstrate that supplementation of BMP4 in a basal, serum-free media
results in mesoderm differentiation and phenotypic analyses suggest the differentiated
phenotypes may be more indicative of a trajectory along the hematopoietic lineages,
rather than cardiac (Chapter 4). Interestingly, opposing roles of the Wnt and BMP4
pathways have been established, with Noggin (BMP4 antagonist) downstream of the
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Wnt signaling. Therefore, the further analysis of the spatiotemporal context for Wnt
signaling in BMP4-mediated mesoderm differentiation may elucidate synergistic and
antagonistic signaling contexts responsible for hematopoiesis.
These data also establish a three-dimensional morphogenesis characteristic of an
epithelial-to-mesenchymal transition (EMT) accompanying mesoderm differentiation
via supplementation of serum-free media with BMP4 (Chapter 4). Interestingly, such
phenomena have not been reported in monolayer cultures, highlighting the possibility
to direct distinct cell fate decisions and organization in 3D. As waves of EMT are
well characterized during embryonic development [322], particularly during the early
cell fate decisions that constitute primitive streak formation and migration, this plat-
form may serve as an in vitro functional assay, amenable to screening the effects of
biochemical or environmental stimuli on early embryonic development. While these
data demonstrate changes in the extracellular milieu via changes in the glycosamino-
glycan (GAG) presentation and composition accompanying EMT, future work should
continue to address the influence of GAGs and other ECM molecules on the pattern-
ing and differentiation of mesodermal populations. For example, hyaluronan (HA)
has been correlated with tumor invasiveness [29] and loss of one of the hyaluronan
synthase isoforms (HAS-2) results in inhibition of EMT and abnormal cardiac devel-
opment during embryonic development, which can be rescued via soluble HA [45].
Consistent with these results, HAS-2 gene expression is significantly increased during
differentiation toward mesoderm lineages (Chapter 4). Similarly, in addition to its
role in mesoderm differentiation (Appendix A), accumulation of nuclear β-catenin,
indicative of active Wnt signaling, is implicated in tumor metastasis via remodeling
of E-cadherin and subsequent EMT [37]. Therefore, more robust EMT and/or meso-
derm differentiation may be attained by altering the biochemical, cell adhesive and
extracellular milieu. Routes to locally enrich the GAG composition within the 3D
spheroid structure include the integration of biomaterials to directly present various
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GAG species or to present a binding motif (i.e. HA-binding protein) amenable to re-
taining endogenously secreted HA molecules. Moreover, manipulating cell adhesions
or actomyosin contractility (Chapter 4) may be sufficient to initiate EMT [83]. While
biochemical cues are classically thought to initiate EMT, a pool of β-catenin becomes
available following cadherin internalization [139]; therefore, engineering selective sub-
strates or imparting regions of increased tension may also provide biophysical cues to
physically disrupt adhesions and incite downstream signaling via β-catenin, leading
to the appearance of classical mesenchymal morphologies and associated functional
changes. Together, the data presented throughout this thesis highlight the inter-
connected nature of matrix, adhesions, cell contractility, and downstream signaling,
which together coordinately regulate mesoderm differentiation and morphogenesis.
7.2 Characterization and perturbation of EB structural com-
ponents as a route to direct patterning
Owing to such crosstalk between biophysical cues and downstream signaling, dynamic
changes in local biophysical characteristics, including ECM composition and adhesive
signature of cells may also be responsible or permissive for patterning and cell fate.
This work demonstrates that stem cell spheroids differentiated toward divergent fates,
including those comprised largely cells from endoderm and mesoderm lineages, ex-
hibit distinct patterns of mechanical stiffness and viscoelasticity, with mesodermal
cells stiffening during differentiation and mesenchymal morphogenesis (Chapter 4).
While these data suggest that unique profiles may be characteristic of different stages
of differentiation and phenotypic lineages, questions remain regarding the biophysical
profiles of other lineages and in spheroids with unique morphological characteristics.
Future studies should continue to verify the validity of the biophysical assay as a
means to both understand and perturb the structure and differentiation state of stem
cell spheroids. In particular, as many of the recently reported organoid structures rely
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on the use of exogenous matrix (i.e. Matrigel), it would be interesting to probe the
dynamic changes in biophysical characteristics as those structures are formed and as
they undergo changes in multicellular organization, including invagination and evagi-
nation of structures [285]. In addition, structural characteristics of organoids may
identify underlying mechanisms relevant to in vitro patterning, which will ultimately
inform engineering approaches to perturb the microenvironment.
While these studies provide a foundation for understanding the structural compo-
nents within stem cell spheroids, questions remain regarding the specific structural ele-
ments. For example, a recent report identified the intracellular distribution of myosin
isoforms as a key regulator of symmetric and asymmetric division in hematopoi-
etic stem cells [300]. While the bulk mechanical properties characterized through
these studies identify the actomyosin cytoskeleton as a central mediator of microtissue
stiffness, the cell-scale mechanical properties, particularly the specific elements and
molecular distribution contributing to dynamic morphogenic changes, remain largely
unknown in the context of stem cell spheroids. While traditional methods, such as
atomic force microscopy, are not easily amenable to measuring local changes inside
of aggregates, the advent of novel technologies for assessing [48] and modeling [250]
local tension will enable future work to address such questions. In addition to the
understanding of cellular contractility, explored herein, there are likely several other
mechanisms underlying the biophysical changes in microtissue architecture during dif-
ferentiation. For example, the nuclear structure has previously been correlated with
tissue stiffness, with lamin expression being influenced by matrix stiffness [317]. How-
ever, there is no currently available method for acute (i.e. small molecule) knockdown
of lamin-A expression or structural integrity. Perturbation of EBs using approaches
such as siRNA and shRNA knockdown of lamin would likely result in widespread
changes in the differentiation trajectories and therefore would confound the analysis.
Therefore, future studies should systematically interrogate nuclear changes during
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3D ESC differentiation. Similarly, the relative contribution of adhesions is not eas-
ily studied in the context of stem cell spheroids, as simple disruption via blocking
antibodies or ion chelation results in aggregate disassembly. Therefore, additional
methods, such as laser ablation, should be explored to more systematically perturb
elements of the physical structure. Biomaterial incorporation may also be amenable
to perturbing local cellular tension and adhesive profiles, as MSC spheroids exhibited
an increase in bulk stiffness upon incorporation of gelatin microparticles [15]. While
spheroids comprised of ESCs in the same context did not exhibit increased stiffness,
it would be interesting to explore the presentation of alternative molecules, such as
cadherins.
As studies presented herein also identified the cellular composition (Chapter 3) and
aggregation kinetics (Appendix A) as critical determinants of cell fate, questions also
remain regarding the biophysical characteristics in various differentiation contexts.
For example, the E-cadherin expression and distribution was dynamically modulated
within culture conditions that influenced the aggregation kinetics; therefore, it is
likely that associated structural elements may also be modulated in a context depen-
dent fashion, upon simple environmental perturbations such as mixing conditions.
Therefore, future studies should continue to study the biophysical cues associated
with β-catenin signaling and EB formation. Similarly, EB size affects cell polarity
by modulating the number of cells exposed at the exterior boundary; systematically
testing the biophysical properties of EBs of varying sizes may, therefore, provide in-
sight into the contribution of the exterior cells in maintaining the structural integrity
of the spheroid. Similarly, changes in microtissue shape have been previously shown
to pattern EMT within regions of high stress Gomez:2010gb. Therefore, these data
together motivate the development engineering approaches to perturb the spheroidal
nature of stem cell aggregates, as a novel biophysical route to induce morphogenesis
via EMT, and identify both signaling (Wnt/β-catenin) and biophysical metrics for
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characterizing subsequent changes in morphogenesis and cell fate.
7.3 Spatiotemporal delivery and retention of exogenous and
endogenous biochemical morphogens
In addition to the physical cues presented within the microtissue structure via cell-cell
contacts and multicellular organization, the biochemical milieu is also a critical deter-
minant of cell fate. This study has identified important transport properties of stem
cell spheroids (Chapter 5), which likely contribute to complexity and heterogene-
ity within individual aggregates. Specifically, the high cell density inherent within
cellular aggregates leads to transport limitations, particularly for biochemical com-
positions at concentrations typically employed for monolayer differentiation. More-
over, as differentiation protocols are increasingly moving toward using small molecule
inhibitors as pathway antagonists, these data highlight the additional barriers as-
sociated with the increased uptake rate of such molecules. However, the transport
limitations within spheroids also afford opportunities to further understand the role
of endogenous signaling within stem cell populations. As the exogenously delivered
factors are largely constrained to the exterior of EBs, the patterning and organization
occurring within the center of EBs is likely directed primarily by cell-secreted signals
or those presented locally within the microenvironment. This is particularly inter-
esting in the context of organoid morphogenesis, as the protocols rely on EBs that
are much larger than those traditionally employed, suggesting that the biomimetic
structures emerging within organoids may be a result of self-organization and self-
directed differentiation. The transport characteristics of spheroids also highlights a
new paradigm, whereby approaches may focus on directing the differentiation of the
exterior cells toward populations known to secrete signals of interest or those which
are responsible for patterning adjacent structures during embryonic development (i.e.
direct endoderm differentiation to influence mesoderm differentiation).
145
While the secretome of stem cell populations has been of widespread interest, with
recent advances in labeling of endogenous molecules for mass spectrometry analysis,
the heterogeneity within differentiated populations poses additional challenges for
identifying the source(s) of specific secreted morphogens. Therefore, novel reporters,
such as the sentinel signaling cells, are transformative technologies, which may enable
the spatiotemporal analysis of pathway activation. Similarly, in situ hybridization,
traditionally used to characterize developmental signals, enable systematic assessment
of spatial signaling within EBs. Ideally, the analysis of the spatiotemporal context
for multiple pathways simultaneously will enable the derivation of systems biology
computational approaches to model network regulation at the multicellular scale.
More robust models created via the aforementioned experimental approaches may
also enable additional parameters to be defined, including the relative uptake rates
for different types of molecules and the role of dynamic feedback in pathway regulation
and stem cell differentiation.
In addition, while these studies highlight a role for microparticles in modulating
the physical structure of stem cell spheroids, the localized release of morphogens from
microparticles should also be modeled and experimentally measured within stem cell
aggregates, in order to define the transport characteristics upon localized release.
The increased understanding of microparticle delivery may, therefore, enable the de-
velopment of engineering approaches to more homogeneously deliver morphogens or
to create point sources amenable to impacting small, localized populations. For ex-
ample, the incorporation of GAG species, as previously characterized in endodermal
and mesodermal microenvironments (Chapter 4), may also exert secondary effects
through the local binding and presentation of growth factors. Therefore, the platform
for assessing transport established herein may also be implemented in the context of
studying transport in the presence of endogenous and exogenous matrices. In the
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context of BMP4-mediated mesodermal differentiation, the histological staining pat-
terns suggest a decrease in sulfated GAGs, with an increase in non-sulfated species,
such as HA. Therefore, based upon the BMP binding capacity of sulfated GAGs, the
transport of BMP4 may be less restricted within later stage, mesodermal spheroids
compared to those at early stages, which exhibit robust safranin-O staining, indicative
of sulfated GAG expression. Similarly, BMP signaling upon incorporation of exoge-
nous sulfated GAGs, such as heparin, should be assessed to determine the extent to
which transport of soluble morphogens is further limited and the spatial extent of
gradients are created by sequestration in the ECM.
In addition to biomaterial approaches, manipulation of transport is also increas-
ingly being explored via microfluidics [111], as the implementation of convective fluid
flow is easily amenable to creating gradients or altering delivery in a precisely spatially
controlled manner. While all of the studies presented herein demonstrate transport
in the context of diffusion, as is standard in most traditional cultures of stem cell
spheroids, the transport profiles within convective culture platforms, including ro-
tary orbital suspension and bioreactor cultures, should be further studied. The data
presented herein demonstrate that rotary orbital suspension cultures both implement
convective mixing and maintain spheroids as homogeneous, individual aggregates by
inhibiting agglomeration (Chapter 3). Therefore, the combination of size control
and mixing may alter biochemical transport. While the convective nature of scal-
able bioreactor platforms has traditionally been implemented to maintain well-mixed
conditions through the bulk media volume, the movement of spheroids may also in-
fluence the dynamics of morphogen transport. While previous work has characterized
the fluid shear profile within mixed bioreactor platforms [282], it is difficult to assess
the influence of fluid mixing on individual spheroids, as the fluid dynamics are al-
tered as a function of the spatial position in the dish and the EBs are free to move,
rather than being fixed, in contrast to traditional tissue engineering approaches [32].
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Therefore, while fluid mixing may increase transport within the spheroid structure,
substantial fluidic convection within the aggregate is not likely.
7.4 Fluidic convection to manipulate the biochemical milieu
and harness the secretome of differentiating ESCs
To address such complexity, a novel culture platform has been developed to immobi-
lize spheroids within a convective context, which is amenable to increasing transport
through the aggregate structure (Chapter 6). Similar to rotary orbital suspension
(Chapter 3), the implementation of a microwell array, via laser-drilled holes, enables
the maintenance of individual spheroids, in order to maintain control of size without
agglomeration. The subsequent operation of perfused fluidic convection via the appli-
cation of a pressure drop across the immobilized EBs then enables modulation of the
transport profile. The platform developed herein is also amenable to implementation
in parallel with secondary approaches for increasing transport, including biological
of biomaterial-based methods for increasing EB permeability. For example, the use
of enzymatic agents, such as collagenase, or non-enzymatic chelating agents, such as
EDTA, are amenable to dissociating or perturbing the ECM or cell-cell adhesions
to increase transport [278]. The introduction of such agents is particularly ideal in
the perfusion bioreactor platform, as the fast exchange kinetics enable solutions to be
introduced and washed out in a rapid or pulsatile manner, such that the EB structure
would not be completely disrupted. Similarly, the introduction of physical conduits
for fluid flow, as in the incorporation of microparticles or other biomaterial constructs,
may permit fluid access to increase transport while minimizing detrimental fluid shear
within the spheroid volume.
The perfusion bioreactor platform developed through this thesis enables a wide
range of opportunities for studying, perturbing, and controlling and the EB microen-
vironment by directly employing the novel features and through parallel operation
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with additional enabling stem cell technologies. For example, the implementation of
perfusion via microfluidics provides opportunities for parallelization of different cul-
ture platforms for independent control, screening, and monitoring in high throughput.
In combination with technologies such as the sentinel signaling cells and imaging plat-
forms, microfluidic perfusion would enable real time tracking of population dynamics.
In addition, the convective transport afforded through perfusion may also be amenable
to combination with other means of spatial control, including microparticles to release
or sequester morphogens. By tuning the flow parameters and transport characteristics
in such platforms, it may be possible to develop and maintain morphogen gradients,
in order to direct regional patterning and emulate aspects of embryonic development.
In addition, the culture of larger aggregates or assemblies of aggregates may also
facilitate gradient formation.
The controlled perfusion also creates opportunities for identifying fluidic parame-
ters permissive for directing the differentiation of specific cell phenotypes. For exam-
ples, increased fluid velocities may also be explored for applications aimed at directing
vasculogenesis or cardiogenesis, analogous to the role of fluid shear in the initiation of
primitive hematopoietic and cardiac events. Similarly, pulsatile flow may be executed
within the platform, in order to provide durations of increased transport while also
permitting a residence time for molecules within the spheroid structure. This tactic
may be especially applicable in contexts aimed to maintain endogenously secreted
molecules, as constant perfusion flow will likely remove factors secreted by the cells.
Finally, the forced convection through spheroids also provides opportunities for
capturing the perfusate. The comparison of the perfusate with the bulk media may
enable more quantitative characterization of relative uptake over time, which will
inform the development of more robust computational approaches to assess transport
(Chapter 5), as discussed previously. Moreover, as the perfused volume is relatively
small and not diluted by the bulk media, the perfusion of EBs may serve as a novel
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route to concentrate the secretome of EBs for subsequent analysis of the temporal
profile of morphogen secretion. In addition, the concentrated EB secretome may be
amenable to use as a therapeutic, due to the wide range of morphogens involved in
regeneration and self-renewal. Therefore, in addition to the primary functionality
of delivering nutrients, growth factors, and other morphogens within differentiating
spheroids, the mode of perfusion operation is also amenable to secondary questions
and applications for capturing and analyzing the EB milieu.
To date, many approaches have been developed or proposed as means to precisely
control the biophysical characteristics of stem cell aggregates, including high through-
put platforms to control the spheroid size and homogeneity, microfluidic approaches to
increase the precision and profile of molecular transport, and biomaterial techniques
to deliver, present, and/or sequester inductive cues (physical, chemical) in a highly
efficient and spatiotemporally controlled manner. However, as has been underscored
throughout, the impact of biophysical cues are manifested through multiparamet-
ric, synergistic responses to simple perturbations. Therefore, opportunities remain
to develop experimental and mathematical approaches to understand the complex
interrelationship between cellular composition (adhesions, remodeling) and physical
characteristics (mechanics, transport), particularly as a function of space and time
during morphogenesis. Ongoing efforts should focus on establishing advanced mathe-
matical models to simulate the dynamic changes within the EB structure as the func-
tion of time (differentiation state, phenotype) and developing sensitive experimental
tools to sample and control the microenvironment within aggregates. Such advances
will elucidate the relative influences of various biophysical factors in mediating de-
velopmental dynamics and ultimately inform engineering approaches to perturb and
control stem cell morphogenesis to guide the formation of tissue-specific microtissues
amenable to screening and therapeutic applications.
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APPENDIX A
TEMPORAL MODULATION OF β-CATENIN
SIGNALING BY MULTICELLULAR AGGREGATION
KINETICS IMPACTS EMBRYONIC STEM CELL
CARDIOMYOGENESIS1
A.1 Introduction
Pluripotent embryonic stem cells (ESCs) are a promising cell source for therapies
aimed to treat degenerative and chronic diseases in which native tissues are damaged
beyond their endogenous capacity for repair. Elucidating the mechanisms regulating
ESC fate decisions will significantly aid in the development of directed differentiation
approaches, in order to produce large quantities of differentiated cells for regenerative
therapies. Differentiation of ESCs is commonly initiated by the spontaneous aggre-
gation of cells via E-cadherin, a Ca2+ dependent homophilic adhesion molecule [183].
The resulting multicellular aggregates, termed embryoid bodies (EBs), recapitulate
morphogenic events similar to those of pre-implantation stage embryos, including
differentiation into cell phenotypes comprising the three germ lineages (ectoderm, en-
doderm and mesoderm) [146, 88]. Although EBs often lack the spatial organization
to directly mimic the regulation of tightly controlled spatiotemporal signaling exhib-
ited in vivo, ESCs maintain the capacity to respond to similar molecular cues, thus
motivating the analysis of developmentally relevant signaling pathways in the context
of stem cell differentiation [156].
1Modified from: MA Kinney, CY Sargent, and TC McDevitt. (2013). Temporal Modulation
of β-Catenin Signaling by Multicellular Aggregation Kinetics Impacts Embryonic Stem Cell Car-
diomyogenesis. Stem Cells Dev, 22(19), 26652677. doi:10.1089/scd.2013.0007
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Transcriptional activation induced by the β-catenin signaling pathway controls
cell fate decisions during early embryonic development, aiding in the regulation of
embryonic patterning and axis formation [367], primitive streak formation [218],
and mesoderm differentiation [125]. Similarly, in ESCs, β-catenin signaling is re-
quired for the maintenance of pluripotency [287, 158], and mesoderm differentia-
tion [196], as well as self-organization and axis formation within EBs [321]. Two
main pools of β-catenin are present within cells [121]: 1) β-catenin sequestered at
the cell membrane within adherens junctions, specifically as a mediator between
cadherins and the actin cytoskeleton [159, 1, 360], and 2) stabilized cytoplasmic
β-catenin, which mediates transcription upon destabilization and translocation to
the nucleus [133, 25]. Canonical Wnt signaling is a well-studied pathway, which is
involved in the initiation of β-catenin-regulated transcription [65]. In the absence
of Wnt, cytoplasmic β-catenin is phosphorylated by the glycogen synthase kinase
3β (GSK3β)/adenomatous poliposis coli (APC)/Axin complex and is targeted for
ubiquitination [367, 336, 126, 248]. Upon Wnt binding to members of the seven-
transmembrane Frizzled receptor family, the Frizzled receptor heterodimerizes with
low-density lipoprotein receptor-related protein 5 and/or 6 (LRP5/6) [66], which in
turn causes the disruption of the GSK3β/APC/Axin complex [206], resulting in the
accumulation of stabilized, cytoplasmic β-catenin [226, 170]. The cytoplasmic sta-
bilization of dephosphorylated β-catenin permits translocation of β-catenin to the
nucleus, where it acts as a transcriptional co-activator with T-cell factor/lymphoid
enhancer-binding factor (TCF/LEF) transcription factors [25] to regulate the tran-
scription of target genes involved in a wide range of cellular processes, including
cardiac specification and morphogenesis during embryonic development [141, 195]
and ESC differentiation [194, 232, 251]. Thus, β-catenin is a central component in
cell-cell interactions and gene transcription, both of which are key factors regulating
embryonic and ESC morphogenesis.
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Although the presence of Wnt ligands and the destabilization of the GSK3β/APC/
Axin complex are required to permit the transcriptional activity of β-catenin, the
temporal onset and duration of signaling may also be modulated by the presence
of E-cadherin adhesions between cells, which sequester β-catenin at the membrane
[238, 208]. Studies have illustrated the potential for cross-talk between β-catenin as-
sociated with E-cadherin and its availability to participate in signaling and transcrip-
tional activities [151]; therefore, the intercellular adhesion events mitigating initial
EB formation may also regulate downstream β-catenin regulated transcription, thus
potentially modulating the cardiomyogenic potential of the ESC population.
The formation and maintenance of EBs in rotary orbital suspension culture pro-
duces increased yields of homogeneous EB populations (Chapter 3; [52, 282, 283])
and is a relatively facile technique to modulate ESC aggregation kinetics by simply
varying the orbital mixing speed [282]. Interestingly, previous studies demonstrated
that the extent of cardiomyogenic differentiation in rotary cultures was modulated by
the orbital speed, with the conditions promoting accelerated EB formation kinetics
also exhibiting increased cardiomyocyte differentiation [282]. Therefore, the control
of ESC aggregation afforded by the rotary orbital suspension culture platform enables
a systematic study of aggregation-induced modulation of β-catenin signaling kinetics
and the associated regulation of cardiomyocyte differentiation.
The objective of the present study was to investigate the dynamics of β-catenin
transcriptional activity in response to modulation of ESC aggregation kinetics dur-
ing EB formation. β-catenin protein expression and localization were assessed via
immunostaining for total and dephosphorylated β-catenin isoforms and immunoblot-
ting of cytoplasmic and nuclear protein fractions, in conjunction with analysis of
transcriptional activity using stably transduced luciferase TCF/LEF reporter mouse
ESCs. Additionally, gene expression of downstream targets of β-catenin signaling and
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cardiomyocyte differentiation were analyzed to determine the relationship between β-
catenin protein expression, localization, Wnt/β-catenin pathway signaling dynamics,
and differentiated phenotypes. The findings of this work demonstrate that the dy-
namics of ESC aggregation during multicellular assembly via cadherins modulates the
β-catenin signaling pathway and alters cardiomyogenic gene transcription in ESCs.
A.2 Materials and Methods
A.2.1 Embryonic Stem Cell Culture
Murine ESCs (D3 cell line) were cultured on 0.1% gelatin-coated tissue culture-treated
plates (Corning). Culture media consisted of Dulbeccos modified Eagles medium
(DMEM) supplemented with 15% fetal bovine serum (Hyclone), 100 U/mL peni-
cillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin (Mediatech), 2mM
L-glutamine (Mediatech), 1x MEM nonessential amino acid solution (Mediatech), 0.1
mM β-mercaptoethanol (Fisher), and 103 U/mL of leukemia inhibitory factor (LIF;
ESGRO, Chemicon). Cultures were re-fed with fresh media every other day, and
passaged at approximately 70% confluence.
A.2.2 Embryoid Body Formation and Culture
Embryoid bodies were formed, as described previously, by inoculating a single-suspension
of ESCs at 2 x 105 cells/mL into 100 mm bacteriological grade polystyrene Petri dishes
with 10 mL ESC media without LIF [51]. Dishes were incubated at 37C with 5%
CO2 either statically or placed on rotary orbital shakers (Lab-Line Lab Rotator,
Barnstead International) at 25, 40, or 55 rpm to impart hydrodynamic conditions
Sargent:2010ct. 90% of media was exchanged every two days by collecting the EBs
via gravity sedimentation and re-suspending the cultures in fresh media.
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A.2.3 Whole-mount Embryoid Body Immunostaining
Embryoid bodies were collected by sedimentation at days 1, 2, 4, and 7 of differentia-
tion, rinsed 3x with PBS, and formalin (4% formaldehyde) fixed at room temperature
for 45 minutes with rotation. EBs were then rinsed 3x (5 minutes with rotation) in
EB wash/block buffer (2% BSA/0.1% Tween-20 in PBS) and permeabilized in 0.05%
Triton X-100 and 2% BSA solution for 1 hour at 4C with rotation. EBs were blocked
in wash/block buffer for 2 hours at 4C with rotation. After permeabilization and
blocking, EBs were incubated with polyclonal rabbit anti-β-catenin (Millipore, 1:200)
and monoclonal mouse anti-active β-catenin (Millipore, 1:50) specific to dephospho-
rylated Ser-33 and Thr-41 [336] (anti-aβC, Millipore, 1:50) or with monoclonal rat
anti-E-cadherin (Sigma, 1:200) at 4C overnight with rotation, rinsed in wash buffer,
and incubated with secondary antibodies (Alex Fluor 488 anti-rabbit and Alexa Fluor
546 anti-mouse, Invitrogen, 1:200) for 4 hours at 4C with rotation. EBs were rinsed,
counterstained with Hoechst (1:100) and imaged with a multiphoton laser scanning
confocal microscope (Zeiss LSM 510 NLO).
A.2.4 Quantification of Immunostaining
The relative intensity of expression of E-cadherin, β-catenin, and aβC was quantified
with CellProfiler image analysis software [54] using a custom-written script. Briefly,
the outlines of individual cells were determined based on primary identification of
nuclei followed by expansion of the bounded region to determine cell boundaries.
The intensity of staining for E-cadherin, β-catenin, and aβC was then determined on
a per cell basis, with approximately 50-100 cells per EB. The total expression levels




Lentiviral transduction of mESCs with a luciferase TCF/LEF reporter construct
(Cignal TCF/LEF luciferase reporter; SA Biosciences) was performed to generate
stably transduced puromycin resistant clones that expressed luciferase in response to
β-catenin signaling. ESCs were plated at 50,000 cells/well on 0.1% gelatin-coated
tissue culture treated 6-well dishes (Corning) and cultured for 24 hours prior to the
introduction of Cignal Lenti vectors. Stable transduction of D3 ESCs was accom-
plished by incubating cells with Cignal Lenti TCF/LEF vectors at Multiplicity of
Infection (MOI) levels (3, 10, or 25) for 24 hours in the presence of 1 µg/mL poly-
brene (Sigma). ESCs were incubated with lentivirus particles for 24 hours, and after
an additional 72 hours, transduced cells were selected using 3 µg/mL of puromycin
(Sigma); concentration was determined from a kill curve using 0.5 3.0 µg/mL. After
transduction and selection, individual colonies were chosen using cloning rings and
0.05% trypsin-EDTA, and plated onto 0.1% gelatin-coated tissue culture treated 100
mm dishes. The selected clones were maintained in ESC media supplemented with 3
µg/mL puromycin for an additional 2 weeks and assessed for luciferase expression via
anti-luciferase immunostaining, luciferase activity (with and without LiCl treatment),
and alkaline phosphatase activity.
A.2.6 ESC Immunostaining
Transduced clones and naive D3s were cultured on 0.1% gelatin-adsorbed tissue cul-
ture treated polystyrene 6-well dishes. At ∼70% confluence, cells were rinsed 3x with
PBS, formalin fixed in the wells for 10 minutes, and rinsed again with PBS. At ∼70%
confluence, ESCs were fixed with formalin (4% formaldehyde), rinsed with PBS, per-
meabilized and blocked with 0.05% Triton X-100/2% BSA/PBS solution for 1 hour at
room temperature. ESCs were then incubated overnight at 4C with polyclonal rab-
bit anti-β-catenin (Millipore, 1:200), monoclonal rat anti-E-cadherin (Sigma, 1:200)
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[336], monoclonal mouse anti-luciferase (Santa Cruz Biotech, 1:50) or polyclonal goat
anti Oct-4 (Santa Cruz Biotech, 1:100). Cells were rinsed with PBS 3x, and then in-
cubated with Alexa Fluor conjugated secondary antibodies (Invitrogen, 1:200) for 2
hours at room, counterstained with Hoechst (10 µg/mL), mounted and cover-slipped.
To assess alkaline phosphatase activity, ESCs were stained using the Vector Red al-
kaline Phosphatase Substrate kit (Vector Laboratories). Briefly, cells were incubated
in Vector Red substrate in 100 mM Tris-HCl buffer to allow color development for
30 minutes at room temperature while protected from light. Following color develop-
ment, cells were rinsed with Tris-HCl buffer and water, mounted and cover-slipped.
Images were acquired with a Nikon TE 2000 inverted microscope (Nikon Inc.) with a
SpotFlex camera (Diagnostic Instruments) or an EVOS fl inverted microscope (Ad-
vanced Microscopy Group).
A.2.7 Luciferase Activity Quantification
ESCs were cultured with or without the addition of LiCl (25 mM) for 24 hours
to disrupt the GSK3β/APC/Axin complex and inhibit the phosphorylation of β-
catenin, ultimately resulting in increased TCF/LEF activity within transduced cells
[10]. Luciferase activity was quantified using the Luciferase Assay System (Promega),
according to manufacturers instructions. Briefly, ESCs or EBs were rinsed 3x in PBS,
lysed with rotation at 4C for 10 minutes, vortexed for 5 seconds, and centrifuged at
10,000 rcf for 5 minutes. The supernatant was collected and transferred to a pre-
chilled microcentrifuge tube. Twenty microliters of the cell lysate was added to 100
µL of Luciferase Assay Reagent and luminescence was detected using a Femtomaster
FB12 luminometer (Zylux Corporation). Relative light units (RLUs) were normalized
to µg of DNA per sample as determined by Quant-It PicoGreen assay (Invitrogen).
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A.2.8 Protein Fractionation
EBs were collected at days 2 and 4 of differentiation for Western blot analysis. The
NE-PER cell fractionation kit (Pierce) was used to separate the cytoplasmic and
nuclear fractions of undifferentiated cells and differentiating EBs. Briefly, cells and
EBs were lysed using CER I reagent supplemented with 500x protease inhibitor cock-
tail (Calbiochem) and 50x phosphatase inhibitor cocktail (Calbiochem), followed by
addition of the CER II reagent. After centrifugation at 16,000 rcf, the cytoplas-
mic supernatant fraction was collected. The remaining nuclear pellet was incubated
in the NER reagent containing 500x protease and 50x phosphatase inhibitors, and
centrifuged at 16,000 rcf for 10 minutes followed by collection of the supernatant
containing the nuclear fraction.
A.2.9 Western Blotting
Sample protein concentration was determined using the BCA Protein Quantification
kit (Pierce); equal amounts of protein per sample (10 µg for cytoplasmic fractions; 35
µg for nuclear fractions) were mixed with loading buffer (0.1 M Tris-HCl containing
SDS, glycerol, biomophenol blue, and β-mercaptoethanol), incubated at 95C for 5
minutes, and loaded in 4-15% Mini-PROTEAN TGX gels (Bio-Rad). Vertical elec-
trophoresis was performed using the Mini-PROTEAN Treta Cell (Bio-Rad) system
with SDS/PAGE running buffer (Tris base/glycine/SDS solution) at 200V for 30 min-
utes. A protein ladder (Precision Plus Protein Kaleidoscope, 10-250 kDa, Bio-Rad)
was also loaded into each gel as a molecular weight reference.
Following SDS/PAGE separation, protein was transferred to a nitrocellulose mem-
brane (Bio-rad) via semi dry transfer (Trans-Blot SD, Bio-Rad) at 25V for 20 minutes.
Membranes were then blocked in near infrared blocking medium (Rockland Immuno-
chemicals) for 1 hour and subsequently incubated with primary antibodies for β-
catenin (polyclonal rabbit anti-β-catenin; Millipore; 1:400) and loading controls for
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cytoplasmic (polyclonal rabbit anti-GAPDH; Pierce; 1:400) and nuclear (monoclonal
mouse anti-TATA binding protein, TBP; Abcam; 1:2000) fractions overnight at 4C.
Primary antibody incubation was followed washes in 0.01% Tween-20/PBS solution,
and membranes were incubated with IR secondary antibodies (680 anti-mouse and
anti-rabbit, LiCor Biosciences, 1:2000), followed by washes in PBS/0.1% Tween-20
solution. Blots were imaged using the Odyssey Infrared imager (LiCor Biosciences).
A.2.10 Quantitative PCR
Expression of Wnt pathway agonists and antagonists, as well as cardiogenic genes
were assessed via quantitative PCR from EBs formed with different aggregation ki-
netics, as well as for those supplemented with Wnt inhibitors (5 µM Inhibitor of
Wnt Production-4, IWP-4; Stemgent) during the first 4 days of differentiation [194].
RNA was extracted from undifferentiated ESCs and from EBs using the RNeasy
Mini kit (Qiagen Incorporated, Valencia, CA). Reverse transcription for complemen-
tary DNA synthesis was performed from 1 µg RNA using the iScript cDNA synthesis
kit (Bio-Rad, Hercules, CA), and quantitative PCR was performed with SYBR green
technology on the MyiQ cycler (Bio-Rad). Primer sequences and annealing tem-
peratures are listed in Table 5 for Wnt-1, Wnt-3a, Dickkopf-1 (Dkk-1 ), Brachyury
T (B-T ), mesoderm posterior 1 (Mesp-1 ), myocyte enhancer factor-2c (Mef-2c),
Nkx2.5, α-myosin heavy chain (α-MHC ), myosin light chain-2 ventricle (MLC-2v),
and 18S ribosome. Each primer set was designed with either Beacon Designer soft-
ware (Invitrogen, Carlsbad, CA) (B-T, Mesp-1, Mef-2c, α-MHC, and MLC-2v) or the
Integrated DNA technologies INC design website (www.idtdna.com) (Wnt11, Wnt3a,
Dkk-1, Nkx2.5 ) and validated with appropriate cell controls. In order to account for
variability in expression of housekeeping genes, absolute gene expression concentra-











































































































































































































































































































































































































































































































Experimental conditions were examined with triplicate samples for a minimum of
two independent experiments and the data values presented reflect the mean value
standard error. One- or two-way analysis of variance were performed to determine
statistical significance (p≤0.05) between experimental groups and time points, and
where significant, was followed by post-hoc Tukey analysis to define statistical differ-
ences (p≤0.05) between specific experimental variables.
A.3 Results
A.3.1 Spatial localization of E-cadherin and association with β-catenin
in ESCs
Previous studies have demonstrated that the Wnt signaling pathway is an important
regulator of pluripotency, and that nuclear accumulation of β-catenin via treatment
using a GSK-3 inhibitor aids in maintenance of ESC self-renewal [287]. Consistent
with published reports, undifferentiated mESC colonies expressed β-catenin, which
was co-localized with E-cadherin at the plasma membrane, as well as expressed within
the cytoplasm and nucleus (Fig. A-1). The spatial distribution of both proteins was
similar throughout the majority of cells in the colony, with the exception of cells
exhibiting pyknotic nuclei, which demonstrated disrupted patterns of both β-catenin
and E-cadherin. Additionally, cells at the perimeter of colonies expressed decreased β-
catenin at the membrane, concurrent with decreases in E-cadherin in regions lacking
intercellular connections. Overall, the spatial localization of β-catenin and E-cadherin
indicates the existence of both molecules during undifferentiated expansion prior to
EB formation, as well as the localization of β-catenin both at the membrane (localized
with E-cadherin) and in the cytoplasm and nucleus.
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Figure A-1: β-catenin and E-cadherin expression patterns within ESCs.
Localization of (A) nuclei, (B) E-cadherin, and (C) β-catenin in undifferentiated
ESCs demonstrates expression primarily at the cell membrane between adjacent cells
(D). Green = E-cadherin, red = β-catenin, blue = nuclei. Scale bar = 50 µm.
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A.3.2 Temporal and spatial expression of E-cadherin in response to EB
formation kinetics
Upon aggregation and continued differentiation of EBs in rotary orbital suspension
culture, E-cadherin was localized to the cell membrane at sites of intercellular connec-
tions, and was relatively homogeneously expressed throughout by most cells in the EB
(Fig. A-2). Altering the kinetics of cell-cell aggregation via changes in rotary orbital
speed [282] suggested the modulation of E-cadherin expression during the course of
differentiation. Specifically, the delayed aggregation kinetics of EBs formed at 55 rpm
led to significantly decreased E-cadherin expression after 1 day (Fig. A-2 D), com-
pared to 25 rpm rotary orbital conditions, which support more rapid EB formation
(Fig. A-2 B). Additionally, while the expression of E-cadherin appeared to decrease
over 4 days of differentiation at 25 rpm (Fig. A-2 L), cultures maintained at 40 and
55 rpm (Fig. A-2 M&N) exhibited significantly increased expression of E-cadherin at
the cell membrane. Taken together, β-catenin was co-localized with E-cadherin in un-
differentiated ESCs, and upon EB formation, E-cadherin localization was temporally
modulated in response to altered cell association kinetics.
A.3.3 Temporal and spatial expression of β-catenin in response to EB
formation kinetics
Based on the temporal modulation of E-cadherin and its established association with
β-catenin, the spatial patterns of total (β-catenin+, red in Fig. A-3) and dephospho-
rylated, transcriptionally active β-catenin (aβC+, green in Fig. A-3) were assessed
within EBs maintained in different culture conditions during the first 7 days of differ-
entiation. Overall, static EBs exhibited significantly increased expression of β-catenin
at early and late time points, compared to rotary conditions (Fig. A-3 A&E). More-
over, EBs maintained in static conditions exhibited nuclear expression of aβC at day
2 of differentiation (Fig. A-3 A, inset), accompanied by intercellular β-catenin expres-
sion at the cell membrane. Conversely, EBs from rotary orbital suspension cultures
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Figure A-2: E-cadherin expression patterns during EB differentiation. Static
(A,F,K,P) and rotary EBs at 25 (B,G,L,Q), 40 (C,H,M,R), and 55 rpm (D,I,N,S)
were stained for E-cadherin+ cells at days 1 (A-D), 2 (F-I), 4 (K-N), and 7 (P-
S) of differentiation. Quantification of the staining patterns of E-cadherin (E,J,O,T),
suggesting that E-cadherin expression within EBs was dynamically modulated during
differentiation as a result of changes in ESC aggregation kinetics. Scale bar = 50 µm.
Green = E-cadherin, blue = nuclei. n=3, * = p≤0.05.
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exhibited more homogeneous expression patterns of β-catenin and aβC over time, in
which β-catenin was distinctly located either within the nucleus or at the cell mem-
brane (Fig. A-3 B-D, H-J, N-P). After 2 days of differentiation, significantly decreased
expression of β-catenin and aβC were observed within rotary EBs (Fig. A-3 B&C,
inset), and aβC appeared to be sequestered at the cell membrane (Fig. A-3 B-D).
However, at day 4 of differentiation, aβC expression appeared to increase within 25
and 40 rpm EBs and altered localization of aβC was suggested by the appearance of
aβC+ nuclei, which was distinct from aβC previously observed at the cell membrane
(Fig. A-3 H&I). In general, 55 rpm EBs exhibited little dephosphorylated β-catenin,
and the majority of β-catenin expression was restricted to the cell membrane at days
2 and 4 of differentiation (Fig. A-3 D&J). After 7 days of differentiation, expression
of β-catenin was significantly decreased in all rotary conditions compared to static
EBs, and little to no nuclear staining of β-catenin was observed in EBs from any
of the culture conditions (Fig. A-3 M-P), suggesting that β-catenin transcriptional
activity was diminished. Overall, patterns of β-catenin expression within differenti-
ating EBs indicated that ESC aggregation modulates both the expression patterns
and phosphorylation state of β-catenin.
Interestingly, comparison of the dynamic expression patterns of E-cadherin (Fig. A-
2) and β-catenin (Fig. A-3) over time revealed significant correlations, including a
positive correlation (p=0.01) between E-cadherin and aβC after 2 days of differen-
tiation and a negative correlation (p=0.03) between E-cadherin and total β-catenin
expression after 4 days of differentiation (Table 6). Together, such results suggest
an interplay between intercellular adhesions and β-catenin, with increased early ex-
pression of E-cadherin, followed by decreased E-cadherin levels supporting increased
expression of aβC and total β-catenin, respectively.
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Figure A-3: Expression and phosphorylation state of β-catenin within EBs.
Static (A,G,M) and rotary EBs at 25 (B,H,N), 40 (C,I,O), and 55 rpm (D,J,P) were
stained for β-catenin+ and aβC+ cells at days 2 (A-D), 4 (G-J), and 7 (M-P) of dif-
ferentiation. Quantification of the expression of β-catenin (E,K,Q) and aβC (F,L,R)
indicated differences in β-catenin phosphorylation and location during differentiation.
Scale bar = 20 µm. Red = β-catenin, green = aβC, yellow = β-catenin/aβC overlay,
blue = nuclei. n=3, * = p≤0.05.
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Table 6: Correlation of E-cadherin and β-catenin expression dynamics
Day Protein Expression Pearson’s r p-value
2 E-cadherin Total B-catenin 0.80 0.20
2 E-cadherin Active B-catenin 0.99 0.01
4 E-cadherin Total B-catenin -0.97 0.03
4 E-cadherin Active B-catenin 0.03 0.97
7 E-cadherin Total B-catenin 0.67 0.33
7 E-cadherin Active B-catenin 0.85 0.15
A.3.4 β-catenin cellular localization in response to EB formation kinetics
The intracellular localization of total β-catenin was further examined by Western
blot analysis of cytoplasmic (Fig. A-4 A) and nuclear (Fig. A-4 B) protein fractions
from EBs cultured in static or rotary (25, 40, and 55 rpm) conditions at days 2
and 4 of differentiation. EBs from all conditions expressed total β-catenin in both
the cytoplasm and nucleus at all time points examined (Fig. A-4 A&B). Overall,
the expression of β-catenin in the cytoplasm remained relatively constant across all
conditions at both time points examined (Fig. A-4 A). In contrast, nuclear fractions
suggested differences in the β-catenin expression across different EB formation condi-
tions. Specifically, EBs maintained at 25 rpm appeared to exhibit increased nuclear
expression of total β-catenin at both days 2 and 4 of differentiation compared to
other rotary conditions (Fig. A-4 B), which was consistent with the increased expres-
sion of aβC noted by immunofluorescence in 25 rpm EBs at day 4 of differentiation
(Fig. A-3 F). Taken together, these data suggest the dynamic regulation of β-catenin
protein expression, phosphorylation state, and localization during the initial stages
of differentiation in response to intercellular adhesion kinetics.
A.3.5 TCF/LEF activity in response to ESC aggregation kinetics
To quantitatively assess β-catenin transcriptional activity with high temporal reso-
lution during the initial stages of EB differentiation, ESCs were transduced with a
TCF/LEF-luciferase lentivirus. Transduced cells retained a typical undifferentiated
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Figure A-4: β-catenin cellular localization. Although cytoplasmic (A) expression
of β-catenin was similar among culture conditions, nuclear (B) β-catenin exhibited
changes in expression among static and rotary (25, 40, 55 rpm) EBs after days 2 and
4 of differentiation.
morphological appearance at all MOI levels examined (Fig. A-5 A-C); however, only
ESCs transduced with 10 and 25 MOI survived after puromycin treatment (Fig. A-5
D-F). Stably transduced clones were characterized based upon morphological appear-
ance, doubling time, pluripotency (alkaline phosphatase activity, and Oct-4 protein
expression), luciferase expression, and the capacity to form embryoid bodies (Fig. A-
6), all of which supported the maintenance of the pluripotent ESC phenotype. The
clones that exhibited the greatest dynamic range in luciferase activity in response
to LiCl treatment were selected for additional analyses (Fig. A-6 G). Importantly,
transduced ESCs formed and maintained EBs that were similar in size and appear-
ance to EBs formed from naive ESCs [282] at various rotary speeds (25, 40 and 55
rpm) and in static conditions (Fig. A-6 H), indicating the capacity to quantitatively
assess β-catenin transcriptional activity in response to ESC aggregation kinetics.
EBs cultured under all conditions exhibited transient β-catenin transcriptional
activity during the first 2-6 days of differentiation (Fig. A-7). After 2 days of EB dif-
ferentiation, static and 25 rpm EBs exhibited the highest levels of luciferase activity,
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Figure A-5: ESC transduction. ESCs were incubated with lentiviral particles
containing the luciferase TCF/LEF reporter construct for 24 hours at 3 (A), 10 (B),
and 25 (C) MOI. Selection with puromycin resulted in no transduced colonies from
3 MOI (D), but colonies from 10 MOI (E) and 25 MOI (F) remained after 1 week of
puromycin treatment (3 µg/mL). Scale bar = 250 µm
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Figure A-6: TCF/LEF activity and pluripotent phenotype of transduced
ESCs. Naive and transduced mESCs expressed alkaline phosphatase (A&D) and
Oct-4 (B&E); however, only transduced cells expressed luciferase (C&F). Transduced
cells expressed a higher baseline level of luciferase activity compared to naive cells
and also exhibited increased activity upon stimulation with LiCl (25 mM) (G). In
addition, transduced ESCs were capable of formation and differentiation as EBs in
rotary and static culture conditions (H). Scale bar = 50 µm. n=3, P ≤ 0.05: *
compared to naive +/- LiCl, † compared to -LiCl.
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compared to 40 and 55 rpm (p ≤ 0.05). By day 3, EBs from all rotary conditions ex-
hibited increased β-catenin transcriptional activity compared to static cultures (p ≤
0.001, 25 rpm; p ≤ 0.01, 40 rpm; p ≤ 0.05, 55 rpm), with the β-catenin transcription
in 25 rpm EBs statistically increased compared to the other two rotary conditions (p
≤ 0.05). Whereas EBs cultured in rotary orbital suspension increased transcription
activity between days 2 and 3 of differentiation, statically cultured EBs exhibited
decreased TCF/LEF activity over the same time course (Fig. A-7). Within 6 days
of differentiation, all cultures exhibited decreased β-catenin transcription, below the
initial levels at day 2, though static EBs maintained an increased level of TCF/LEF
activity compared to any of the rotary orbital culture conditions (p ≤ 0.001) (Fig. A-
7). Overall, the TCF/LEF transcriptional activity was most active within the first
3 days of EB differentiation and increasing the EB aggregation kinetics via rotary
orbital conditions (25 rpm) enhanced the peak β-catenin transcriptional activity be-
tween days 2-4 of differentiation, consistent with immunofluorescence and Western
blot, which together reflected increased β-catenin protein expression and nuclear lo-
calization.
A.3.6 Temporal dynamics of β-catenin-target gene expression
Since β-catenin expression, phosphorylation state, localization, and transcriptional
activity were modulated by ESC aggregation kinetics, the downstream expression
of β-catenin-target genes was examined. The expression patterns of canonical and
non-canonical Wnt genes (Wnt3a and Wnt11, respectively) exhibited similar tempo-
ral expression (Fig. A-8 A,B). After 2 days of differentiation, EBs from all culture
conditions expressed similar levels of both Wnt11 and Wnt3a; however, after 4 days
of differentiation, 25 rpm EBs significantly decreased Wnt11 expression compared to
static and 55 rpm (p ≤ 0.05, static; p ≤ 0.01, 55 rpm), accompanied by a decrease in
Wnt3a expression compared to 55 rpm (p ≤ 0.05). At day 6 of differentiation, 40 rpm
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Figure A-7: TCF/LEF activity in differentiating EBs. TCF/LEF-mediated
luciferase activity was transiently increased by rotary orbital culture compared to
static EBs, with a peak in expression after 3 days of differentiation; within rotary
conditions, EBs maintained at 25 rpm yielded the largest increase in luciferase activ-
ity. p ≤ 0.05, # = compared to all other conditions, * = compared to static, † =
compared to 40 rpm, and †† = compared to 55 rpm.
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EBs exhibited increased Wnt11 and Wnt3a expression levels compared to all other
conditions (p ≤ 0.05) (Fig. A-8 A,B). Interestingly, expression of Dkk-1, a canonical
Wnt inhibitor, increased in 25 rpm EBs at days 4 and 8 compared to static and 55
rpm EBs (p ≤ 0.05) (Fig. A-8 A,B,C). Moreover, Dkk-1 expression increased in all
rotary conditions compared to static culture at day 4 of differentiation (p ≤ 0.001,
25 rpm; p ≤ 0.01, 40 rpm; p ≤ 0.05, 55 rpm) (Fig. A-8 C).
Expression of Brachyury-T (B-T ), an early marker associated with primitive
streak formation and mesoderm differentiation, was increased significantly after 2
days of differentiation within 25 rpm EBs compared to all other culture conditions
(p ≤ 0.05), followed by increased expression at day 4 in all rotary conditions com-
pared to static culture (p ≤ 0.01). Mesoderm posterior 1 (Mesp-1 ), a direct target
of TCF/LEF regulated transcription [81], which is also implicated in early mesoderm
differentiation within ESCs [196], exhibited increased expression in 25 rpm conditions
at day 4 of differentiation compared to all other culture conditions (p ≤ 0.001).
Temporally controlled Wnt/β-catenin signaling has been implicated in the speci-
fication of mesoderm cells toward cardiac progenitors and subsequent cardiomyocyte
maturation [177, 195, 231]. Nkx2.5, an early marker of cardiomyocyte progenitors,
exhibited increased expression at early time points in all rotary orbital culture con-
ditions compared to static (Fig. A-8 G,H). After 6 days of differentiation, Nkx2.5
expression was greater in all rotary conditions compared to static culture (p ≤ 0.005,
25 rpm; p ≤ 0.001, 40 rpm; p ≤ 0.05, 55 rpm) and Nkx2.5 continued to exhibit
increased expression in 25 rpm EBs compared to all other culture conditions after 10
days of differentiation (p ≤ 0.005). Likewise, 25 rpm EBs expressed increased levels
of myocyte enhancer 2c (Mef-2c) after 10 days of differentiation compared to all other
conditions (p ≤ 0.005, static; p ≤ 0.01, 40 & 55 rpm).
Expression of sarcomeric muscle related genes α-myosin heavy chain (α-MHC )
and myosin light chain 2 ventricle (MLC-2v), phenotypic markers of more mature
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Figure A-8: Expression of β-catenin-target cardiomyogenic genes. qPCR
analysis of RNA from static and rotary EBs (25, 40, 55 rpm) was performed at day
2, 4, 6, 8, and 10 of differentiation. Expression levels of non-canonical and canonical
Wnts (A,B) was similar, but was modulated by culture condition, with 25 rpm rotary
conditions exhibiting decreased levels of both Wnt11 and Wnt3. In contrast, Wnt
inhibitor Dkk-1 expression was increased within rotary EBs compared to static EBs
(C), also corresponding to increased mesoderm-related gene expression within rotary
conditions compared to static (D,E). Additionally, early cardiomyogenic markers Mef-
2c and Nkx2.5 were increased by rotary orbital culture (F,G), with 25 rpm conditions
resulting in increased expression of sarcomeric muscle genes α-MHC and MLC-2v
(H,I). n=3, p ≤ 0.05, # = compared to all other conditions, * = compared to static,
** = compared to 25 rpm, † = compared to 40 rpm, and †† = compared to 55 rpm.
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cardiomyocytes, were observed by day 10 of differentiation within EBs maintained at
25 rpm (Fig. A-8 H,I). MLC-2v expression was significantly increased within 25 rpm
EBs compared to other culture conditions (p ≤ 0.05, static; p ≤ 0.01, 40 & 55 rpm) as
early as day 8 of differentiation compared to other culture conditions, and continued
to exhibit increased expression after 10 days of differentiation (p ≤ 0.005) (Fig. A-8
I). Together, the targets of the Wnt/β-catenin pathway (Mesp-1, Mef-2c) exhibited
increased expression at early stages of differentiation (day 4), followed by increased
expression of Wnt and β-catenin inhibitors (Dkk-1, Nkx2.5 ) and cardiomyogenic gene
transcription in response to accelerated aggregation kinetics within 25 rpm rotary
orbital cultures.
A.3.7 Regulation of cardiomyogenic gene transcription by Wnt/β-catenin
signaling
To establish a more mechanistic link between the observed regulation of β-catenin sig-
naling and cardiomyogenic gene transcription, 25 rpm EBs were supplemented with
inhibitors of canonical Wnt/β-catenin signaling (IWP-4; 5 µM) during the initial
4 days of differentiation (Fig. A-9 A). As expected, the pluripotency marker Oct-
4 was significantly decreased compared to ESCs and expression of genes related to
endoderm (Foxa2 ) and ectoderm (Nestin) lineages were significantly increased com-
pared to ESCs; however, Wnt inhibition did not significantly affect the expression
of genes related to pluripotency, endoderm, or ectoderm differentiation. In contrast,
inhibition of Wnt signaling significantly abrogated the previously observed increase
in cardiomyogenic genes α-MHC and MLC-2v, thus indicating the role of canonical
Wnt/β-catenin signaling in mediating the cardiomyogenic gene transcription down-
stream of intercellular aggregation at 25 rpm. The results of this study suggest that
the dynamic interplay between E-cadherin-mediated cellular adhesion and Wnt sig-
naling leads to nuclear accumulation and TCF/LEF transcriptional activation via
dephosphorylated, β-catenin (aβC), thereby inducing downstream cardiomyogenic
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gene expression (Fig. A-9 B).
A.4 Discussion
In this study, β-catenin expression, localization and transcriptional activity, as well
as cardiomyogenic gene transcription were assessed in response to changes in ESC ag-
gregation kinetics. Overall, rotary orbital culture increased β-catenin-regulated tran-
scription and cardiomyogenic gene expression compared to static culture conditions.
The spatiotemporal location and phosphorylation state of β-catenin was modulated
by rotary orbital speed, with slower rotary speeds (faster ESC aggregation kinetics)
resulting in increased accumulation of nuclear, dephosphorylated β-catenin at early
time points (Fig. A-3 and Fig. A-4). Additionally, gene transcription downstream
of β-catenin was increased initially by slower rotary speeds, evidenced by increased
TCF/LEF activity and the expression of Mesp-1 and Mef-2c (Fig. A-8). Moreover,
inhibition of Wnt signaling significantly decreased cardiomyogenic gene transcrip-
tion. Overall, this study illustrates that β-catenin signaling and downstream car-
diomyogenic gene transcription are enhanced within culture conditions that promote
increased multicellular aggregation kinetics.
Recent studies have illustrated that activation of the β-catenin pathway can play
both inductive and repressive roles in cardiomyogenesis, depending on the tempo-
ral onset and duration of transcriptional activity [231, 194, 334]. Early activation
of β-catenin within differentiating ESCs has been linked to increased mesoderm dif-
ferentiation and proliferation of Mesp-1+, Isl-1+, and Mef-2c+ cardiomyocyte pro-
genitor cells [196, 231, 251, 334, 178, 268]. However, persistent β-catenin signaling
(i.e. beyond day 4 of differentiation) inhibits subsequent cardiomyocyte maturation
[231, 334]; conversely, inhibition of β-catenin signaling through natural (eg. Dkk-1)
or small molecule Wnt inhibitors at later stages of differentiation (day 4+) increases
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Figure A-9: Influence of canonical Wnt/β-catenin signaling in aggregation-
mediated cardiogenic gene transcription. Expression of genes related to pluripo-
tency (Oct-4 ), endoderm (Foxa2 ), and ectoderm (Nestin) phenotypes were not al-
tered by inhibition of Wnt signaling via treatment with IWP-4 during the first 4 days
of differentiation at 25 rpm; however, cardiomyogenic markers α-MHC and MLC-2v
were significantly decreased upon Wnt inhibition (A). The proposed model depict-
ing Wnt/β-catenin-mediated increase in cardiomyogenic gene transcription resulting
from intercellular adhesion of ESCs (B). n=3, * = p ≤ 0.05
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mature cardiomyocyte development within EBs [272, 344, 352, 194]. A similar bipha-
sic regulation of β-catenin activity and inhibitor expression was observed in this study
in response to accelerated cellular adhesion kinetics. Nuclear total β-catenin expres-
sion was modulated by ESC aggregation kinetics (Fig 4 B), with increased expression
of signaling active β-catenin within 25 rpm rotary conditions at early time points
of differentiation (days 2 and 4, Fig. A-3), significantly increased TCF/LEF acti-
vation at day 3 of differentiation (Fig. A-4 C), and increased Mesp-1 and Mef-2c
expression (day 4) compared to other conditions (Fig. A-8). Subsequently, expression
of β-catenin signaling inhibitors Dkk-1 and Nkx2.5 [274] was also increased within
the same rotary orbital condition, concomitant with decreased Wnt expression levels
(days 4-6). The increase in Dkk-1 expression may be related to increased Mesp-1 ex-
pression within 25 rpm rotary conditions, as Mesp-1 is a transcription factor capable
of directly increasing Dkk-1 expression [81]. Thus, the expression of Mesp-1, Dkk-1,
and Nkx2.5 at later stages of differentiation supports the maturation of cardiomy-
ocyte progenitors, as evidenced by increased expression of MLC-2v in 25 rpm rotary
conditions (Fig. A-8 I). Consistent with our previous results [282, 283], rotary orbital
culture promoted cardiomyogenic gene transcription in a speed-dependent manner,
and the results from this study suggest that β-catenin signaling may be implicated
in the regulation of mesoderm differentiation and maturation of cardiomyocyte pro-
genitors (Fig. A-9) in response to changes in early ESC aggregation kinetics.
Until recently, the membrane associated and nuclear signaling roles of β-catenin
have been largely studied independently; however, increasing evidence suggests that
the two processes may be intimately coordinated through competition for the total
pool of available β-catenin in the cell [238, 151]. Studies using recombinant forms
of β-catenin indicate that the binding domains of β-catenin which mediate interac-
tions with cadherins, TCF/LEF and APC are mutually exclusive [249]. The loss of
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E-cadherin expression is correlated with invasive phenotypes during cancer progres-
sion and is exhibited concomitant with upregulation of the Wnt/β-catenin signaling,
suggesting the possible interplay between E-cadherin expression and β-catenin tran-
scriptional activation [121, 115, 252, 148, 233, 120]. In the undifferentiated state,
ESCs largely express β-catenin at the plasma membrane, presumably bound to E-
cadherin, with little nuclear localization and signaling (Fig. A-1) [10]. Moreover, the
culture of ESCs in a three-dimensional microwell format increased E-cadherin ex-
pression and subsequently increased Wnt signaling upon EB formation, suggesting a
link between intercellular adhesions, Wnt signaling, and cardiogenesis in ESCs [14].
Similarly, in this study, E-cadherin was dynamically regulated, including significant
correlations between E-cadherin (Fig. A-2) and β-catenin (Fig. A-3) expression over
time (Table 6), concurrent with increased TCF/LEF transcriptional activity (Fig. A-
7). The regulation of intercellular adhesions in EBs is consistent with changes during
embryonic development, whereby E-cadherin is down-regulated as cells traverse the
primitive streak and β-catenin signaling is increased to promote axis formation and
mesoderm differentiation [43, 44, 64, 128, 129, 18]. It is likely that similar interrelated
signaling between cadherins and β-catenin may enable the pool of cadherin-bound
β-catenin to become available for nuclear translocation and signaling upon remodel-
ing of cadherins following EB formation. Although the direct relationship between
cadherin and TCF/LEF mediated regulation of the β-catenin pool remains unclear
[36, 207, 151], evidence from this study suggests a correlation between E-cadherin
and β-catenin signaling during EB formation and ESC differentiation.
Rotary orbital suspension culture has previously demonstrated the modulation of
EB formation kinetics across a range of mixing conditions, with slower speeds resulting
in increased EB formation kinetics [52, 282]. The changes in β-catenin transcriptional
activity as a function of rotary speed, in conjunction with changes in E-cadherin ex-
pression, indicate that cell association kinetics during EB formation can impact the
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subsequent pathway activation and ESC differentiation. β-catenin transcriptional ac-
tivity was significantly increased at early stages of differentiation in EBs that exhibit
faster cell association kinetics during EB formation at slower rotary speeds. Studies
indicate that mixed culture conditions also modulate EB size, which may be partially
responsible for changes in ESC differentiation [282]. Mesoderm induction in different
sized EBs, however, is thought to result from paracrine actions of endoderm cells at
the exterior of EBs [22], which do not arise until later stages of differentiation. In the
context of this study, the initial cell specification resulting from changes in β-catenin
signaling at early time points (days 2-4) is likely independent of signaling from di-
vergent cell populations. The observed changes in cell aggregation kinetics due to
rotary orbital suspension culture conditions may also be modulated across a range of
suspension culture formats [166]; β-catenin transcriptional activity may be implicated
in the modulation of cardiogenic differentiation as a function of bioreactor configu-
ration, mixing speed, and cell density [146, 298]. Hanging drop cultures exhibit an
increased endogenous propensity to differentiate toward mesoderm lineages and de-
velop functional cardiomyocytes compared to other formats [283, 366]. In contrast to
suspension cultures, which rely on the random collision of cells in larger volume sus-
pensions to form EBs, hanging drop cultures force ESC aggregation in small volumes
to more precisely control EB size, which likely results in faster association kinetics
compared to suspension cultures. The increased cardiac differentiation yielded by
hanging drops, therefore, is consistent with the observed increase in cardiomyogenic
gene transcription in response to slower rotary speed and faster aggregation kinetics.
Many recently developed technologies for spheroid formation may also alter the for-
mation kinetics, by controlling aggregation within microwells or on micropatterned
surfaces [219, 335, 253]; EBs formed via forced aggregation exhibited increased ho-
mogeneity and endogenous differentiation capacities across a similar range of rotary
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conditions examined in this study (Chapter 3). Thus, techniques to control intercellu-
lar adhesion dynamics may impact the differentiation capacity of stem and progenitor
cells to either aid or hinder directed differentiation protocols, depending on the ap-
plication. The results from this study, coupled with the developing understanding
of the complex relationship between E-cadherin and β-catenin, highlight the impor-
tant roles of β-catenin signaling in ESCs, which may be modulated by increasing cell
association kinetics during EB formation to enhance cardiomyogenic differentiation.
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[10] Anton, R., Kestler, H. A., and Kühl, M., “Beta-catenin signaling con-
tributes to stemness and regulates early differentiation in murine embryonic
stem cells,” FEBS Lett, vol. 581, pp. 5247–5254, Nov. 2007.
182
[11] Antonica, F., Kasprzyk, D. F., Opitz, R., Iacovino, M., Liao, X.-H.,
Dumitrescu, A. M., Refetoff, S., Peremans, K., Manto, M., Kyba,
M., and Costagliola, S., “Generation of functional thyroid from embryonic
stem cells.,” Nature, vol. 491, pp. 66–71, Nov. 2012.
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[48] Campàs, O., Mammoto, T., Hasso, S., Sperling, R. A., O’Connell,
D., Bischof, A. G., Maas, R., Weitz, D. A., Mahadevan, L., and In-
gber, D. E., “Quantifying cell-generated mechanical forces within living em-
bryonic tissues.,” Nat Methods, Dec. 2013.
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